
<html lang="en"     class="pb-page"  data-request-id="a4718e4b-21db-4ea5-857c-339c2085d232"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm200128m;issue:issue:10.1021/jmcmar.2011.54.issue-9;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Optimization of Potent, Selective, and Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors of Heat Shock Protein 90. Identification of Development Candidate 2-Amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide" /></meta><meta name="dc.Creator" content="Luke  Zehnder" /></meta><meta name="dc.Creator" content="Michael  Bennett" /></meta><meta name="dc.Creator" content="Jerry  Meng" /></meta><meta name="dc.Creator" content="Buwen  Huang" /></meta><meta name="dc.Creator" content="Sacha  Ninkovic" /></meta><meta name="dc.Creator" content="Fen  Wang" /></meta><meta name="dc.Creator" content="John  Braganza" /></meta><meta name="dc.Creator" content="John  Tatlock" /></meta><meta name="dc.Creator" content="Tanya  Jewell" /></meta><meta name="dc.Creator" content="Joe Zhongxiang  Zhou" /></meta><meta name="dc.Creator" content="Ben  Burke" /></meta><meta name="dc.Creator" content="Jeff  Wang" /></meta><meta name="dc.Creator" content="Karen  Maegley" /></meta><meta name="dc.Creator" content="Pramod P.  Mehta" /></meta><meta name="dc.Creator" content="Min-Jean  Yin" /></meta><meta name="dc.Creator" content="Ketan S.  Gajiwala" /></meta><meta name="dc.Creator" content="Michael J.  Hickey" /></meta><meta name="dc.Creator" content="Shinji  Yamazaki" /></meta><meta name="dc.Creator" content="Evan  Smith" /></meta><meta name="dc.Creator" content="Ping  Kang" /></meta><meta name="dc.Creator" content="Anand  Sistla" /></meta><meta name="dc.Creator" content="Elena  Dovalsantos" /></meta><meta name="dc.Creator" content="Michael R.  Gehring" /></meta><meta name="dc.Creator" content="Robert  Kania" /></meta><meta name="dc.Creator" content="Martin  Wythes" /></meta><meta name="dc.Creator" content="Pei-Pei  Kung" /></meta><meta name="dc.Description" content="A novel class of heat shock protein 90 (Hsp90) inhibitors was discovered by high-throughput screening and was subsequently optimized using a combination of structure-based design, parallel synthesi..." /></meta><meta name="Description" content="A novel class of heat shock protein 90 (Hsp90) inhibitors was discovered by high-throughput screening and was subsequently optimized using a combination of structure-based design, parallel synthesi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 20, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm200128m" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm200128m" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm200128m" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm200128m" /></link>
        
    
    

<title>Optimization of Potent, Selective, and Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors of Heat Shock Protein 90. Identification of Development Candidate 2-Amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm200128m" /></meta><meta property="og:title" content="Optimization of Potent, Selective, and Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors of Heat Shock Protein 90. Identification of Development Candidate 2-Amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0009.jpeg" /></meta><meta property="og:description" content="A novel class of heat shock protein 90 (Hsp90) inhibitors was discovered by high-throughput screening and was subsequently optimized using a combination of structure-based design, parallel synthesis, and the application of medicinal chemistry principles. Through this process, the biochemical and cell-based potency of the original HTS lead were substantially improved along with the corresponding metabolic stability properties. These efforts culminated with the identification of a development candidate (compound 42) which displayed desired PK/PD relationships, significant efficacy in a melanoma A2058 xenograft tumor model, and attractive DMPK profiles." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm200128m"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm200128m">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm200128m&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm200128m&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm200128m&amp;href=/doi/10.1021/jm200128m" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 3368-3385</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm2001162" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm200180f" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Optimization of Potent, Selective, and Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors of Heat Shock Protein 90. Identification of Development Candidate 2-Amino-4-{4-chloro-2-[2-(4-fluoro-1<i>H</i>-pyrazol-1-yl)ethoxy]-6-methylphenyl}-<i>N</i>-(2,2-difluoropropyl)-5,7-dihydro-6<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxamide</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luke++Zehnder">Luke Zehnder</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Bennett">Michael Bennett</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jerry++Meng">Jerry Meng</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Buwen++Huang">Buwen Huang</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sacha++Ninkovic">Sacha Ninkovic</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fen++Wang">Fen Wang</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Braganza">John Braganza</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Tatlock">John Tatlock</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tanya++Jewell">Tanya Jewell</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joe+Zhongxiang++Zhou">Joe Zhongxiang Zhou</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ben++Burke">Ben Burke</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeff++Wang">Jeff Wang</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karen++Maegley">Karen Maegley</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pramod+P.++Mehta">Pramod P. Mehta</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Min-Jean++Yin">Min-Jean Yin</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ketan+S.++Gajiwala">Ketan S. Gajiwala</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+J.++Hickey">Michael J. Hickey</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shinji++Yamazaki">Shinji Yamazaki</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Evan++Smith">Evan Smith</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ping++Kang">Ping Kang</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anand++Sistla">Anand Sistla</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elena++Dovalsantos">Elena Dovalsantos</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+R.++Gehring">Michael R. Gehring</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Kania">Robert Kania</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Wythes">Martin Wythes</a></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pei-Pei++Kung">Pei-Pei Kung</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div><div class="corresp-info"><strong>*</strong>Phone: 858-526-4867. Fax: (877) 481-1781. E-mail: <a href="/cdn-cgi/l/email-protection#0777626e77626e296c7269604777616e7d62752964686a"><span class="__cf_email__" data-cfemail="0e7e6b677e6b6720657b60694e7e6867746b7c206d6163">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm200128m&amp;href=/doi/10.1021%2Fjm200128m" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 3368â3385</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 25, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 February 2011</li><li><span class="item_label"><b>Published</b> online</span>20 April 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 May 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm200128m" title="DOI URL">https://doi.org/10.1021/jm200128m</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3368%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLuke%2BZehnder%252C%2BMichael%2BBennett%252C%2BJerry%2BMeng%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D9%26contentID%3Djm200128m%26title%3DOptimization%2Bof%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BBioavailable%2BPyrrolodinopyrimidine-Containing%2BInhibitors%2Bof%2BHeat%2BShock%2BProtein%2B90.%2BIdentification%2Bof%2BDevelopment%2BCandidate%2B2-Amino-4-%257B4-chloro-2-%255B2-%25284-fluoro-1H-pyrazol-1-yl%2529ethoxy%255D-6-methylphenyl%257D-N-%25282%252C2-difluoropropyl%2529-5%252C7-dihydro-6H-pyrrolo%255B3%252C4-d%255Dpyrimidine-6-carboxamide%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3385%26publicationDate%3DMay%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm200128m"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4487</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">27</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm200128m" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Optimization of Potent, Selective, and Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors of Heat Shock Protein 90. Identification of Development Candidate 2-Amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxamide&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Luke&quot;,&quot;last_name&quot;:&quot;Zehnder&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Bennett&quot;},{&quot;first_name&quot;:&quot;Jerry&quot;,&quot;last_name&quot;:&quot;Meng&quot;},{&quot;first_name&quot;:&quot;Buwen&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Sacha&quot;,&quot;last_name&quot;:&quot;Ninkovic&quot;},{&quot;first_name&quot;:&quot;Fen&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Braganza&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Tatlock&quot;},{&quot;first_name&quot;:&quot;Tanya&quot;,&quot;last_name&quot;:&quot;Jewell&quot;},{&quot;first_name&quot;:&quot;Joe&quot;,&quot;last_name&quot;:&quot;Zhongxiang Zhou&quot;},{&quot;first_name&quot;:&quot;Ben&quot;,&quot;last_name&quot;:&quot;Burke&quot;},{&quot;first_name&quot;:&quot;Jeff&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;Maegley&quot;},{&quot;first_name&quot;:&quot;Pramod&quot;,&quot;last_name&quot;:&quot;P. Mehta&quot;},{&quot;first_name&quot;:&quot;Min-Jean&quot;,&quot;last_name&quot;:&quot;Yin&quot;},{&quot;first_name&quot;:&quot;Ketan&quot;,&quot;last_name&quot;:&quot;S. Gajiwala&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;J. Hickey&quot;},{&quot;first_name&quot;:&quot;Shinji&quot;,&quot;last_name&quot;:&quot;Yamazaki&quot;},{&quot;first_name&quot;:&quot;Evan&quot;,&quot;last_name&quot;:&quot;Smith&quot;},{&quot;first_name&quot;:&quot;Ping&quot;,&quot;last_name&quot;:&quot;Kang&quot;},{&quot;first_name&quot;:&quot;Anand&quot;,&quot;last_name&quot;:&quot;Sistla&quot;},{&quot;first_name&quot;:&quot;Elena&quot;,&quot;last_name&quot;:&quot;Dovalsantos&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;R. Gehring&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Kania&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Wythes&quot;},{&quot;first_name&quot;:&quot;Pei-Pei&quot;,&quot;last_name&quot;:&quot;Kung&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;3368-3385&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm200128m&quot;},&quot;abstract&quot;:&quot;A novel class of heat shock protein 90 (Hsp90) inhibitors was discovered by high-throughput screening and was subsequently optimized using a combination of structure-based design, parallel synthesis, and the application of medicinal chemistry principles. Through this process, the biochemical and cell-based potency of the original HTS lead were substantially improved along with the corresponding metabolic stability properties. These efforts culminated with the identification of a development candidate (compound 42) which displayed desired PK/PD relationships, significant efficacy in a melanoma A2058 xenograft tumor model, and attractive DMPK profiles.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200128m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200128m" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200128m&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200128m" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200128m&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200128m" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm200128m&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200128m&amp;href=/doi/10.1021/jm200128m" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm200128m" /></input><a href="/doi/pdf/10.1021/jm200128m" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm200128m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm200128m%26sid%3Dliteratum%253Aachs%26pmid%3D21438541%26genre%3Darticle%26aulast%3DZehnder%26date%3D2011%26atitle%3DOptimization%2Bof%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BBioavailable%2BPyrrolodinopyrimidine-Containing%2BInhibitors%2Bof%2BHeat%2BShock%2BProtein%2B90.%2BIdentification%2Bof%2BDevelopment%2BCandidate%2B2-Amino-4-%257B4-chloro-2-%255B2-%25284-fluoro-1H-pyrazol-1-yl%2529ethoxy%255D-6-methylphenyl%257D-N-%25282%252C2-difluoropropyl%2529-5%252C7-dihydro-6H-pyrrolo%255B3%252C4-d%255Dpyrimidine-6-carboxamide%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D9%26spage%3D3368%26epage%3D3385%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jmcmar.2011.54.issue-9/production/jmcmar.2011.54.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A novel class of heat shock protein 90 (Hsp90) inhibitors was discovered by high-throughput screening and was subsequently optimized using a combination of structure-based design, parallel synthesis, and the application of medicinal chemistry principles. Through this process, the biochemical and cell-based potency of the original HTS lead were substantially improved along with the corresponding metabolic stability properties. These efforts culminated with the identification of a development candidate (compound <b>42</b>) which displayed desired PK/PD relationships, significant efficacy in a melanoma A2058 xenograft tumor model, and attractive DMPK profiles.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00331" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00331" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Molecular chaperones are attractive targets for cancer therapy because of their roles in regulating many proteins involved in signaling pathways and cell proliferation. One such molecular chaperone, heat shock protein 90 (Hsp90), was identified in 1987 as one of the most abundant intracellular proteins.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Hsp90 functions to promote the maturation and conformational stabilization of its client proteins which include many kinases (Her2, Akt, Raf, and Cdk 4), receptors (androgen and estrogen receptors), and transcription factors (Hif1Î±).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> As many of these client proteins have been implicated as key regulators of oncogenic signaling and/or cell proliferation,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> inhibition of Hsp90 chaperone activity represents a novel approach for the identification of new cancer therapies.</div><div class="NLM_p">Hsp90 is an ATPase and undergoes large conformational changes during the course of its ATP cycle and upon binding certain Hsp90 cochaperones.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The N-terminal domain of the protein contains an adenine triphosphate (ATP) binding site, and most of the Hsp90 inhibitors identified to date associate with this ATP binding pocket. The shape of the Hsp90 ATP binding pocket is unique<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> compared to other ATPase and kinases, and the isolated ATP-binding domain has low intrinsic ATPase activity.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The natural product geldanamycin (GA, <b>1a</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) was first identified as an Hsp90 inhibitor in 1994.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Its semisynthetic analogues 17-allylamino-17-demethoxygeldanamycin (17-AAG, <b>1b</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) and 17-dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG, <b>1c</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) have been developed as less toxic analogues.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> 17-AAG was the first Hsp90 inhibitor to enter clinical trials, and although antitumor activity was observed in early assessments of the compound, the poor solubility and limited oral bioavailability of this agent may limit its future utility.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> A prodrug of 17-AAG (IPI-504) has been identified that improves the pharmaceutical features of 17-AAG and is currently reported to be in phase II/III clinical trials.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">In the past several years, significant progress has been made in identifying non-quinone-containing small molecule Hsp90 inhibitors (recently reviewed by Janin<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a>), and several such compounds are currently undergoing clinical trials as intravenously or orally administered agents. The latter compounds, orally bioavailable molecules reported in the literature, include CNF2024,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> SNX5422,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and NVP-BEP800<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> (<b>2</b>, <b>3</b>, <b>4</b>, respectively, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). In spite of these advances, there remains a need for the identification of new small molecule Hsp90 inhibitors with improved potency, pharmacokinetic properties, and safety profiles relative to existing anti-Hsp90 agents. In this report, we describe our medicinal chemistry efforts that afforded a novel class of Hsp90 inhibitors that exhibit potent efficacy in animal tumor models along with other desirable pharmaceutical properties.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Geldanamycin and its semisynthetic derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0012.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of known orally bioavailable Hsp90 non-benzoquinone inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Result and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60285" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60285" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our Hsp90 research program began with a high throughput screening campaign using a competition binding assay in which the ability of test compounds to displace a tritium-labeled resorcinol amide related to compound <b>5</b> (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) from Hsp90 was assessed. This effort led to the discovery of the 4-methyl-2-aminopyrimidine-containing inhibitor <b>6</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) which displayed a <i>K</i><sub>i</sub> of 1.2 Î¼M in the binding assay and an IC<sub>50</sub> of greater than 50 Î¼M in a cell-based assay which examined the degradation of the Hsp90 client protein Akt.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The calculated ligand efficiency<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (LE = 0.53) and ligand lipophilicity efficiency<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (LipE = 4.25) for <b>6</b> using its <i>K</i><sub>i</sub> were both considered acceptable for initiating further structureâactivity optimization efforts. However, we were concerned that the chlorine atom contained in <b>6</b> might be biologically reactive and/or unstable,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and we therefore replaced this substituent with a methyl group. Although the resulting compound (<b>7</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, LipE = 3.34) displayed somewhat reduced Hsp90 inhibitory activity and LipE relative to <b>6</b>, it was considered to be a better starting point for SAR development and property optimization because of its lack of obvious structural liabilities.</div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0013.gif" alt="" id="fx1" /></img><div class="NLM_p">To facilitate potency improvements we obtained a 1.7 Ã cocrystal structure of compound <b>6</b> bound to Hsp90 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3R4M">3R4M</a>) and compared it to the corresponding cocrystal structure of a potent resorcinol amide Hsp90 inhibitor (compound <b>5</b>, <i>K</i><sub>i</sub> = 13 nM).<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> This analysis (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) suggested that addition of an <i>o</i>-chlorine atom to the phenyl ring of <b>6</b> or <b>7</b> (vide infra) would duplicate key space-filling interactions with the Hsp90 protein made by the chlorine present in resorcinol <b>5</b>. Encouragingly, introduction of such an <i>o</i>-chloro moiety into the 2-aminopyrimidine scaffold afforded a molecule that displayed 10-fold improved Hsp90 inhibition relative to the unsubstituted compound (compare <b>8</b> with <b>7</b>; Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). However, the new inhibitor <b>8</b> did not exhibit measurable activity in the cell-based assay, indicating the need for further potency and/or property improvements.</div><div class="NLM_p">Examination of the cocrystal structure of <b>6</b> with Hsp90 protein suggested that the methoxy moiety present in <b>6</b> made beneficial space-filling interactions with the protein. Not surprisingly, replacement of the methoxy group present in inhibitor <b>8</b> with a phenol resulted in a slight loss of anti-Hsp90 activity in the biochemical assay (compound <b>9</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Seeking to recover and improve Hsp90 inhibition activity, we rapidly explored diverse substitution of the phenolic oxygen present in <b>9</b> using parallel synthesis methods (â¼100 compounds prepared). One compound identified by this parallel synthesis effort (<b>10</b>) displayed significantly improved Hsp90 enzyme inhibitory potency relative to both phenol <b>9</b> and the methoxy-containing inhibitor <b>8</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Importantly, compound <b>10</b> also exhibited measurable anti-Hsp90 activity in the cell-based assay (IC<sub>50</sub> = 7.3 Î¼M). Encouraged by this result, we focused our optimization efforts on further improving the biochemical and cell-based Hsp90 inhibition properties of compound <b>10</b>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0014.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overlap of bound conformations of <b>6</b> and <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR around the Phenyl Moiety of Compound 7</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0015.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0016.gif" alt="" id="_i4" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Enzymatic <i>K</i><sub>i</sub> was calculated from enzymatic IC<sub>50</sub> using the ChengâPrusoff equation. Assay error is 10â15%.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Assay error is 10â15%.</p></div></div></div><div class="NLM_p">Accordingly, we obtained a 2.0 Ã cocrystal structure of <b>10</b> bound to Hsp90 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3R4N">3R4N</a>) and observed that the trifluorobutyl group occupied the same hydrophobic pocket (formed by Lys58, ILE96, and Ala55) that was filled by the isoindoline moiety of resorcinol amide <b>5</b> (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). This cocrystal structure also revealed a vacant hydrophobic pocket surrounding the para-position of the phenyl moiety present in <b>10</b> and suggested that addition of a lipophilic substituent to this portion of the inhibitor might improve Hsp90 binding affinity. The dichloro-containing molecule <b>11</b> was therefore prepared, and it exhibited more potent anti-Hsp 90 activity relative to <b>10</b> in both the biochemical and cell-based assays (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). This improvement, however, came at the expense of ligand lipophilicity efficiency relative to lead compound <b>7</b> (LipE = 3.13 vs 3.34). Unfortunately, compound <b>11</b> also displayed moderate activity in a high-throughput ligand displacement assay designed to assess its potential to block human ether-a-go-go-related gene (hERG) ion channel function (dofetilide displacement;<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a><i>K</i><sub>i</sub> = 11.6 Î¼M). The ratio of hERG IC<sub>50</sub> values relative to the compound's cell potency was calculated to better define the separation between desired anti-Hsp90 activity and unwanted off-target effects (âtherapeutic indexâ, TI). To increase the window between desired anti-Hsp90 cellular activity and the undesired hERG affinity from <b>6</b> (TI = 6), we focused our research efforts on further improving the inhibitory potency of the 2-aminopyrimidine-containing compounds.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0018.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structure of <b>10</b> bound to the Hsp90 enzyme.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Toward this end, we incorporated a pyrrolourea moiety into our inhibitor scaffold that was anticipated to form beneficial hydrogen bonds with the side chain of Asn106 and backbone amide carbonyl of Gly97 (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Similar interactions with Gly97 have also been noted by others to be important for obtaining Hsp90 inhibitory potency,<a onclick="showRef(event, 'ref21 ref25'); return false;" href="javascript:void(0);" class="ref ref21 ref25">(21, 25)</a> and analysis/modeling performed with the Hsp90-<b>10</b> cocrystal structure suggested the pyrrolourea as a good moiety to form these desired proteinâligand contacts. The resulting compound (<b>12</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) exhibited somewhat improved biochemical and cell-based Hsp90 inhibition properties relative to <b>11</b> along with more attractive ligand lipophilicity efficiency (LipE = 4.47 vs 3.13). The additional hydrogen bonds anticipated to be formed between the new inhibitor scaffold and the Hsp90 protein were confirmed by subsequently obtaining a cocrystal structure of a related inhibitor (<b>16</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3R4O">3R4O</a>). Importantly, the new design also provided a vector off the urea moiety that could be utilized to explore additional space-filling interactions with the enzyme in order to further improve potency.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0017.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Design of pyrrolodinopyrimidine Hsp90 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0019.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Crystal structure of <b>16</b> bound to the Hsp90 enzyme. The urea moiety of <b>16</b> forms additional hydrogen-bond interactions with Asn106 and Gly97 of Hsp90 protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Four additional compounds (<b>13</b>â<b>16</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) using commercially available amines were then synthesized to develop the SAR associated with varying the urea substituent present in <b>12</b>. This effort identified several molecules that exhibited biochemical Hsp90-binding activity similar to that displayed by <b>12</b> (inhibitors <b>12</b>â<b>16</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Compound <b>1c</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) was also evaluated in the same biochemical and cellular assays as a comparison (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, entry 1). One of these compounds (<b>16</b>, LipE = 4.55) also exhibited significantly improved anti-Hsp90 cell-based activity relative to the other inhibitors, albeit at the expense of in vitro human liver microsomal (HLM) stability. Although the exact reason for the cell-based improvement was not known with certainty, we nevertheless focused our efforts on preparing additional cyclobutylurea-containing inhibitors with the goal of further improving both cell-based activity and microsomal stability.</div><div class="NLM_table-wrap" id="tbl2">Table 2<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0020.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0021.gif" alt="" id="fx6" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Enzymatic <i>K</i><sub>i</sub> was calculated from enzymatic IC<sub>50</sub> using the ChengâPrusoff equation. Assay error is 10â15%.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Assay error is 10â15%.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">CLint is intrinsic clearance.</p></div></div></div><div class="NLM_p">Accordingly, we combined the cyclobutylurea moiety with multiple phenol substituents that varied in size, shape, and polarity (<b>17</b>â<b>26</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Some of these combinations afforded inhibitors with comparable or improved microsomal stability relative to <b>16</b>, but only one (<b>26</b>) also exhibited similarly potent cell-based activity. Since the pyrazole-containing inhibitor <b>26</b> was considerably less lipophilic than <b>16</b> (clogP = 2.6 vs 3.6, respectively; LipE = 5.62 vs 4.55, respectively), we viewed the former molecule as an attractive starting point for continued optimization. Many additional pyrazole-containing compounds where then synthesized in which the urea substituent was again altered (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). A multidimensional approach was employed to in vitro metabolic stability in which some of the new designs further lowered compound lipophilicity relative to <b>26</b> (<b>27</b>â<b>30</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) while others incorporated functional groups (e.g., F atoms) expected to block potential sites of oxidation of the cyclobutyl urea moiety in the molecules (<b>31</b> and <b>32</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). A few hybrid designs were also prepared that incorporated elements of both of these strategies (<b>33</b>â<b>35</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_table-wrap" id="tbl3">Table 3<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0022.gif" alt="" id="fx7" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0023.gif" alt="" id="fx8" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Enzymatic <i>K</i><sub>i</sub> was calculated from enzymatic IC<sub>50</sub> using the ChengâPrusoff equation. Assay error is 10â15%.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Assay error is 10â15%.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">CL<sub>int</sub> is intrinsic clearance.</p></div></div></div><div class="NLM_table-wrap" id="tbl4">Table 4<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0024.gif" alt="" id="fx9" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0025.gif" alt="" id="fx10" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Enzymatic <i>K</i><sub>i</sub> was calculated from enzymatic IC<sub>50</sub> using the ChengâPrusoff equation. Assay error is 10â15%.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Assay error is 10â15%.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">CL<sub>int</sub> is intrinsic clearance.</p></div></div></div><div class="NLM_p">Encouragingly, many of these pyrazole-containing combinations exhibited significantly better stability in the in vitro microsomal assay relative to <b>26</b> and also displayed comparable or improved anti<b>-</b>Hsp90 cell-based activity (<b>30</b>â<b>35</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). These molecules also maintained the high ligand lipophilicity efficiency exhibited by other pyrazole-containing inhibitors (LipE = 5.62â6.09). To help differentiate these new molecules, we profiled them in assays designed to assess their in vitro permeability as well as their potential to form reactive metabolites upon metabolic activation. Incubation of compound <b>33</b> with human liver microsomes in the presence of glutathione (GSH) led to significant formation of GSH adducts (data not shown). This result suggested the significant formation of metabolism-derived reactive metabolites from <b>33</b>, and additional characterization of the compound was therefore deprioritized in favor of the other inhibitors (all of which exhibited this behavior to a much lower extent; data not shown). In addition, the low Caco-2 apical to basolateral (AB)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> value measured for inhibitor <b>30</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) suggested a poor potential to exhibit acceptable absorption following oral administration, and this molecule was similarly deprioritized.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0026.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Crystal structure of <b>35</b> bound to the Hsp90 enzyme. The pyrazole moiety occupied the same space as the trifluoromethyl moiety present in compound <b>17</b> as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The remaining inhibitors were profiled in assays designed to assess their ability to inhibit the cytochrome P450 3A4 (CYP3A4) enzyme as well as their potential to block hERG (IKr)<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> function. In each case, the ratio of CYP3A4 and hERG IC<sub>50</sub> values relative to the compound's cell potency was calculated to better define the separation between desired anti-Hsp90 activity and unwanted off-target effects (TI). The binding of the compounds to human plasma proteins was also determined so that the impact of such association could be reflected in the in vitro metabolic stability assessments (i.e., determine unbound HLM clearance values). As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, the CYP3A4 inhibition noted for compounds <b>32</b>, <b>34</b>, and <b>35</b> exhibited was >10-fold weaker than the corresponding cell IC<sub>50</sub> values. An even larger TI (>100) was noted when comparing the compounds' IKr and cell assay activities. To improve the potential for clinical success, we sought to increase the TI values for the series against both CYP3A4 and IKr by further improving cellular potency without compromising other desirable pharmaceutical properties.</div><div class="NLM_p">To assist with this activity, the cocrystal structure of <b>35</b> in complex with the Hsp90 enzyme was obtained (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3R4P">3R4P</a>). Analysis of this cocrystal structure identified a small hydrophobic pocket surrounding the pyrazole moieties of the inhibitor. In an attempt to fill this pocket, a methyl or chloride atom was introduced at the C3-position of the pyrazole to increase hydrophobic interactions between the compounds and the Hsp90 enzyme. Unfortunately, the resulting 3-methylpyrazole (<b>36</b>) lost cellular potency relative to the unsubstituted inhibitor (<b>32</b>). In contrast, the 3-chloropyrazole-containing compound (<b>37</b>) displayed cellular potency equivalent to that of <b>32</b> but, likely due to a clogP increase of 0.8 units, also displayed increased HLM clearance. In an attempt to minimize increases in compound lipophilicity while simultaneously filling the small Hsp90 hydrophobic pocket, a fluorine atom was introduced at the 3-position of the pyrazole moiety present in compounds <b>32</b>, <b>34</b>, and <b>35</b>. Encouragingly, the resulting new molecules exhibited improved cellular potency relative to the original compounds (<b>38</b> with <b>32</b>, <b>39</b> with <b>34</b>, and <b>41</b> with <b>35</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Unfortunately, inhibitor <b>38</b> exhibited higher metabolic clearance properties relative to <b>32</b> after correcting for protein binding effects.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In addition, compounds <b>39</b> and <b>41</b> displayed greater CYP3A4 and IKr inhibition relative to <b>34</b> and <b>35</b>, resulting in nearly identical TI values for the four compounds. We speculated that the higher lipophilicity of <b>39</b> and <b>41</b> was responsible for their increased CYP3A4 inhibition and subsequently explored reducing such lipophilicity by replacing the <i>o</i>-chloro atom in each molecule with a methyl group. The two 6-methylphenyl-containing compounds (<b>40</b> and <b>42</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) maintained good anti-Hsp90 cell-based activity, exhibited good in vitro stability toward human liver microsomes, and displayed increased CYP3A4 and IKr TI values relative to the 2-chlorophenyl-containing analogues. Among the compounds listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, compound <b>42</b> (LipE = 5.82) exhibited the highest CYP3A4 and IKr TI values and was therefore selected for further in vitro and in vivo evaluation.</div><div class="NLM_table-wrap" id="tbl5">Table 5<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0027.gif" alt="" id="fx11" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0028.gif" alt="" id="fx12" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Assay error is <20%.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Unbound plasma clearance calculated based on human plasma protein binding. CL<sub>int</sub> is intrinsic clearance.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">CEREP bioprint assay; 7-benzyloxy-4-trifluoromethylcoumarin (BFC) was used as the substrate.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">The rato between off-target activity IC<sub>50</sub> and cell potency.</p></div></div></div><div class="NLM_p">Compound <b>42</b> displayed attractive in vitro HLM CL, permeability, solubility (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>), minimal undesired hERG activity (IKr IC<sub>50</sub>, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), and a low potential to cause unwanted drugâdrug interactions (DDI IC<sub>50</sub>, Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). The compound was therefore assessed in both rat and dog in vivo pharmacokinetic studies where it displayed oral bioavailability of 15â20% in rats and 50â60% in dogs (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). The oral bioavailability values in rats and dogs were consistent with their in vivo clearance value (77 and 8.4 mL/min/kg, respectively), suggesting near complete absorption (>90%) in both rats and dogs. Encouragingly, high volumes of distribution for <b>42</b> were noted in both rat and dog, and as a likely result, the compound exhibited a long half-life in both species. Similar oral bioavailability results were observed using amorphous and crystalline forms of the compound.</div><div class="NLM_p">Compound <b>42</b> also displayed potent antiproliferation effects across a wide range of cell lines representing different human cancers. The IC<sub>50</sub> values obtained by testing the compound against some of these lines are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>. The ability of <b>42</b> to modulate pharmacodynamic biomarkers, such as Akt and Her2, in a melanoma cell line (A2058) was also determined in a single dose PK/PD experiment. Thus, compound <b>42</b> was dosed intraperitoneally (ip) in rats at 50 mg/kg and the plasma samples were subsequently taken after 4, 7, 24, 48, and 72 h. The compound maintained unbound plasma levels >2-fold above its in vitro IC<sub>50</sub> (20 nM) for up to 7 h (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). In these experiments, the plasma levels of the Hsp90 client proteins (Akt and Her2) were observed to be lower (40â60%) than the control group for up to 72 h. The prolonged on-target effects of <b>42</b> on both Akt and Her2 protein levels could be due to the retention of compound in the target tumor,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> although other explanations are possible. Encouraged by these results, we further evaluated the in vivo efficacy of <b>42</b> in a tumor growth inhibition (TGI) study using a human melanoma (A2058)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> as the mouse xenograft model.</div><div class="NLM_p">This tumor growth inhibition experiment employed daily oral administration of various inhibitor doses over 14 days in order to access the potential of the compound to function as an oral therapeutic agent (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). In this experiment, compound <b>42</b> demonstrated dose-dependent inhibition of tumor growth with >50% reduction observed with most doses (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>A). For comparison, <b>1c</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) was also administered in the same model at its maximum tolerated dose (MTD) (10 mg/kg) and displayed only 34% tumor reduction at this dose (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>B). The 25 mg/kg dose of compound <b>42</b> was well tolerated, with no significant body weight loss (<10%) observed over the treatment period (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>). These results demonstrated a superior antitumor efficacy of <b>42</b> in this human melanoma model relative to <b>1c</b>. In addition, the converted survival study (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>) confirmed that two mice dosed with compound <b>42</b> were tumor-free at the end of the study (120 days after the last dose of 25 mg/kg).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vitro Clearance, P450 Inhibition, Permeability, and Solubility Properties of <b>42</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">liver microsome CL (Î¼L/min/mg)</th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th><th class="colsep0 rowsep0" align="center" char=".">Â </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char=".">dog</th><th class="colsep0 rowsep0" align="center" char=".">MDCK AB (10<sup>â6</sup>, cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">MDCK BA (10<sup>â6</sup>, cm/s)</th><th class="colsep0 rowsep0" align="center" char=".">Cyp enzymes,<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> IC<sub>50</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char=".">solubility (Î¼M)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="char" char=".">9.6</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">200</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">1A2, 2B6, 2C8, 2C9, 2C19, 2D6, 3A4.</p></div></div></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. In Vivo Pharmacokinetic Parameters of <b>42</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">route</th><th class="colsep0 rowsep0" align="center">CL<sub>plasma</sub> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center">Vd<sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i><sub>oral</sub> (%)<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat WH</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left">9.6</td><td class="colsep0 rowsep0" align="left">6.7</td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">13<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">19,<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> 15<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog beagle</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">8.4</td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">16<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">63,<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> 58<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Solution formulation: 40% PEG400 in saline.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Suspension formulation: 0.5% MC.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last"><i>F</i><sub>oral</sub> (%) = (dose<sub>iv</sub>)(AUC<sub>po</sub>)/[(dose<sub>po</sub>)(AUC<sub>iv</sub>)].</p></div></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. In Vitro Antiproliferation IC<sub>50</sub> of <b>42</b> in Various Human Cancer Lines</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" align="center">tumor type</th><th class="rowsep1 colsep0" colspan="4" align="center">melanoma</th><th class="rowsep1 colsep0" align="center">colorectal</th><th class="rowsep1 colsep0" align="center">prostate</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" valign="top">cell line</th><th class="colsep0 rowsep0" align="center" valign="top">A2058</th><th class="colsep0 rowsep0" align="center" valign="top">MeWo<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" valign="top">A375</th><th class="colsep0 rowsep0" align="center" valign="top">SK-MEL2</th><th class="colsep0 rowsep0" align="center" valign="top">HT-29</th><th class="colsep0 rowsep0" align="center" valign="top">LNCap</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">206</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">30</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Wild type B-Raf.</p></div></div></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0029.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Relationship between in vivo biomarkers (Her and Akt) inhibition and plasma unbound concentration for <b>42</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0001.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Tumor growth inhibition experiments of <b>42</b> (A) and <b>1c</b> (B) in A2058 model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0002.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Body weight measurement during tumor growth inhibition experiment using <b>42</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0003.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Compound <b>42</b> prolongs the survival of A2058 tumor-bearing animals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24350" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24350" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The syntheses of compounds <b>7</b> and <b>8</b> are reported in the literature.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The syntheses of compounds <b>9</b>, <b>10</b>, and <b>11</b> are described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. The amines required for the preparation of compounds <b>32</b><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and <b>33</b><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> were prepared using literature methods.</div><div class="NLM_p">The pyrrolodinopyrimidine-containing Hsp90 inhibitors described in this study were prepared using the methods described in Schemes <a class="ref internalNav" href="#sch2" aria-label="2">2</a>â<a class="ref internalNav" href="#sch5" aria-label="5">5</a>. The starting materials used for these syntheses were <b>45</b> or <b>46</b> and their syntheses are described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. In Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, compound <b>43</b> was synthesized by following the known literature procedure.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Cyclization of <b>43</b> with guanidine carbonate gave compound <b>44</b> in reasonable yield. Subsequent chlorination using phosphorus oxychloride (POCl<sub>3</sub>) provided compound <b>45</b> in reasonable yield. Removal of the ethyl carbamate present in <b>45</b> using a strong Lewis acid (iodotrimethylsilane, TMSI) also converted the associated 4-chloro atom to an iodide and gave <b>46</b> as the hydrogen iodide salt. We then developed several ways to synthesize the desired 2-amino-5,7-dihydro-6<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidine-containing Hsp90 inhibitors starting from either <b>45</b> or <b>46</b>.</div><div class="NLM_p">In Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, compound <b>46</b> was coupled with either commercially available isocyanates or various amines in the presence of 1,1-carbonyldiimidazole (CDI)<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> to form different urea moieties (intermediates <b>47a</b>â<b>e</b>). This CDI-mediated reaction successfully derivatized the pyrroloamino group present in <b>46</b> without simultaneously modifying the exocyclic amino group of the pyrimidine ring. Subsequent Suzuki coupling using 2,4,6-trisubstituted phenylboronic acid (<b>61</b>) and employing 1,4-dioxane as the solvent gave intermediates <b>48a</b>â<b>e</b> in good yields. Performing these coupling reactions using other solvents (e.g., acetonitrile, DMF, and DMSO) gave lower yields compared with 1,4-dioxane. Alkylation of <b>48a</b>â<b>e</b> with 1-iodo-4,4,4-trifluorobutane in the presence of Cs<sub>2</sub>CO<sub>3</sub> then gave compounds <b>12</b>â<b>16</b> in good yield. The phenol present in <b>48e</b> was also alkylated using a variety of electrophiles to give compounds <b>16</b>â<b>23</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><div class="NLM_p">In Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, Suzuki coupling of compound <b>45</b> with boronic acid <b>61</b> provided intermediate <b>49</b> in good yield. Subsequent alkylation of <b>49</b> with 1-(2-bromoethyl)-1<i>H</i>-pyrazole<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> afforded compound <b>50</b>. The ethyl carbamate group present in <b>50</b> was deprotected using TMSI to give compound <b>51</b> as the corresponding hydrogen iodide salt. Compound <b>51</b> was then reacted with CDI and either 2,2,2-trifluoroethylamine or 2,2-difluoropropylamine<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> to form the urea-containing compounds <b>34</b> and <b>35</b>, respectively.</div><div class="NLM_p">An alternative and more convergent synthesis is depicted in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. The pyrroloamino group present in <b>46</b> was protected as a <i>tert</i>-butyl carbamate (compound <b>52</b>). This compound was then coupled with 2,4,6-trisubstituted boronic acids <b>61</b> and <b>63</b> to give compounds <b>53</b> and <b>54</b> in reasonable yields. The phenol moiety present in both <b>53</b> and <b>54</b> was derivatized using several pyrazole-containing alkylating agents (1-(2-bromoethyl)-1<i>H</i>-pyrazole<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and <b>65</b>) to give intermediates <b>55</b>â<b>57</b>. The <i>tert</i>-butyl carbamate protecting group was subsequently removed from these molecules, and the resulting pyrroloamines (<b>58</b>â<b>60</b>) were transformed to the corresponding ureas (<b>26</b>â<b>35</b>, <b>38</b>â<b>42</b>) via CDI-mediated coupling with a variety of amines.</div><figure id="sch1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0004.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) guanidine carbonate, <i>t</i>-BuOH, 85 Â°C, 12 h, 52%; (b) POCl<sub>3</sub>, CH<sub>3</sub>CN, 81 Â°C, 3 h, 23%; (c) iodotrimethylsilane, CH<sub>3</sub>CN, 81 Â°C, 4 h, 79%.</p></p></figure><figure id="sch2" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0005.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) isocyanates, DMSO, 23 Â°C, 3 h, or amines, CDI, THF, 23 Â°C, 3 h, 19â64%; (b) <b>61</b>, Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, 85 Â°C, 8 h; (c) 1-iodo-4,4,4-trifluorobutane, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 65 Â°C, 4 h, 36%.</p></p></figure><figure id="sch3" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0006.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>62</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 50 Â°C, 1 h, 53.7%; (b) <b>61</b>, Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, 85 Â°C, 8 h; (c) alkylating agents, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 65 Â°C, 1 h, 23â51%.</p></p></figure><figure id="sch4" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0007.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>61</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, 85 Â°C, 4.5 h, 76%; (b) 2-bromoethylpyrazole, K<sub>2</sub>CO<sub>3</sub>, DMSO, 55 Â°C, 1.5 h, 64%; (c) iodotrimethylsilane, CHCl<sub>3</sub>, 23 Â°C, 24 h, 96%; (d) CDI, amines, THF, TEA, 60 Â°C, 4 h, 40â53%.</p></p></figure><figure id="sch5" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0008.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) di-<i>tert</i>-butyl dicarbonate, DIPEA, H<sub>2</sub>O/dioxane, 23 Â°C, 1.5 h, 22%; (b) <b>61/63</b>, Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, microwave 120 Â°C, 40 min, 38%/60%; (c) bromoethylpyrazole/<b>65</b>, Cs<sub>2</sub>CO<sub>3</sub>/K<sub>2</sub>CO<sub>3</sub>, DMF, 70â100 Â°C, 1â2 h, 60â67%; (d) HCl (in dioxane, 4 M), 23 Â°C, 1â3 h; (e) CDI, amines, THF, TEA, 60 Â°C, 2 h, 27â59% (<b>26</b>â<b>33</b>) and 52â95.6% (<b>38</b>â<b>42</b>).</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35018" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35018" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, novel, potent, metabolically stable, and orally bioavailable non-quinone-containing Hsp90 inhibitors were identified from an HTS lead. Analysis of multiple X-ray cocrystal structures enabled the design and optimization of a novel class of 2-amino-5,7-dihydro-6H-pyrrolo[3,4-<i>d</i>]pyrimidine-containing compounds. The ligand lipophilicity efficiency (LipE) of the initial lead was improved considerably during the course of these optimization activities (3.34 increased to >5.50). These efforts culminated with the identification of compound <b>42</b> which displayed good efficacy in a melanoma A2058 tumor model, exhibited expected pharmacodynamic effects in vivo, and possessed many other desirable pharmaceutical properties (e.g., high crystallinity and good solubility). The attractive attributes of <b>42</b> warranted its further examination for the treatment of cancer, and these studies will be reported in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68660" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68660" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Scintillation Proximity Assay (SPA)</h3><div class="NLM_p last">The ability of compounds to compete with a tritium labeled ligand for binding to N-terminus human Hsp90Î± was determined. The resultant IC<sub>50</sub> is then used to calculate the <i>K</i><sub>i</sub> by using the ChengâPrusoff equation. Chemical structure for this tritium labeled ligand and details relating to the SPA assay can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Client Protein Degradation and Cell Growth Inhibition Assays</h3><div class="NLM_p last">Primary cell assay IC<sub>50</sub> was determined by the degradation of Akt in the non-small-cell lung carcinoma cell line NCI-H1299 as described previously.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The PD effects of Hsp90 inhibitors were measured by the client protein (Akt and Her2) degradation measured by Luminex technology and ELISA. The details relating to these two assays can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Pharmacokinetics</h3><div class="NLM_p last"> Male Wistar Han rats (<i>n</i> = 2 per group) were given <b>42</b> intravenously at 2.5 mg/kg or orally at 10 mg/kg in PEG400/saline solution (3:7, v/v). Male beagle dogs (<i>n</i> = 2 per group) were also given <b>42</b> intravenously or orally at 0.5 mg/kg in PEG400/saline solution (3:7, v/v). Blood samples were collected from all animals at predetermined time points with the anticoagulant (K<sub>2</sub>EDTA or K<sub>3</sub>EDTA) and were then centrifuged. The resulting plasma samples were stored at approximately â20 Â°C until analysis. Liquid chromatographyâtandem mass spectrometry (LCâMS/MS) was used for quantitative analysis, and pharmacokinetic parameters were calculated using a standard noncompartmental method (Watson LIMS, version 7.2, Thermo Fisher Scientific, MA).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Microsomal Stability Studies</h3><div class="NLM_p last">Compounds (1 Î¼M) were incubated at 37 Â°C for 45 min in a final volume of 200 Î¼L of 100 mM potassium phosphate buffer (pH 7.4) containing pooled liver microsomes (0.8 mg/mL protein) and 2 mM NADPH. Reactions were initiated with the addition of NADPH following a 10 min preincubation. Aliquots of incubation samples were protein precipitated with cold methanol containing 0.1 Î¼M buspirone (internal standard) and centrifuged, and supernatants were analyzed by LCâMS/MS. All incubations were performed in triplicate. In vitro intrinsic clearance (CL<sub>int</sub>) was calculated from the half-life (<i>t</i><sub>1/2</sub>) of the parent drug disappearance, which was determined by the slope (<i>k</i>) of logâlinear regression analysis from the concentration versus time profiles, i.e., <i>t</i><sub>1/2</sub> = âln(2)/<i>k</i>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Human Plasma Binding Measurements</h3><div class="NLM_p last">In vitro plasma protein bindings were determined by equilibrium dialysis technique using a 96-well Teflon dialysis chamber (HTDialysis LLC, Gales Ferry, CT) with a semipermeable membrane (Spectra/Por4, Spectrum, Laguna Hills, CA) with a 12000â14000 Da molecular mass cutoff. Compounds (1 Î¼M) were incubated in plasma at 37 Â°C for 6 h. Appropriate volumes of plasma and buffer were protein-precipitated with cold acetonitrile and centrifuged, and supernatants were analyzed by LCâMS/MS. All incubations were performed in triplicate.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Efficacy Study in A2058 Melanoma Xenografts</h3><div class="NLM_p last">Six- to eight-week-old nu/nu athymic female mice were obtained from The Jackson Laboratory and maintained in pressurized ventilated caging at the Pfizer La Jolla animal facility. All studies were done in compliance with Institutional Animal Care and Use Committees guidelines. Tumors were established by injecting 2 Ã 10<sup>6</sup> cells suspended 1:1 (v/v) with reconstituted basement membrane (Matrigel, BD Biosciences). Mice with established tumors of â¼150 mm<sup>3</sup> were selected and randomized, then orally treated with compound <b>42</b> once daily. Tumor dimensions were measured with vernier calipers, and tumor volumes were calculated using the formula of (Ï/6)(larger diameter)(smaller diameter)<sup>2</sup>. Tumor growth inhibition percentage (TGI %) was calculated as 100 Ã (1 â Î<i>T</i>/Î<i>C</i>). For the survival study, the dosing was stopped for all animals and measurement was performed 3 times/week, and the animals were sacrificed and noted âdeadâ when the tumor size reached 1500 mm<sup>3</sup>. The survival study was performed for 120 days.</div></div><div id="sec4_7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry. General Methods</h3><div class="NLM_p last">All commercial reagents were used as received from their perspective supplier. The structures of the compounds of the following examples were confirmed by one or more of the following: proton magnetic resonance spectroscopy and liquid chromatographyâmass spectrometry. Compound purity is determined by elemental microanalyses or high pressure liquid chromatography (HPLC) or high resolution mass spectrometry (HRMS). Proton magnetic resonance (<sup>1</sup>H NMR) spectra were determined using either a Varian UNITY plus 300 or a Bruker 400. Chemical shifts are reported in parts per million (ppm, Î´) downfield from an internal tetramethylsilane standard. Coupling constants are given in hertz. Flash column chromatography was performed using silica gel 60 (Merck Art 9385). Elemental microanalyses were performed by Atlantic Microlab Inc., Norcross, GA. HPLC conditions utilized are as follows: gradient, 5â95% B in 10 min, 95% B 10â12 min; flow rate 0.6 mL/min; column, Waters Acquity UPLC BEH C18, 1.7 Î¼m, 2.1 mm Ã 100 mm; column temperature, 80 Â°C; mobile phase A, water (0.1% formic acid and 0.05% ammonium formate); mobile phase B, methanol (0.1% formic acid and 0.05% ammonium formate); UV detector, 254 and 224 nm. Retention times (<i>t</i><sub>R</sub>) are in minutes, and purity is calculated as percent total area. Elemental microanalysis results of all final compounds were within Â±0.4% of the theoretical values or were >95% pure by HPLC.</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-Amino-4-hydroxy-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Ethyl Ester (<b>44</b>)</h3><div class="NLM_p">A 20 L vessel equipped with nitrogen inlet, condenser, temperature probe, and overhead stirrer was charged with 1408 g (6.14 mol) of <b>43</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and 11.5 L of <i>t</i>-BuOH. The mixture was stirred at 40â50 Â°C to give a clear orange solution. Then 1134 g (6.29 mol) of guanidine carbonate was added in one portion (strong evolution of gas was observed), and the orange-brown mixture was refluxed. More evolution of gas was observed. The mixture became somewhat darker, and some solid precipitated. The mixture was refluxed at 85 Â°C for 12 h. A beige suspension was obtained. The solution was adjust to pH 5 by adding 1 N HCl (aq). The milky solution was extracted with EtOAc. TLC (EtOAc/hexanes, 1:1) indicated that the starting material was consumed completely. Starting material was used as reference (<i>R<sub>f</sub></i> = 0.50 with tailing). The solvent was removed under reduced pressure to give a beige solid.</div><div class="NLM_p last">The material was suspended in 4.5 L of hot water and heated to 80 Â°C. Hydrochloric acid (30%, 575 mL) was added until pH was 7â6. The suspension was cooled to 0 Â°C and stirred for 2 h at 0 Â°C. The solid was collected and dried for 12 h. The light beige hard paste (about 2600 g) was transferred into a 20 L round-bottom flask for the large-scale rotavapor, and water was removed by stripping for five cycles with toluene (9 L) to give the title compound (996 g, 4.44 mol, 72%).</div></div><div id="sec4_7_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-Amino-4-chloro-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Ethyl Ester (<b>45</b>)</h3><div class="NLM_p last">A 20 L reaction vessel, equipped with temperature probe, overhead stirrer, condenser, and nitrogen inlet, was charged with 9.5 L of CH<sub>3</sub>CN. Compound <b>44</b> (990 g, 4.42 mol) was suspended in the solvent. Phosphorus oxychloride (POCl<sub>3</sub>) (4.0 L, 43.7 mol) was added to this light beige suspension in 15 min. The internal temperature went up from 17 to 30 Â°C. The gray suspension was heated to reflux. Gas evolution was observed first, and the suspension became thicker. After 3 h of reflux, the internal temperature was 81 Â°C and the suspension had become somewhat browner and thinner. After 24 h of reflux the mixture was allowed to cool to room temperature. The volatiles were removed in vacuum, and the red-brown residue was dissolved in CH<sub>3</sub>CN (2.5 L). The solvent was then removed in vacuum, and this was repeated one time with another 2.5 L of CH<sub>3</sub>CN. All volatiles were removed in vacuum (16 mbar) to yield a red-brown foam. The red-brown foam was pulverized, and 4 L of water and 3 kg of ice were added. The red-brown suspension was stirred overnight at room temperature to destroy all remaining PO<sub><i>x</i></sub>Cl<sub><i>y</i></sub> compounds. The red-brown suspension was cooled to 0 Â°C, and 30% NaOH (aq) was added slowly to pH 8, keeping the internal temperature below 12 Â°C. The mixture became more yellow brownish. The suspension was stirred overnight at room temperature. The solid was collected and dried completely by evaporating with toluene (9 L) for four cycles. The light brown solid was purified by Soxhlet extraction with 1,4-dioxane to yield a light brown solid as the title compound 630 g (2.6 mol, 59%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 4.45 (d, 4H); 4.10 (q, 2H); 1.24 (t, 3H). Anal. Calcd for C<sub>9</sub>H<sub>11</sub>N<sub>4</sub>O<sub>2</sub>ClÂ·0.2 H<sub>2</sub>O: C, 43.89%; H, 4.67%; N, 22.75%; Cl, 14.40%. Found: C, 44.06%; H, 4.63%; N, 22.43%; Cl, 14.35%.</div></div><div id="sec4_7_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 4-Iodo-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-2-ylamine (<b>46</b>)</h3><div class="NLM_p last">Iodotrimethylsilane (100 mL, 703 mmol) was added to a suspension of <b>45</b> (30.6 g, 126 mmol) in acetonitrile (750 mL). The resulting reaction mixture was heated at reflux for 4 h. After cooling to ambient temperature, the reaction mixture was quenched with MeOH (27 mL) and concentrated to dryness in vacuo. Traces of MeOH were removed via coevaporation with toluene (150 mL). The resulting residue was treated with Et<sub>2</sub>O (200 mL), and the precipitate was filtered and washed with Et<sub>2</sub>O. The crude brown powder was then stirred in refluxing EtOAc (250 mL) and cooled to ambient temperature. The resulting solid was collected by filtration and washed with more ethyl acetate to afford the desired product as a brown powder (52.2 g, 79%), which was used in the next step with further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 4.25 (t, <i>J</i> = 5.1, 2H), 4.37 (t, <i>J</i> = 5.4, 2H), 9.41 (br s, 1H). MS: (M + H <i>m</i>/<i>z</i>) = 263.0.</div></div><div id="sec4_7_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 2-Amino-4-iodo-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid <i>tert</i>-Butyl Ester (<b>52</b>)</h3><div class="NLM_p last">Compound <b>46</b> (52.2 g, 100 mmol) was dissolved in dioxane (150 mL) and water (150 mL). Diisopropylethylamine (69.7 mL, 400 mmol) and di-<i>tert</i>-butyl dicarbonate (43.6 g, 200 mmol) were added to the solution, and the mixture was warmed to 45 Â°C. The mixture was then stirred at ambient temperature for an additional 1.5 h. The reaction mixture was poured into EtOAc (3.0 L) and saturated NaHCO<sub>3</sub> (aq) (1.0 L), and the mixture was stirred. The layers were separated, and the aqueous layer was washed once more with EtOAc (1.0 L). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The product was purified using a plug of silica gel and eluting with EtOAc (3 L) to give the title compound (8 g, 22%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>-<i>d</i>) Î´ 5.17 (br s, 2H), 4.51â4.65 (m, 2H), 4.37â4.51 (m, 2H), 1.47â1.56 (m, 9H).</div></div><div id="sec4_7_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-Amino-4-(2,4-dichloro-6-hydroxyphenyl)-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid <i>tert</i>-Butyl Ester (<b>53</b>)</h3><div class="NLM_p last">Compound <b>61</b> (2.0 g, 2.76 mmol) was added to a suspension of <b>52</b> (1.0 g, 2.76 mmol) and sodium carbonate (3.0 mL, 2 M in H<sub>2</sub>O) in dioxane (10 mL). The reaction mixture was purged with N<sub>2</sub> for 20 min. Then tetrakis(triphenylphosphine)palladium (319 mg, 0.28 mmol) was added. The resulting mixture was heated in a microwave at 120 Â°C for 40 min. After cooling to room temperature, the mixture was poured into H<sub>2</sub>O (50 mL) and the aqueous solution was neutralized with HCl (1 N). EtOAc (3 Ã 100 mL) was added to extract the aqueous solution. The combined organic layer was dried, filtered, and concentrated to give a brown yellow oil. The product was purified by silica gel column and eluted at 60â70% EtOAc in hexanes to afford the title compound (419 mg, 38%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.6 (br s, 1 H), 7.14 (s, 1 H), 6.97 (d, <i>J</i> = 2.0, 1 H), 6.79 (s, 2 H), 4.44 (d, <i>J</i> = 7.6, 2 H), 4.09â4.24 (m, 2 H), 1.43 (d, 9 H, two rotamer peaks). MS: (M + H <i>m</i>/<i>z</i>) = 398. Anal. Calcd for C<sub>17</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>3</sub>Â·0.14EtOAc: C, 51.49; H, 4.71; N, 13.68. Found: C, 51.51; H, 4.83; N, 13.42.</div></div><div id="sec4_7_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2-Amino-4-[2,4-dichloro-6-(2-pyrazol-1-ylethoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid <i>tert</i>-Butyl Ester (<b>55</b>)</h3><div class="NLM_p last">1-(2-Bromoethyl)-1<i>H</i>-pyrazole (220 mg, 1.3 mmol) was added to a solution of <b>53</b> (250 mg, 0.63 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (615 mg, 1.89 mmol) in DMSO (6 mL). This mixture was heated at 70 Â°C for 2 h. After cooling to room temperature, the reaction mixture was partitioned between ethyl acetate (50 mL) and water (50 mL). The organic phase was separated, washed with water (1 Ã 50 mL) and brine (1 Ã 50 mL), dried over sodium sulfate, and concentrated to dryness. The desired product was purified by chromatography and eluted with 60â70% EtOAc in hexanes to afford the title compound as a solid (206 mg, 67% yield). MS: (M + H <i>m</i>/<i>z</i>) = 491.05.</div></div><div id="sec4_7_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 4-[2,4-Dichloro-6-(2-pyrazol-1-ylethoxy)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-2-ylamine (<b>58</b>)</h3><div class="NLM_p last">A mixture of <b>55</b> (200 mg, 0.407 mmol) in 4 mL of TFA was stirred at room temperature for 3 h. After removal of excess TFA, the resulting residue was dissolved in a small amount of CH<sub>3</sub>CN, neutralized with aqueous sodium bicarbonate, and concentrated to afford a solid, which was then suspended in ethyl acetate and filtered. The resulting filtrate was concentrated to afford the title compound. MS: (M + H <i>m</i>/<i>z</i>) = 391.00.</div></div><div id="sec4_7_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 2-Amino-4-[2,4-dichloro-6-(2-pyrazol-1-ylethoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Cyclobutylamide (<b>26</b>)</h3><div class="NLM_p last">Cyclobutylamine (58 mg, 0.81 mmol) was added to a solution of 1,1-carbonyldiimidazole (132 mg, 0.81 mmol) in THF (2 mL) at 0 Â°C for 3 h. The resulting solution and TEA (0.17 mL, 1.2 mmol) were added to a solution of <b>58</b> (132 mg, 0.41 mmol) THF (2 mL). This reaction mixture was heated at 60 Â°C for 2 h. After concentration to dryness, the resulting residue was concentrated to dryness and purified by preparative HPLC to afford the title compound as a solid (104 mg, 52% yield over two steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ ppm 7.45 (d, <i>J</i> = 1.3, 1 H), 7.15 (d, <i>J</i> = 1.5, 1 H), 7.02 (d, <i>J</i> = 1.8, 1 H), 6.86 (d, <i>J</i> = 1.5, 1 H), 6.12 (t, <i>J</i> = 1.8, 1 H), 5.29 (s, 2 H), 4.62 (s, 2 H), 4.33â4.47 (m, 4 H), 4.22â4.33 (m, 2 H), 4.13 (d, <i>J</i> = 12.4, 1 H), 3.75 (d, <i>J</i> = 11.4, 1 H), 2.31â2.48 (m, 2 H), 1.79â1.94 (m, 2 H), 1.65â1.78 (m, 2 H). MS: (M + H <i>m</i>/<i>z</i>) = 488.05; HRMS calcd for C<sub>22</sub>H<sub>24</sub>Cl<sub>2</sub>N<sub>7</sub>O<sub>2</sub> (M + H) 488.1363, found 488.1355, error = â1.72 ppm. Anal. Calcd for C<sub>22</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>7</sub>O<sub>2</sub>Â·0.46H<sub>2</sub>O: C, 53.20; H, 4.85; N, 19.74; Found: C, 53.10; H, 4.81; N, 19.60. HPLC purity (254 nm): 99.0%. <i>t</i><sub>R</sub> = 11.452 min.</div></div><div id="sec4_7_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-Amino-4-[2,4-dichloro-6-(2-pyrazol-1-ylethoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Methylamide (<b>28</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of <b>26</b> but substituting cyclobutylamineâCDI complex with methylamine provided the title compound in 44% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.32 (d, <i>J</i> = 1.8, 1H), 7.29 (d, <i>J</i> = 1.5, 1H), 7.25 (d, <i>J</i> = 1.8, 1H), 7.19 (d, <i>J</i> = 2.0, 1H), 6.78 (br s, 2H), 6.18 (q, <i>J</i> = 4.3, 1H), 6.00 (t, <i>J</i> = 2.0, 1H), 4.30â4.45 (m, 6H), 3.92 (dd, <i>J</i> = 1.5, 12.6, 1H), 3.60 (d, <i>J</i> = 12.6, 1H), 2.59 (d, <i>J</i> = 4.3, 3H). MS: (M + H <i>m</i>/<i>z</i>) = 448.2. HRMS calcd for C<sub>19</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>7</sub>O<sub>2</sub> [M + H]<sup>+</sup> 448.1050, found 448.1053. HPLC purity (254 nM): 98.80%. <i>t</i><sub>R</sub> = 7.699 min.</div></div><div id="sec4_7_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-Amino-4-[2,4-dichloro-6-(2-pyrazol-1-ylethoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Amide (<b>27</b>)</h3><div class="NLM_p last">Trimethylsilyl isocyanate (21 mg, 0.15 mmol) was added to a solution of <b>58</b> (40 mg, 0.1 mmol) in 2-butanol (3 mL) at 23 Â°C. The mixture was stirred at 23 Â°C for 12 h. The solvent was evaporated and the residue was purified by reversed phase HPLC to provide the title compound (44 mg, 74%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.32 (d, <i>J</i> = 1.8, 2H), 7.25 (d, <i>J</i> = 1.8, 1H), 7.19 (d, <i>J</i> = 2.0, 1H), 6.79 (s, 2H), 6.03 (t, <i>J</i> = 2.0, 1H), 5.91 (s, 2H), 4.39 (d, <i>J</i> = 4.6, 2H), 4.25â4.36 (m, 4H), 3.92 (d, <i>J</i> = 12.6, 1H), 3.62 (d, <i>J</i> = 13.1, 1H); MS: (M + H <i>m</i>/<i>z</i>) = 434.2. Anal. Calcd for C<sub>20</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>7</sub>O<sub>2</sub>Â·0.75H<sub>2</sub>OÂ·0.25CH<sub>3</sub>OH: C, 48.09%; H, 4.31%; N, 21.51%.  Found: C, 48.19%; H, 4.13%; N, 21.21%.</div></div><div id="sec4_7_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-Amino-4-[2,4-dichloro-6-(2-pyrazol-1-ylethoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Ethylamide (<b>29</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of compound <b>28</b> but substituting methyl isocyanate with ethyl isocyanate provided the title compound in 27% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.32 (d, <i>J</i> = 1.8, 1H), 7.29 (d, <i>J</i> = 1.3, 1H), 7.25 (d, <i>J</i> = 1.8, 1H), 7.19 (d, <i>J</i> = 1.8, 1H), 6.78 (s, 2H), 6.23 (t, <i>J</i> = 4.8, 1H), 6.00 (t, <i>J</i> = 2.0, 1H), 4.36â4.47 (m, 2H), 4.33 (s, 4H), 3.87â3.97 (m, 1H), 3.59 (d, <i>J</i> = 12.9, 1H), 2.98â3.14 (m, 2H), 1.02 (t, <i>J</i> = 7.2, 3H). MS: (M + H <i>m</i>/<i>z</i>) = 463.1. Anal. Calcd for C<sub>20</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>7</sub>O<sub>2</sub>Â·0.75CH<sub>3</sub>CO<sub>2</sub>HÂ·1.2H<sub>2</sub>O: C, 48.73%; H, 5.04%; N, 18.50%.  Found: C, 48.63%; H, 4.68%; N, 18.20%.</div></div><div id="sec4_7_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-Amino-4-[2,4-dichloro-6-(2-pyrazol-1-ylethoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid (2,2-Difluoroethyl)amide (<b>33</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of <b>26</b> but substituting cyclobutylamine with 2,2-difluoroethylamine provided the title compound in 29% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.32 (d, <i>J</i> = 1.8, 1H), 7.30 (d, <i>J</i> = 1.8, 1H), 7.26 (d, <i>J</i> = 1.8, 1H), 7.20 (d, <i>J</i> = 2.0, 1H), 6.80 (br s, 2H), 6.70 (br s, 1H), 6.00 (t, <i>J</i> = 2.0, 1H), 5.98 (tt, <i>J</i> = 56.3 and 4.0, 1H), 4.30â4.49 (m, 6H), 3.94 (d, <i>J</i> = 12.9, 1H), 3.56 (d, <i>J</i> = 12.6, 1H), 3.37â3.48 (m, 2H). MS: (M + H <i>m</i>/<i>z</i>) = 498.2. HRMS calcd for C<sub>20</sub>H<sub>19</sub>Cl<sub>2</sub>F<sub>2</sub>N<sub>7</sub>O<sub>2</sub> [M + H]<sup>+</sup> 498.101â811, found 498.102â539. Anal. Calcd for C<sub>20</sub>H<sub>19</sub>Cl<sub>2</sub>F<sub>2</sub>N<sub>7</sub>O<sub>2</sub>Â·0.86H<sub>2</sub>O: C, 46.75%; H, 4.06%; N, 19.08%. Found: C, 46.83%; H, 4.02%; N, 18.95%.</div></div><div id="sec4_7_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2-Amino-4-[2,4-dichloro-6-(2-pyrazol-1-ylethoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid (3,3-Difluorocyclobutyl)amide (<b>31</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of <b>26</b> but substituting cyclobutylamine with 3,3-difluorocyclobutylamine provided the title compound in 59% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.32 (d, <i>J</i> = 1.8, 1H), 7.29 (d, <i>J</i> = 1.5, 1H), 7.26 (d, <i>J</i> = 1.5, 1H), 7.20 (d, <i>J</i> = 2.0, 1H), 6.77 (br s, 2H), 6.60 (d, <i>J</i> = 6.3, 1H), 6.00 (t, <i>J</i> = 2.0, 1H), 4.30â4.47 (m, 6H), 3.99â4.08 (m, 1H), 3.95 (d, <i>J</i> = 12.9, 1H), 3.60 (d, <i>J</i> = 12.9, 1H), 2.77â2.90 (m, 2H), 2.57â2.70 (m, 2H). MS: (M + H <i>m</i>/<i>z</i>) = 524.0. HRMS calcd for C<sub>22</sub>H<sub>21</sub>Cl<sub>2</sub>F<sub>2</sub>N<sub>7</sub>O<sub>2</sub> [M + H]<sup>+</sup> 524.117â461, found 524.118â902. HPLC purity: <i>t</i><sub>R</sub> = 9.166, 99.20%. Anal. Calcd for C<sub>22</sub>H<sub>21</sub>Cl<sub>2</sub>F<sub>2</sub>N<sub>7</sub>O<sub>2</sub>Â·0.65H<sub>2</sub>O: C, 49.29%; H, 4.19%; N, 18.29%. Found: C, 49.45%; H, 4.19%; N, 17.91%.</div></div><div id="sec4_7_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2-Amino-4-[2,4-dichloro-6-(2-pyrazol-1-ylethoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Bicyclo[1.1.1]pent-1-ylamide (<b>32</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of <b>26</b> but substituting cyclobutylamine with bicyclo[1.1.1]pent-1-ylamine<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> provided the title compound in 49% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.32 (d, <i>J</i> = 1.8, 1H), 7.30 (d, <i>J</i> = 1.8, 1H), 7.25 (d, <i>J</i> = 1.8, 1H), 7.19 (d, <i>J</i> = 2.0, 1H), 6.85 (br s, 1H), 6.78 (br s, 2H), 6.01 (t, <i>J</i> = 2.0, 1H), 4.29â4.44 (m, 6H), 3.89 (d, <i>J</i> = 12.9, 1H), 3.53 (d, <i>J</i> = 13.1, 1H), 2.35 (s, 1H), 1.95 (s, 6H). MS: (M + H <i>m</i>/<i>z</i>) = 500.2. HRMS calcd for C<sub>23</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>7</sub>O<sub>2</sub> [M + H]<sup>+</sup> 500.136â305, found 500.136â392. Anal. Calcd for C<sub>23</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>7</sub>O<sub>2</sub>Â·0.94H<sub>2</sub>O: C, 53.40%; H, 4.85%; N, 18.95%. Found: C, 53.57%; H, 4.80%; N, 18.95%.</div></div><div id="sec4_7_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-Amino-4-(4-chloro-2-hydroxy-6-methylphenyl)-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid <i>tert</i>-Butyl Ester (<b>54</b>)</h3><div class="NLM_p last">Compound <b>63</b> (300 mg, 1.6 mmol) was added to a suspension of <b>52</b> (583 mg, 1.61 mmol) and sodium carbonate (2.4 mL, 2 M in H<sub>2</sub>O) in dioxane (8 mL). The reaction mixture was purged with N<sub>2</sub> for 20 min. Then tetrakis(triphenylphosphine)palladium (116 mg, 0.1 mmol) was added. The resulting mixture was heated in a microwave at 120 Â°C for 40 min. After cooling to room temperature, the mixture was poured into H<sub>2</sub>O (20 mL) and the aqueous solution was neutralized with HCl (1 N). EtOAc (3 Ã 30 mL) was added to extract the aqueous solution. The combined organic layer was dried, filtered, and concentrated to give a brown yellow oil. The product was purified by silica gel column and eluted at 60â70% EtOAc in hexanes to afford the title compound (361 mg, 59.6%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.07 (s, 1H), 6.82 (s, 1H), 6.80 (s, 1H), 6.71 (s, 2H), 4.05â4.48 (m, 4H), 2.03 (s, 3H), 1.38â1.46 (d, 9H, two rotamer peaks); MS: (M + H <i>m</i>/<i>z</i>) = 377.2.</div></div><div id="sec4_7_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-(4-Fluoropyrazol-1-yl)ethanol (<b>64</b>)</h3><div class="NLM_p last">Sodium hydride (13.8 g, 0.35 mol) was added to a solution of 4-fluoro-1<i>H</i>-pyrazole<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> (20 g, 0.23 mol) in DMF (200 mL) at 0 Â°C. The mixture was stirred at 23 Â°C for 1 h, and then 2-bromoethanol (43 g, 0.35 mol) was added dropwise at 0 Â°C. The resulting mixture was stirred at 40 Â°C for 12 h. TLC (petroleum ether/EtOAc = 1:1) indicated the reaction was complete. The mixture was partitioned between H<sub>2</sub>O (1 L) and ethyl ether (1 L). The aqueous solution was extracted with more ethyl ether (4 Ã 1 L). The combined organic layer was dried, filtered, and concentrated to provide the title compound as a yellow oil (20 g, 66%).</div></div><div id="sec4_7_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Methanesulfonic Acid 2-(4-Fluoropyrazol-1-yl)ethyl Ester (<b>65</b>)</h3><div class="NLM_p last">Methylsulfonyl chloride (0.44 mL, 5.6 mmol) was added to a solution of <b>64</b> (500 mg, 3.75 mmol), 4-dimethylaminopyridine (46 mg, 0.38 mmol), and DIPEA (1.3 mL, 7.5 mmol) in DCM (10 mL) at 0 Â°C. The mixture was stirred at room temperature for 12 h. The mixture was poured into H<sub>2</sub>O (40 mL), and the aqueous solution was extracted with EtOAc (3 Ã 30 mL). The combined organic layer was dried, filtered, and concentrated to give the title compound as a brown yellow oil. This compound was used for the next step reaction without further purification.</div></div><div id="sec4_7_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-Amino-4-(4-chloro-2-hydroxy-6-methylphenyl)-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid <i>tert</i>-Butyl Ester (<b>57</b>)</h3><div class="NLM_p last">Compound <b>65</b> (116 mg, 0.6 mmol) was added to a solution of <b>54</b> (84 mg, 0.22 mmol) and K<sub>2</sub>CO<sub>3</sub> (154 mg, 1.2 mmol) in DMF (3 mL) at 23 Â°C under N<sub>2</sub>. The reaction mixture was heated at 100 Â°C for 1 h. The mixture was poured into H<sub>2</sub>O (20 mL), and the aqueous solution was extracted with EtOAc (3 Ã 50 mL). The combined organic layer was dried, filtered, and concentrated to give the product as a brown yellow oil. The product was purified by silica gel column and eluted at 90â100% EtOAc in hexanes to afford the title compound (66 mg, 60%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.42 (dd, <i>J</i> = 4.4, 10.7, 1H), 7.28 (dd, <i>J</i> = 4.3, 18.4, 1H), 7.04 (s, 1H), 6.99 (s, 1H), 6.70 (s, 2H), 4.33â4.41 (m, 2H), 4.17â4.31 (m, 4H), 3.83 (dd, <i>J</i> = 12.9, 25.5, 1H), 3.50 (dd, <i>J</i> = 13.4, 23.5, 1H), 2.00 (s, 3H), 1.44 (d, 9H, two rotamer peaks). Anal. Calcd for C<sub>23</sub>H<sub>26</sub>N<sub>6</sub>O<sub>3</sub>ClFÂ·0.25CH<sub>3</sub>CO<sub>2</sub>C<sub>2</sub>H<sub>5</sub>Â·0.5H<sub>2</sub>O: C, 55.44%; H, 5.62%; N, 16.16%. Found: C, 55.78%; H, 5.49%; N, 15.93%.</div></div><div id="sec4_7_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 4-(4-Chloro-2-{2-[<i>N</i>-((<i>E</i>)-2-fluoro-propenyl)-<i>N</i>â²-methylenehydrazino]ethoxy}-6-methylphenyl)-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-2-ylamine (<b>60</b>)</h3><div class="NLM_p last">Hydrogen chloride (5 mL, 4 M in dioxane, 20.5 mmol) was added to <b>57</b> (500 mg, 1 mmol) in methanol. The mixture was stirred at 23 Â°C for 12 h. The solvent was evaporated to give the title compound as a light yellow solid residue. This compound was used for the next step reaction without further purification.</div></div><div id="sec4_7_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-Amino-4-{4-chloro-2-[2-(4-fluoropyrazol-1-yl)ethoxy]-6-methylphenyl}-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid (2,2-Difluoropropyl)amide (<b>42</b>)</h3><div class="NLM_p last">Triethylamine (1.5 mL, 3.5 mmol) was added to a solution of 2,2-difluoropropylamine hydrochloride<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (250 mg, 1.8 mmol) and 1,1â²-carbonyldiimidazole (340 mg, 2.1 mmol) in DMF (15 mL). The solution was stirred at 23 Â°C for 12 h. The resulting solution and DIPEA (1.5 mL) were added to a solution of <b>60</b> (397 mg, 1 mmol), and the mixture was heated at 75 Â°C for 2 h. The reaction mixture was poured into H<sub>2</sub>O (20 mL) and extracted with EtOAc (2 Ã 50 mL). The combined organic layer was dried, filtered, and concentrated to give a brown yellow oil. The desired product was purified by chromatography and eluted at 0â10% methanol in EtOAc to afford the title compound as a white solid (497 mg, 95.6%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.36 (d, <i>J</i> = 4.6, 1H), 7.26 (d, <i>J</i> = 4.0, 1H), 7.05 (s, 1H), 7.00 (d, <i>J</i> = 1.3, 1H), 6.70 (s, 2H), 6.65 (s, 1H), 4.40 (s, 2H), 4.20â4.31 (m, 4H), 3.92 (d, <i>J</i> = 12.9, 1H), 3.65 (d, <i>J</i> = 12.9, 1H), 3.37â3.52 (m, 2H), 2.01 (s, 3H), 1.55 (t, <i>J</i> = 19.0, 3H). Anal. Calcd for C<sub>22</sub>H<sub>23</sub>N<sub>7</sub>O<sub>2</sub>ClF<sub>3</sub>Â·0.25H<sub>2</sub>O: C, 51.37%; H, 4.60%; N, 19.06%. Found: C, 51.34%; H, 4.65%; N, 18.70%.</div></div><div id="sec4_7_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-Amino-4-{2,4-dichloro-6-[2-(4-fluoropyrazol-1-yl)ethoxy]phenyl}-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Bicyclo[1.1.1]pent-1-ylamide (<b>38</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of <b>26</b> but substituting cyclobutylamine with bicyclo[1.1.1]pent-1-ylamine<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and bromoethylpyrazole with <b>65</b> provided the title compound in 72% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.36 (d, <i>J</i> = 4.6, 1H), 7.34 (d, <i>J</i> = 1.8, 1H), 7.23â7.29 (m, 2H), 6.89 (br s, 1H), 6.79 (s, 2H), 4.30â4.43 (m, 4H), 4.20â4.28 (m, 2H), 3.93 (d, <i>J</i> = 13.1, 1H), 3.65 (d, <i>J</i> = 13.1, 1H), 2.34 (s, 1H), 1.94 (s, 6H). Anal. Calcd for C<sub>23</sub>H<sub>22</sub>N<sub>7</sub>O<sub>2</sub>Cl<sub>2</sub>FÂ·1.0H<sub>2</sub>O: C, 51.50%; H, 4.51%; N, 18.28%. Found: C, 51.81%; H, 4.34%; N, 18.02%.</div></div><div id="sec4_7_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-Amino-4-{2,4-dichloro-6-[2-(4-fluoropyrazol-1-yl)ethoxy]phenyl}-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid (2,2,2-Trifluoroethyl)amide (<b>39</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of <b>38</b> but substituting 2,2-difluoropropylamine with 2,2,2-trifluoroethylamine provided the title compound in 82% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.37 (d, <i>J</i> = 4.6, 1H), 7.34 (d, <i>J</i> = 1.8, 1H), 7.28 (d, <i>J</i> = 1.5, 1H), 7.24 (d, <i>J</i> = 4.3, 1H), 6.97 (s, 1H), 6.82 (s, 2H), 4.40â4.45 (m, 2H), 4.31â4.38 (m, 2H), 4.20â4.28 (m, 2H), 3.99 (d, <i>J</i> = 12.6, 1H), 3.77â3.87 (m, 2H), 3.68 (d, <i>J</i> = 13.1, 1H). Anal. Calcd for C<sub>20</sub>H<sub>17</sub>N<sub>7</sub>O<sub>2</sub>Cl<sub>2</sub>F<sub>4</sub>: C, 44.96%; H, 3.21%; N, 18.35%. Found: C, 44.71%; H, 3.26%; N, 18.03%.</div></div><div id="sec4_7_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-Amino-4-{4-chloro-2-[2-(4-fluoropyrazol-1-yl)ethoxy]-6-methylphenyl}-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid (2,2,2-Trifluoroethyl)amide (<b>40</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of <b>42</b> but substituting 2,2-difluoropropylamine with 2,2,2-trifluoroethylamine provided the title compound in 82% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.37 (d, <i>J</i> = 4.3, 1H), 7.23 (d, <i>J</i> = 4.0, 1H), 7.06 (s, 1H), 7.01 (d, <i>J</i> = 1.3, 1H), 6.90 (s, 1H), 6.72 (s, 2H), 4.40 (s, 2H), 4.26 (dd, <i>J</i> = 3.8, 12.9, 4H), 3.91 (d, <i>J</i> = 12.6, 1H), 3.76â3.86 (m, 2H), 3.61 (d, <i>J</i> = 13.1, 1H), 2.01 (s, 3H). Anal. Calcd for C<sub>21</sub>H<sub>20</sub>N<sub>7</sub>O<sub>2</sub>ClF<sub>4</sub>: C, 49.08%; H, 3.92%; N, 19.08%. Found: C, 48.82%; H, 3.99%; N, 18.89%.</div></div><div id="sec4_7_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2-Amino-4-{2,4-dichloro-6-[2-(4-fluoropyrazol-1-yl)ethoxy]phenyl}-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid (2,2-Difluoropropyl)amide (<b>41</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of <b>38</b> but substituting 2,2,2-trifluoroethylamine with 2,2-difluoropropylamine provided the title compound in 33% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.36 (d, <i>J</i> = 4.8, 1H), 7.34 (d, <i>J</i> = 1.8, 1H), 7.28 (d, <i>J</i> = 1.8, 1H), 7.26 (d, <i>J</i> = 4.3, 1H), 6.81 (s, 2H), 6.69 (s, 1H), 4.40â4.47 (m, 2H), 4.31â4.37 (m, 2H), 4.20â4.28 (m, 2H), 4.00 (d, <i>J</i> = 12.9, 1H), 3.69 (d, <i>J</i> = 13.1, 1H), 3.43â3.55 (m, 2H), 1.56 (t, <i>J</i> = 19.0, 3H). Anal. Calcd for C<sub>21</sub>H<sub>20</sub>N<sub>7</sub>O<sub>2</sub>Cl<sub>2</sub>F<sub>3</sub>Â·1.75H<sub>2</sub>O: C, 44.89%; H, 4.22%; N, 17.45%. Found: C, 45.22%; H, 3.90%; N, 17.12%.</div></div><div id="sec4_7_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 2-Amino-4-iodo-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Isopropylamide (<b>47c</b>)</h3><div class="NLM_p last">Isopropyl isocyanate (19.0 mg, 0.223 mmol) was added to a solution of <b>46</b> (103 mg, 0.199 mmol) and sodium carbonate (51.2 mg, 0.483 mmol)) in DMSO (1.8 mL) at 65 Â°C. After 3 h, the mixture was filtered and purified by preparative HPLC to provide the title compound (44 mg, 64%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.03 (br s, 2H), 6.15 (d, <i>J</i> = 7.7, 1H), 4.41 (s, 2H), 4.26 (s, 2H), 3.73â3.87 (m, 1H), 1.09 (d, <i>J</i> = 6.6, 6H). MS: (M + H <i>m</i>/<i>z</i>) = 348.2.</div></div><div id="sec4_7_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2-Amino-4-(2,4-dichloro-6-hydroxyphenyl)-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Isopropylamide (<b>48c</b>)</h3><div class="NLM_p last">Sodium carbonate (2 M, 0.45 mL, 0.90 mmol) was added to a solution of <b>61</b> (94 mg, 0.45 mmol) and <b>47c</b> (145 mg, 0.418 mmol) in 1,4-dioxane (6.0 mL). The reaction mixture was purged with N<sub>2</sub> for 20 min before Pd(PPh<sub>3</sub>)<sub>4</sub> (152 mg, 0.132 mmol) was added. The reaction mixture was heated to 85 Â°C for 8 h, cooled to room temperature, and partitioned between EtOAc and H<sub>2</sub>O. The EtOAc layer contained only impurities and was discarded. The aqueous layer was brought to pH 5 with 1 N KH<sub>2</sub>PO<sub>3</sub> and was extracted with EtOAc/<i>i-</i>PrOH. The organics were concentrated to give the desired product as a pale tan powder which was used without further purification. MS: (M + H <i>m</i>/<i>z</i>) = 382.0.</div></div><div id="sec4_7_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 2-Amino-4-[2,4-dichloro-6-(4,4,4-trifluorobutoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Isopropylamide (<b>14</b>)</h3><div class="NLM_p last">1-Iodo-4,4,4-trifluorobutane (75 mg, 0.32 mmol) was added to a solution of <b>48c</b> (69 mg, 0.18 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (192 mg, 0.589 mmol) in DMSO (1.5 mL). The mixture was heated at 65 Â°C for 1 h and filtered. Preparative HPLC provided the title compound as a white powder (29 mg, 32%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.36 (d, <i>J</i> = 1.5, 1H), 7.31 (d, <i>J</i> = 1.3, 1H), 6.81 (br s, 2H), 6.04 (d, <i>J</i> = 7.7, 1H), 4.39 (br s, 2H), 4.05â4.15 (m, 4H), 3.69â3.84 (m, 1H), 2.02â2.20 (m, 2H), 1.68â1.83 (m, 2H), 1.05 (d, 6H). MS: (M + H <i>m</i>/<i>z</i>) = 492.2. HRMS calcd for C<sub>20</sub>H<sub>22</sub>Cl<sub>2</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> 492.1175, found 492.1189. HPLC purity (254 nm): 98.26%. <i>t</i><sub>R</sub> = 11.582 min.</div></div><div id="sec4_7_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Imidazole-1-carboxylic Acid Cyclobutylamide (<b>62</b>)</h3><div class="NLM_p last">Cyclobutylamine (1.00 g, 14.1 mmol, dissolved in THF (9.0 mL)) was added to a solution of 1,1-carbonyldiimidazole (3.54 g, 21.8 mmol) in THF (100 mL) at 0 Â°C dropwise over 10 min. The reaction mixture was allowed to warm to room temperature and was stirred for 2 h. The solvent was removed under reduced pressure, and the resulting oil was purified on silica gel, eluting with 0â10% MeOH/DCM to provide the title compound as a clear oil (2.11 g, 90.8%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 8.12 (s, 1H), 7.36 (t, <i>J</i> = 1.4, 1H), 7.08 (s, 1H), 6.35 (d, <i>J</i> = 6.2, 1H), 4.35â4.54 (m, 1H), 2.36â2.53 (m, 2H), 1.95â2.15 (m, 2H), 1.71â1.90 (m, 2H).</div></div><div id="sec4_7_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-Amino-4-iodo-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Cyclobutylamide (<b>47e</b>)</h3><div class="NLM_p last">Compound <b>62</b> (329 mg, 1.99 mmol) was added to a solution of <b>46</b> (961 mg, 1.86 mmol) and cesium carbonate (604 mg, 1.85 mmol) in DMSO (4 mL). The mixture was heated to 50 Â°C. After 1 h, the reaction mixture was cooled to room temperature and filtered. Preparative HPLC provided the title compound as a white powder (358 mg, 53.7%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.02 (br s, 2H), 6.60 (d, <i>J</i> = 7.7, 1H), 4.41 (s, 2H), 4.26 (s, 2H), 4.06â4.20 (m, 1H), 2.07â2.18 (m, 2H), 1.89â2.05 (m, 2H), 1.48â1.65 (m, 2H). MS: (M + H <i>m</i>/<i>z</i>) = 360.2.</div></div><div id="sec4_7_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2-Amino-4-(2,4-dichloro-6-hydroxyphenyl)-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Cyclobutylamide (<b>48e</b>)</h3><div class="NLM_p last">Sodium carbonate (2 M, 1.4 mL, 2.8 mmol) was added to a solution of <b>61</b> (310 mg, 1.50 mmol) and <b>47e</b> (489 mg, 1.36 mmol) in 1,4-dioxane (20 mL). The reaction mixture was purged with N<sub>2</sub> for 20 min before tetrakis(triphenylphosphine)palladium (152 mg, 0.132 mmol) was added. The reaction mixture was heated to 85 Â°C for 8 h, cooled to room temperature, and partitioned between EtOAc and H<sub>2</sub>O. The EtOAc layer contained only impurities and was discarded. The aqueous layer was brought to pH 5 with 1 N KH<sub>2</sub>PO<sub>3</sub> and was extracted with EtOAc/<i>i</i>-PrOH. The organics were concentrated to give the desired product as a pale tan powder which was used without further purification. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.64 (s, 1H), 7.15 (d, <i>J</i> = 1.3, 1H), 6.96 (d, <i>J</i> = 1.3, 1H), 6.80 (br s, 2H), 6.52 (d, <i>J</i> = 7.9, 1H), 4.40 (br s, 2H), 4.15 (m, 3H), 2.01â2.17 (m, 2H), 1.83â2.00 (m, 2H), 1.45â1.63 (m, 2H). MS: (M + H <i>m</i>/<i>z</i>) = 394.2.</div></div><div id="sec4_7_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2-Amino-4-[2,4-dichloro-6-(4,4,4-trifluorobutoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Cyclobutylamide Hydrochloride (<b>16</b>)</h3><div class="NLM_p last">1-Iodo-4,4,4-trifluorobutane (89.2 mg, 0.38 mmol) was added to a solution of <b>48e</b> (91.1 mg, 0.23 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (174 mg, 0.53 mmol) in DMSO (1.5 mL). The reaction mixture was heated to 65 Â°C for 30 min. The reaction mixture was cooled to 23 Â°C and filtered. Preparative HPLC provided the title compound as a white powder (46 mg, 37%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.37 (d, <i>J</i> = 1.8, 1H), 7.31 (d, <i>J</i> = 1.8, 1H), 6.86 (br s, 2H), 6.51 (d, <i>J</i> = 7.3, 1H), 4.34â4.46 (m, 2H), 4.05â4.18 (m, 5H), 2.03â2.18 (m, 4H), 1.85â1.97 (m, 2H), 1.76 (quin, <i>J</i> = 7.0, 2H), 1.47â1.59 (m, 2H). MS: (M + H <i>m</i>/<i>z</i>) = 504.2. Anal. Calcd for C<sub>21</sub>H<sub>22</sub>N<sub>5</sub>O<sub>2</sub>Cl<sub>2</sub>Â·1.0HCl: C, 46.64%; H, 4.29%; N, 12.95%. Found: C, 46.75%; H, 4.26%; N, 12.69%.</div></div><div id="sec4_7_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-Amino-4-(2,4-dichloro-6-hydroxyphenyl)-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Ethyl Ester (<b>49</b>)</h3><div class="NLM_p last">The reaction was performed under nitrogen. A 10 L reaction vessel, equipped with overhead stirrer, condenser, temperature probe, and nitrogen inlet, was charged with <b>45</b> (142.8 g, 588 mmol), <b>61</b> (120.6 g, 583 mmol, 0.99 equiv), Pd(PPh<sub>3</sub>)<sub>4</sub> (46.7 g, 40.4 mmol, 6.9 mol %), and 1,4-dioxane (5 L). The mixture was bubbled with nitrogen for at least 30 min. Simultaneously, a solution of of Na<sub>2</sub>CO<sub>3(aq)</sub> (187 g, 1.76 mol, 3.0 equiv, 820 mL) was bubbled with nitrogen for 30 min as well. The dioxane mixture was heated, and when the internal temperature was 50 Â°C, the Na<sub>2</sub>CO<sub>3</sub> solution was added to the mixture. The mixture was heated at 84â86 Â°C for 4.5 h and then cooled to room temperature. The volatiles were removed in vacuum, and the orange-brown residue was mixed with NaOH<sub>(aq)</sub> (0.5 N, 10 L). The mixture was washed with TBME (3 Ã 2.5 L). The combined aqueous layers were acidified with KH<sub>2</sub>PO<sub>4</sub>/H<sub>3</sub>PO<sub>4</sub> to pH 5â6. The water layer was extracted with EtOAc (6 Ã 3 L). The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuum to give an orange-yellow solid that was further purified in portions by Soxhlet extraction with a 3:1 mixture of TBME/EtOAc to give the product (165 g, 447 mmol, 76%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 10.65 (br, 1H); 7.11 (s, 1H); 6.95 (s, 1H); 6.80 (s, 2H); 4.45 (d, 2H); 4.20 (m, 2H); 4.03 (2 q, 2H, rotamer A + B); 1.13 (2 t, 3H, rotamer A + B). HRMS calcd for C<sub>15</sub>H<sub>14</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>3</sub> 369.0516 [M + H]<sup>+</sup>, found 369.0521.</div></div><div id="sec4_7_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 2-Amino-4-[2,4-dichloro-6-(2-pyrazol-1-ylethoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Ethyl Ester (<b>50</b>)</h3><div class="NLM_p last">The reaction was performed under nitrogen. A 1000 mL three-necked round-bottom flask was charged with <b>49</b> (57.78 g, 156.5 mmol), K<sub>2</sub>CO<sub>3</sub> (343.3 g, 313 mmol, 2.0 equiv), and DMSO (650 mL). The mixture was heated to 55â56 Â°C. By syringe-pump, 1-(2-bromoethyl)-1<i>H</i>-pyrazole (738 g, 217 mmol, 1.4 equiv) was added in the course of 2.5 h. The orange-brown mixture was heated at 55â56 Â°C for an additional 1.5 h. The mixture was cooled to room temperature. The mixture was poured into 6 L of water and 7 L of toluene. The layers were separated, and the water layer was extracted with toluene (3 Ã 2 L). The combined toluene layers were washed with water (6 Ã 1 L) and dried over Na<sub>2</sub>SO<sub>4</sub>. After filtration the toluene was removed in vacuum. The crude product was dissolved in EtOAc (2 L) and filtered. The EtOAc was removed in vacuum to give 45 g of crude product. The crude product was stirred in toluene (50 mL) and the light yellow solid was collected, washed with toluene (3 Ã 20 mL), and dried by suction to give the title compound (46.5 g, 64%).</div></div><div id="sec4_7_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 4-[2,4-Dichloro-6-(2-pyrazol-1-ylethoxy)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-2-ylamine (<b>51</b>)</h3><div class="NLM_p last">The synthesis and workup were performed under a nitrogen atmosphere. A 1000 mL three-necked round-bottom flask equipped with temperature probe, reflux condenser, and nitrogen inlet was flushed with nitrogen and charged with <b>50</b> (64.5 g, 139.2 mmol) and chloroform (500 mL). Iodotrimethylsilane (114 g, 570 mmol, 4 equiv) was added to the brown solution. The temperature increased from 18 to 27 Â°C. The brown solution was refluxed for 24 h. The reaction mixture was cooled to 0 Â°C, and MeOH (200 mL) was added slowly to keep the internal temperature below 15 Â°C. A sticky, light colored, solid precipitated, and gas evolution was observed. The mixture was stirred at 10â15 Â°C to become a homogeneous brown solution. After 30 min of stirring, the volatiles were removed under reduced pressure, giving an orange-brown solid. The solid was stirred overnight in a mixture of 500 mL of diethyl ether and 200 mL of methanol. The suspension was filtered under a nitrogen atmosphere, and the beige solid was washed with more diethyl ether (3 Ã 200 mL). The solid under reduced pressure gave the title compound (103.7 g, 96%). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) Î´ 8.17 (d, <i>J</i> = 1.9, 1H); 8.03 (d, <i>J</i> = 2.5, 1H); 7.37 (d, <i>J</i> = 1.7, 1H); 7.34 (d, <i>J</i> = 1.7, 1H); 6.59 (t, <i>J</i> = 2.6, 1H); 5.1â4.9 (m, 8H); 4.85 (s, 1H); 4.79 (s, 1H); 4.71 (d, <i>J</i> = 14.9, 2H); 4.56 (d, <i>J</i> = 14.6, 2H).</div></div><div id="sec4_7_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 2-Amino-4-[2,4-dichloro-6-(2-pyrazol-1-ylethoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid (2,2-Difluoropropyl)amide (<b>35</b>)</h3><div class="NLM_p last">Triethylamine (5.1 mL, 37 mmol) was added to a solution of 2,2-difluoropropylamine<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (2.4 g, 18 mmol) and 1,1â²-carbonyldiimidazole (4.6 g, 27.4 mmol) in DCM (80 mL). The solution was stirred at 23 Â°C for 12 h. The resulting solution and TEA (5 mL) were added to a solution of <b>51</b> (4.7 g, 6 mmol) in DMF (36 mL), and the mixture was heated at 60 Â°C for 4 h. The reaction mixture was poured into H<sub>2</sub>O (20 mL) and extracted with EtOAc (2 Ã 50 mL). The combined organic layer was dried, filtered, and concentrated to give a brown yellow oil. The desired product was purified by chromatography and eluted with 0â10% methanol in DCM to afford the title compound as a white solid (1.7 g, 53%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.33 (d, <i>J</i> = 1.8, 1H), 7.29 (d, <i>J</i> = 1.5, 1H), 7.27 (d, <i>J</i> = 1.8, 1H), 7.20 (d, <i>J</i> = 2.3, 1H), 6.82 (s, 2H), 6.67 (s, 1H), 6.00 (t, <i>J</i> = 2.0, 1H), 4.40â4.48 (m, 2H), 4.31â4.37 (m, 4H), 3.97 (d, <i>J</i> = 12.9, 1H), 3.54â3.63 (m, 1H), 3.41â3.54 (m, 2H), 1.57 (t, <i>J</i> = 19.1, 3H). Anal. Calcd for C<sub>21</sub>H<sub>21</sub>N<sub>7</sub>O<sub>2</sub>Cl<sub>2</sub>F<sub>2</sub>: C, 49.23%; H, 4.13%; N, 19.14%. Found: C, 48.95%; H, 4.21%; N, 18.76%.</div></div><div id="sec4_7_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 2-Amino-4-[2,4-dichloro-6-(2-pyrazol-1-ylethoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid (2,2,2-Trifluoroethyl)amide (<b>34</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of <b>35</b> but substituting 2,2-difluoropropylamine with 2,2,2-trifluoroethylamine provided the title compound in 40% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.33 (d, <i>J</i> = 1.8, 1H), 7.27 (d, <i>J</i> = 1.5, 2H), 7.21 (d, <i>J</i> = 1.8, 1H), 6.82 (s, 2H), 5.98 (t, <i>J</i> = 2.0, 1H), 4.41â4.49 (m, 2H), 4.30â4.37 (m, 4H), 3.94 (d, <i>J</i> = 12.9, 1H), 3.85 (dd, <i>J</i> = 6.3, 9.4, 2H), 3.54 (d, <i>J</i> = 12.4, 1H). Anal. Calcd for C<sub>20</sub>H<sub>18</sub>N<sub>7</sub>O<sub>2</sub>Cl<sub>2</sub>F<sub>3</sub>Â·0.5H<sub>2</sub>O: C, 45.73%; H, 3.65%; N, 18.66%. Found: C, 45.89%; H, 3.56%; N, 18.39%.</div></div><div id="sec4_7_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 2-Amino-4-[2,4-dichloro-6-(2-pyrazol-1-ylethoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Cyclopropylamide (<b>30</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of <b>26</b> but substituting cyclobutylamine with cyclopropylamine provided the title compound in 43% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.31 (d, <i>J</i> = 1.5, 1 H), 7.29 (d, <i>J</i> = 1.5, 1 H), 7.24 (d, <i>J</i> = 1.5, 1 H), 7.18 (d, <i>J</i> = 2.0, 1 H), 6.78 (s, 2 H), 6.34 (br s, 1 H), 6.00 (t, <i>J</i> = 1.9, 1 H), 4.35â4.45 (m, 2 H), 4.32 (s, 4 H), 3.85â3.93 (m, 1 H), 3.51â3.58 (m, 1 H), 2.52â2.57 (m, 1 H), 0.49â0.59 (m, 2 H), 0.34â0.44 (m, 2 H). MS: (M + H <i>m</i>/<i>z</i>) = 474.10. HRMS calcd for C<sub>21</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>7</sub>O<sub>2</sub> (M + H) 474.120655, found 474.119412, error = â2.62 ppm. Anal. Calcd for C<sub>21</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>7</sub>O<sub>2</sub>Â·1.19H<sub>2</sub>OÂ·0.13HOAc: C, 50.72%; H, 4.78%; N, 19.49%.  Found: C, 50.79%; H, 4.56%; N, 19.38%. HPLC purity (254 nm): 98.0%. <i>t</i><sub>R</sub> = 8.451 min.</div></div><div id="sec4_7_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 2-Amino-4-[2,4-dichloro-6-(4,4,4-trifluorobutoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Ethylamide (<b>12</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of compound <b>16</b> but substituting compound <b>62</b> with ethyl isocyanate provided the title compound in 52% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.36 (d, <i>J</i> = 1.8, 1H), 7.30 (d, <i>J</i> = 1.8, 1H), 6.82 (s, 2H), 6.54 (s, 1H), 4.30â4.46 (m, 2H), 3.97â4.18 (m, 4H), 2.98â3.13 (m, 2H), 2.06â2.17 (m, 2H), 1.68â1.83 (m, 2H), 1.00 (t, <i>J</i> = 7.1, 3H). Anal. Calcd for C<sub>19</sub>H<sub>20</sub>Cl<sub>2</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub>Â·1.0H<sub>2</sub>O: C, 45.98%; H, 4.47%; N, 14.10%.  Found: C, 45.75%; H, 4.16%; N, 13.85%.</div></div><div id="sec4_7_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 2-Amino-4-[2,4-dichloro-6-(4,4,4-trifluorobutoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Cyanomethylamide (<b>13</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of compound <b>16</b> but substituting compound <b>62</b> with 3-aminopropionitrile provided the title compound in 10% overall yield from <b>46</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.36 (d, <i>J</i> = 1.3, 1H), 7.31 (d, <i>J</i> = 1.5, 1H), 6.85 (br s, 2H), 6.81 (t, <i>J</i> = 5.5, 1H), 4.34â4.50 (m, 2H), 4.04â4.20 (m, 4H), 3.25 (q, <i>J</i> = 6.1, 2H), 2.62 (t, <i>J</i> = 6.3, 2H), 2.02â2.20 (m, 2H), 1.76 (quin, 2H). MS: (M + H <i>m</i>/<i>z</i>) = 503.2. HRMS calcd for C<sub>20</sub>H<sub>19</sub>Cl<sub>2</sub>F<sub>3</sub>N<sub>6</sub>O<sub>2</sub> [M +H]<sup>+</sup> 503.09714, found 503.09674. HPLC purity (254 nm): 95.55%. <i>t</i><sub>R</sub> = 8.890 min.</div></div><div id="sec4_7_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 2-Amino-4-[2,4-dichloro-6-(4,4,4-trifluorobutoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Cyclopropylamide (<b>15</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of compound <b>16</b> but substituting compound <b>62</b> with cyclopropylamine provided the title compound in 19% yield. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 7.23 (d, <i>J</i> = 1.8, 1H), 7.17 (d, <i>J</i> = 1.8, 1H), 4.48â4.54 (m, 2H), 4.21â4.33 (m, 2H), 4.01â4.15 (m, 2H), 2.51â2.61 (m, 1H), 2.00â2.23 (m, 2H), 1.80â1.93 (m, 2H), 0.60â0.71 (m, 2H), 0.43â0.53 (m, 2H). MS: (M + H <i>m</i>/<i>z</i>) = 490.2. HRMS calcd for C<sub>20</sub>H<sub>20</sub>Cl<sub>2</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup> 490.1019, found 490.1029.</div></div><div id="sec4_7_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Amino-4-(2,4-dichloro-6-phenethyloxyphenyl)-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Cyclobutylamide (<b>18</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of <b>16</b> but substituting 1-iodo-4,4,4-trifluorobutane with bromoethylbenzene provided the title compound in 24% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.30 (s, 1H), 7.26 (s, 1H), 7.02â7.18 (m, 3H), 6.98 (d, <i>J</i> = 6.4, 2H), 6.83 (br s, 2H), 6.39 (d, <i>J</i> = 7.7, 1H), 4.34â4.46 (m, 2H), 4.07â4.33 (m, 3H), 3.94 (d, <i>J</i> = 12.2, 1H), 3.60 (d, <i>J</i> = 12.6, 1H), 2.69â2.92 (m, 2H), 2.03â2.18 (m, 2H), 1.83â2.02 (m, 2H), 1.45â1.63 (m, 2H). MS: (M + H <i>m</i>/<i>z</i>) = 498.10/500.05. HRMS calcd for C<sub>25</sub>H<sub>26</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>2</sub> (M + H) 499.1488, found 499.1502, error = 2.85 ppm. HPLC purity (254 nm): 98.1%. <i>t</i><sub>R</sub> = 11.795 min.</div></div><div id="sec4_7_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 2-Amino-4-[2,4-dichloro-6-(3-cyano-3,3-dimethylpropoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Cyclobutylamide (<b>21</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of <b>16</b> but substituting 1-iodo-4,4,4-trifluorobutane with 4-bromo-2,2-dimethylbutyronitrile provided the title compound in 33% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.38 (s, 1H), 7.37 (s, 1H), 6.80 (br s, 2H), 6.51 (d, <i>J</i> = 7.7, 1H), 4.30â4.46 (m, 2H), 4.05â4.24 (m, 5H), 2.01â2.15 (m, 2H), 1.79â2.00 (m, 4H), 1.53 (d, <i>J</i> = 4.5, 2H), 1.19 (d, 6H). MS: (M + H <i>m</i>/<i>z</i>) = 489.2. HRMS calcd for C<sub>23</sub>H<sub>26</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 489.156â706, found 489.156â383. HPLC purity (254 nm): 97.21%. <i>t</i><sub>R</sub> = 9.706 min.</div></div><div id="sec4_7_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 2-Amino-4-[2,4-dichloro-6-(3-hydroxypropoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Cyclobutylamide (<b>22</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of <b>16</b> but substituting 1-iodo-4,4,4-trifluorobutane with 3-iodopropan-1-ol provided the title compound in 24% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.32 (s, 1H), 7.28 (s, 1H), 6.82 (br s, 2H), 6.51 (d, <i>J</i> = 7.54 Hz, 1H), 4.41 (br s, 2H), 4.02â4.19 (m, 5H), 3.31 (t, <i>J</i> = 5.56 Hz, 2H), 2.02â2.15 (m, 2H), 1.93â1.99 (m, 2H), 1.62â1.74 (m, 2H), 1.45â1.60 (m, 2H). MS: (M + H <i>m</i>/<i>z</i>) = 452.2. HRMS calcd for C<sub>20</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup> 452.1251, found 452.1251. HPLC purity (254 nm): 95.13%. <i>t</i><sub>R</sub> 11.273 min.</div></div><div id="sec4_7_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 2-Amino-4-[2,4-dichloro-6-(2-methoxyethoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Cyclobutylamide (<b>23</b>)</h3><div class="NLM_p last">Following the procedure for the preparation of <b>16</b> but substituting 1-iodo-4,4,4-trifluorobutane with 1-bromo-2-methoxyethane provided the title compound in 23% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.34 (d, <i>J</i> = 1.7, 1H), 7.31 (d, <i>J</i> = 1.5, 1H), 6.81 (br s, 2H), 6.49 (d, <i>J</i> = 8.1, 1H), 4.40 (br s, 2H), 4.05â4.23 (m, 5H), 3.45â3.52 (m, 2H), 3.12 (s, 3H), 2.02â2.15 (m, 2H), 1.83â1.99 (m, 2H), 1.46â1.60 (m, 2H). MS: (M + H <i>m</i>/<i>z</i>) = 452.0. HRMS calcd for C<sub>20</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup> 452.1251, found 452.1243. HPLC purity (254 nm): 98.53%. <i>t</i><sub>R</sub> = 9.524 min.</div></div><div id="sec4_7_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 2-Amino-4-[2,4-dichloro-6-(2-pyridin-2-ylethoxy)phenyl]-5,7-dihydropyrrolo[3,4-<i>d</i>]pyrimidine-6-carboxylic Acid Cyclobutylamide (<b>19</b>)</h3><div class="NLM_p last">Diisopropyl azodicarboxylate (0.040 mL, 0.21 mmol) was added to a solution of <b>48e</b> (32 mg, 0.081 mmol), 2-pyridin-2-ylethanol (34 mg, 0.28 mmol), and triphenylphosphine (53 mg, 0.20 mmol) in THF (1.5 mL) at 0 Â°C. The mixture was stirred at 23 Â°C for 3 h, diluted with DMSO (1.5 mL), and then the THF was removed under vacuum. Preparative HPLC provided the title compound as an off white powder (20.8 mg, 51%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.36 (d, <i>J</i> = 4.1, 1H), 7.50 (td, <i>J</i> = 1.8, 7.6, 1H), 7.30 (s, 2H), 6.99â7.07 (m, 1H), 6.91 (d, <i>J</i> = 7.7, 1H), 6.77 (br s, 2H), 6.37 (d, <i>J</i> = 8.1, 1H), 4.26â4.45 (m, 4H), 4.07â4.25 (m, 1H), 3.86 (d, <i>J</i> = 13.0, 1H), 2.91â3.04 (m, 2H), 2.05â2.21 (m, 2H), 1.85â2.03 (m, 2H), 1.47â1.64 (m, 2H). MS: (M + H <i>m</i>/<i>z</i> = 499.2). HRMS calcd for C<sub>24</sub>H<sub>24</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>2</sub> [M + H]<sup>+</sup> 499.1411, found 499.1411. HPLC purity (254 nm): 96.23%. <i>t</i><sub>R</sub> = 9.369 min.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64"><a href="/doi/suppl/10.1021/jm200128m">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58163" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58163" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental details and analytical data for <b>9</b>, <b>10</b>, <b>11</b>, <b>24</b>, <b>25</b>, <b>36</b>, <b>37</b>, <b>61</b>, and <b>63</b>, in vitro enzymatic competitive binding assay, cell assay, in vivo biologicals, and pharmacokinetic experiments. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200128m/suppl_file/jm200128m_si_001.pdf">jm200128m_si_001.pdf (185.75 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm200128m" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65208" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65208" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pei-Pei Kung</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7d0d18140d1814531608131a3d0d1b1407180f531e1210"><span class="__cf_email__" data-cfemail="6717020e17020e490c1209002717010e1d02154904080a">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luke Zehnder</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Bennett</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jerry Meng</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Buwen Huang</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sacha Ninkovic</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fen Wang</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Braganza</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Tatlock</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tanya Jewell</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joe Zhongxiang Zhou</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ben Burke</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeff Wang</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen Maegley</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pramod P. Mehta</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Min-Jean Yin</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ketan S. Gajiwala</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael J. Hickey</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shinji Yamazaki</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Evan Smith</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ping Kang</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anand Sistla</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elena Dovalsantos</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael R. Gehring</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Kania</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Wythes</span> - <span class="hlFld-Affiliation affiliation">La Jolla Laboratories, Pfizer Worldwide Research and Development, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i63">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18206" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18206" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to Dr. Bob Almassy for solving the cocrystal structure of compound <b>6</b> bound to Hsp90, to Muhammad Alimuddin for analytical support, to the Pfizer La Jolla Analytical Group for compound purification, and to Drs. Henry Cheng and Martin Edwards for helpful discussions.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i65" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i65"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i66" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i66"> Abbreviations Used</h2><tr><td class="NLM_term">Akt</td><td class="NLM_def"><p class="first last">serine-threonine kinase Akt</p></td></tr><tr><td class="NLM_term"><i>t</i>-BuOH</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyl alcohol</p></td></tr><tr><td class="NLM_term">CDK4</td><td class="NLM_def"><p class="first last">cyclin-dependent kinase 4, serineâthreonine kinase</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMPK</td><td class="NLM_def"><p class="first last">drug metabolism and pharamcokinetics</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">Et<sub>2</sub>O</td><td class="NLM_def"><p class="first last">diethyl ether</p></td></tr><tr><td class="NLM_term">Her2</td><td class="NLM_def"><p class="first last">human epidermal growth factor receptor 2 protein</p></td></tr><tr><td class="NLM_term">Hif1Î±</td><td class="NLM_def"><p class="first last">hypoxia-inducible factor 1Î±, a transcription factor</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high throughput screening</p></td></tr><tr><td class="NLM_term">LCâMS/MS</td><td class="NLM_def"><p class="first last">liquid chromatographyâmass spectrometry</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">PK/PD</td><td class="NLM_def"><p class="first last">pharmacokinetic/pharmacodynamic</p></td></tr><tr><td class="NLM_term"><i>i</i>-PrOH</td><td class="NLM_def"><p class="first last">isopropanol</p></td></tr><tr><td class="NLM_term">Raf</td><td class="NLM_def"><p class="first last">serineâthrenonine kinase Raf</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>R</sub></td><td class="NLM_def"><p class="first last">retention time</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85640" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85640" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Lai, B.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanek, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keh, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanks, K. W.</span><span> </span><span class="NLM_article-title">Quantitation and intracellular localization of the 85K heat shock protein by using monoclonal and polyclonal antibodies</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2802</span><span class="NLM_x">â</span> <span class="NLM_lpage">2810</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200128m&amp;key=10.1128%2FMCB.4.12.2802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm200128m&amp;key=6396506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A528%3ADyaL2MXit1Cjuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1984&pages=2802-2810&author=B.-T.+Laiauthor=N.+W.+Chinauthor=A.+E.+Stanekauthor=W.+Kehauthor=K.+W.+Lanks&title=Quantitation+and+intracellular+localization+of+the+85K+heat+shock+protein+by+using+monoclonal+and+polyclonal+antibodies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitation and intracellular localization of the 85K heat-shock protein by using monoclonal and polyclonal antibodies</span></div><div class="casAuthors">Lai, Baitang; Chin, Nena W.; Stanek, Albert E.; Keh, William; Lanks, Karl W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2802-10</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">Two monoclonal antibodies were produced against the human 85,000-mol.-wt. heat-shock protein (hsp85).  One of these, 16F1, cross-reacts with the murine homolog and is shown by peptide map immunoblots to be directed against an epitope different from that recognized by the other monoclonal antibody, 9D2.  Both monoclonal antibodies recognize only a single 85,000-mol.-wt. (Mr) species in 2-dimensional immunoblots.  Immunopptn. did not reveal an assocn. of this heat-shock protein with any other protein in HeLa cells.  Immunoperoxidase staining showed a purely cytosolic distribution at both light and electron microscopic levels and no assocn. with membranes, mitochondria, or other organelles.  The 9D2 monoclonal antibody and a polyclonal antimurine hsp85 antibody were used to identify the antigens and to quantitate their levels in a variety of normal tissues by immunoautoradiog.  Relative abundance in the various tissues as detd. by Coomassie blue staining correlates reasonably well with the immunoreactivity.  Testis and brain, for example, have high hsp85 levels, whereas heart and skeletal muscle have little or none.  The Mr-85,000 SDS-polyacrylamide gel band in testis and brain lysates was further confirmed to be hsp85 by one-dimensional partial proteolytic peptide mapping.  Based on these data and previous observations showing that synthesis and levels of the protein are altered by depriving cultured cells of glucose, it is speculated that intracellular hsp85 levels depend on differences in the intermediary metab. of glucose in the various tissues.  Furthermore, it appears that high basal levels of this heat-shock protein may not necessarily protect cells against heat shock, since testis is one of the most heat-sensitive tissues and has the highest hsp85 level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojgyxTUSdHg7Vg90H21EOLACvtfcHk0lgd4B_G8mwmLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXit1Cjuw%253D%253D&md5=8677e1d87c1fcfd121207799ec735a6a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1128%2FMCB.4.12.2802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.4.12.2802%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DB.-T.%26aulast%3DChin%26aufirst%3DN.%2BW.%26aulast%3DStanek%26aufirst%3DA.%2BE.%26aulast%3DKeh%26aufirst%3DW.%26aulast%3DLanks%26aufirst%3DK.%2BW.%26atitle%3DQuantitation%2520and%2520intracellular%2520localization%2520of%2520the%252085K%2520heat%2520shock%2520protein%2520by%2520using%2520monoclonal%2520and%2520polyclonal%2520antibodies%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1984%26volume%3D4%26spage%3D2802%26epage%3D2810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, A.</span><span> </span><span class="NLM_article-title">Hsp90 as a new therapeutic target for cancer therapy: the story unfolds</span> <span class="citation_source-journal">Expert Opin. Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">â</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm200128m&amp;key=10.1517%2F14712598.2.1.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm200128m&amp;key=11772336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVaksw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=3-24&author=P.+Workmanauthor=A.+Maloney&title=Hsp90+as+a+new+therapeutic+target+for+cancer+therapy%3A+the+story+unfolds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 as a new therapeutic target for cancer therapy: the story unfolds</span></div><div class="casAuthors">Maloney, Alison; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-24</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review. Current anticancer drug-development strategies involve identifying novel mol. targets which are crucial for tumorigenesis.  The mol. chaperone heat-shock protein (HSP) 90 is of interest as an anticancer drug target because of its importance in maintaining the conformation, stability and function of key oncogenic client proteins involved in signal transduction pathways leading to proliferation, cell cycle progression, and apoptosis, as well as other features of the malignant phenotype such as invasion, angiogenesis and metastasis.  The natural-product HSP90 inhibitors geldanamycin and radicicol exert their antitumor effect by inhibiting the intrinsic ATPase activity of HSP90, resulting in degrdn. of HSP90 client proteins via the ubiquitin proteosome pathway.  Anticancer selectivity may derive from the simultaneous combinatorial effects of HSP90 inhibitors on multiple cancer targets and pathways. 17-Allylamino-17-demethoxygeldanamycin (17AAG) showed good activity and cancer selectivity in preclin. models and has now progressed to Phase I clin. trials in cancer patients with encouraging initial results.  Phase II trials including combination studies with cytotoxic agents are now being planned and these should allow the therapeutic activity of 17AAG to be detd.  Second-generation HSP90 inhibitors may be designed to overcome some of the drawbacks of 17AAG, including limited oral bioavailability and soly.  They could also be engineered to target specific functions of HSP90, which may not only provide greater mol. selectivity and clin. benefit but may also increase understanding of the complex functions of this mol. chaperone.  HSP90 inhibitors provide proof of concept for drugs directed at HSP90 and protein folding and this principle may be applicable to other medical conditions involving protein aggregation and stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxpya4HhGPu7Vg90H21EOLACvtfcHk0lj5S3L20pP9WQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVaksw%253D%253D&md5=b0542acde22286a95578e3ef4dac0d8e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F14712598.2.1.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14712598.2.1.3%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DMaloney%26aufirst%3DA.%26atitle%3DHsp90%2520as%2520a%2520new%2520therapeutic%2520target%2520for%2520cancer%2520therapy%253A%2520the%2520story%2520unfolds%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2002%26volume%3D2%26spage%3D3%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimnaugh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosser, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarden, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Sensitivity of mature ErbB2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein 90</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">3702</span><span class="NLM_x">â</span> <span class="NLM_lpage">3708</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=3702-3708&author=W.+Xuauthor=E.+Mimnaughauthor=M.+F.+Rosserauthor=C.+Nicchittaauthor=M.+Marcuauthor=Y.+Yardenauthor=L.+Neckers&title=Sensitivity+of+mature+ErbB2+to+geldanamycin+is+conferred+by+its+kinase+domain+and+is+mediated+by+the+chaperone+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DW.%26aulast%3DMimnaugh%26aufirst%3DE.%26aulast%3DRosser%26aufirst%3DM.%2BF.%26aulast%3DNicchitta%26aufirst%3DC.%26aulast%3DMarcu%26aufirst%3DM.%26aulast%3DYarden%26aufirst%3DY.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DSensitivity%2520of%2520mature%2520ErbB2%2520to%2520geldanamycin%2520is%2520conferred%2520by%2520its%2520kinase%2520domain%2520and%2520is%2520mediated%2520by%2520the%2520chaperone%2520protein%252090%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D3702%26epage%3D3708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruo, T.</span><span> </span><span class="NLM_article-title">Modulation of AKT kinase activity by binding to Hsp90</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">10832</span><span class="NLM_x">â</span> <span class="NLM_lpage">10837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=10832-10837&author=S.+Satoauthor=N.+Fujitaauthor=T.+Tsuruo&title=Modulation+of+AKT+kinase+activity+by+binding+to+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DS.%26aulast%3DFujita%26aufirst%3DN.%26aulast%3DTsuruo%26aufirst%3DT.%26atitle%3DModulation%2520of%2520AKT%2520kinase%2520activity%2520by%2520binding%2520to%2520Hsp90%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D10832%26epage%3D10837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siligardi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâBrien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolfson, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panaretou, B.</span><span> </span><span class="NLM_article-title">Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">754</span><span class="NLM_x">â</span> <span class="NLM_lpage">762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=754-762&author=C.+Prodromouauthor=G.+Siligardiauthor=R.+O%E2%80%99Brienauthor=D.+N.+Woolfsonauthor=L.+Reganauthor=B.+Panaretou&title=Regulation+of+Hsp90+ATPase+activity+by+tetratricopeptide+repeat+%28TPR%29-domain+co-chaperones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DSiligardi%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DR.%26aulast%3DWoolfson%26aufirst%3DD.%2BN.%26aulast%3DRegan%26aufirst%3DL.%26aulast%3DPanaretou%26aufirst%3DB.%26atitle%3DRegulation%2520of%2520Hsp90%2520ATPase%2520activity%2520by%2520tetratricopeptide%2520repeat%2520%2528TPR%2529-domain%2520co-chaperones%26jtitle%3DEMBO%2520J.%26date%3D1999%26volume%3D18%26spage%3D754%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Dutta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inouye, M.</span><span> </span><span class="NLM_article-title">GHKL, an emergent ATPase/kinase superfamily</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">â</span> <span class="NLM_lpage">28</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2000&pages=24-28&author=R.+Duttaauthor=M.+Inouye&title=GHKL%2C+an+emergent+ATPase%2Fkinase+superfamily"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DR.%26aulast%3DInouye%26aufirst%3DM.%26atitle%3DGHKL%252C%2520an%2520emergent%2520ATPase%252Fkinase%2520superfamily%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2000%26volume%3D25%26spage%3D24%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Obermann, W. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sondermann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, F. U.</span><span> </span><span class="NLM_article-title">In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">901</span><span class="NLM_x">â</span> <span class="NLM_lpage">910</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=1998&pages=901-910&author=W.+M.+J.+Obermannauthor=H.+Sondermannauthor=A.+A.+Russoauthor=N.+P.+Pavletichauthor=F.+U.+Hartl&title=In+vivo+function+of+Hsp90+is+dependent+on+ATP+binding+and+ATP+hydrolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObermann%26aufirst%3DW.%2BM.%2BJ.%26aulast%3DSondermann%26aufirst%3DH.%26aulast%3DRusso%26aufirst%3DA.%2BA.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26atitle%3DIn%2520vivo%2520function%2520of%2520Hsp90%2520is%2520dependent%2520on%2520ATP%2520binding%2520and%2520ATP%2520hydrolysis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1998%26volume%3D143%26spage%3D901%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimnaugh, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Costa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L. M.</span><span> </span><span class="NLM_article-title">Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">8324</span><span class="NLM_x">â</span> <span class="NLM_lpage">8328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200128m&amp;key=10.1073%2Fpnas.91.18.8324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200128m&amp;key=8078881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A528%3ADyaK2cXlslKnsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=8324-8328&author=L.+Whitesellauthor=E.+G.+Mimnaughauthor=B.+De+Costaauthor=C.+E.+Myersauthor=L.+M.+Neckers&title=Inhibition+of+heat+shock+protein+HSP90-pp60v-src+heteroprotein+complex+formation+by+benzoquinone+ansamycins%3A+essential+role+for+stress+proteins+in+oncogenic+transformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation</span></div><div class="casAuthors">Whitesell, Luke; Mimnaugh, Edward G.; De Costa, Brian; Myers, Charles E.; Neckers, Leonard M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8324-8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The mol. mechanisms by which oncogenic tyrosine kinases induce cellular transformation are unclear.  Herbimycin A, geldanamycin, and certain other benzoquinone ansamycins display an unusual capacity to revert tyrosine kinase-induced oncogenic transformation.  As an approach to the study of v-src-mediated transformation, the authors examd. ansamycin action in transformed cells and found that drug-induced reversion could be achieved without direct inhibition of src phosphorylating activity.  To identify mechanisms other than kinase inhibition for drug-mediated reversion, the authors prepd. a solid phase-immobilized geldanamycin deriv. and affinity pptd. the mol. targets with which the drug interacted.  In a range of cell lines, immobilized geldanamycin bound elements of a major class of heat shock protein (HSP90) in a stable and pharmacol. specific manner.  Consistent with these binding data, the authors found that sol. geldanamycin and herbimycin A inhibited specifically the formation of a previously described src-HSP90 heteroprotein complex.  A related benzoquinone ansamycin that failed to revert transformed cells did not inhibit the formation of this complex.  These results demonstrate that HSP participation in multimol. complex formation is required for src-mediated transformation and can provide a target for drug modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfTW8DJOglQLVg90H21EOLACvtfcHk0liB0mPozTHFMw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlslKnsLw%253D&md5=18f1cad01698df44adaa05ef3da9f850</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.18.8324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.18.8324%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DMimnaugh%26aufirst%3DE.%2BG.%26aulast%3DDe%2BCosta%26aufirst%3DB.%26aulast%3DMyers%26aufirst%3DC.%2BE.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DInhibition%2520of%2520heat%2520shock%2520protein%2520HSP90-pp60v-src%2520heteroprotein%2520complex%2520formation%2520by%2520benzoquinone%2520ansamycins%253A%2520essential%2520role%2520for%2520stress%2520proteins%2520in%2520oncogenic%2520transformation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1994%26volume%3D91%26spage%3D8324%26epage%3D8328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reigan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, D.</span><span> </span><span class="NLM_article-title">Enzymatic reduction and glutathione conjugation of benzoquinone ansamycin heat shock protein 90 inhibitors: relevance for toxicity and mechanism of action</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2050</span><span class="NLM_x">â</span> <span class="NLM_lpage">2057</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=2050-2057&author=W.+Guoauthor=P.+Reiganauthor=D.+Siegelauthor=D.+Ross&title=Enzymatic+reduction+and+glutathione+conjugation+of+benzoquinone+ansamycin+heat+shock+protein+90+inhibitors%3A+relevance+for+toxicity+and+mechanism+of+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DReigan%26aufirst%3DP.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DEnzymatic%2520reduction%2520and%2520glutathione%2520conjugation%2520of%2520benzoquinone%2520ansamycin%2520heat%2520shock%2520protein%252090%2520inhibitors%253A%2520relevance%2520for%2520toxicity%2520and%2520mechanism%2520of%2520action%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D2050%26epage%3D2057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Solit, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikorski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slovin, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLaCruz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egorin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scher, H. I.</span><span> </span><span class="NLM_article-title">Phase 1 trial of 17-allylamino-17-demthoxygeldanamycin in patients with advance cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1775</span><span class="NLM_x">â</span> <span class="NLM_lpage">1782</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm200128m&amp;key=10.1158%2F1078-0432.CCR-06-1863" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200128m&amp;key=17363532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2gtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1775-1782&author=D.+B.+Solitauthor=S.+P.+Ivyauthor=C.+Kopilauthor=R.+Sikorskiauthor=M.+J.+Morrisauthor=S.+F.+Slovinauthor=W.+K.+Kellyauthor=A.+DeLaCruzauthor=T.+Curleyauthor=G.+Hellerauthor=S.+Larsonauthor=L.+Schwartzauthor=M.+J.+Egorinauthor=N.+Rosenauthor=H.+I.+Scher&title=Phase+1+trial+of+17-allylamino-17-demthoxygeldanamycin+in+patients+with+advance+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer</span></div><div class="casAuthors">Solit, David B.; Ivy, S. Percy; Kopil, Catherine; Sikorski, Rachel; Morris, Michael J.; Slovin, Susan F.; Kelly, W. Kevin; DeLaCruz, Anthony; Curley, Tracy; Heller, Glenn; Larson, Steven; Schwartz, Lawrence; Egorin, Merrill J.; Rosen, Neal; Scher, Howard I.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1775-1782</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To define the max. tolerated dose (MTD), toxicities, and pharmacokinetics of 17-allylamino-17-demethoxygeldanamycin (17-AAG) when administered using continuous and intermittent dosing schedules.  Patients with progressive solid tumor malignancies were treated with 17-AAG using an accelerated titrn. dose escalation schema.  The starting dose and schedule were 5 mg/m2 daily for 5 days with cycles repeated every 21 days.  Dosing modifications based on safety, pharmacodynamic modeling, and clin. outcomes led to the evaluation of the following schedules: daily x 3 repeated every 14 days; twice weekly (days 1, 4, 8, and 11) for 2 wk every 3 wk; and twice weekly (days 1 and 4) without interruption.  During cycle 1, blood was collected for pharmacokinetic and pharmacodynamic studies.  Fifty-four eligible patients were treated.  The MTD was schedule dependent: 56 mg/m2 on the daily x 5 schedule; 112 mg/m2 on the daily x 3 schedule; and 220 mg/m2 on the days 1, 4, 8, and 11 every-21-day schedule.  Continuous twice-weekly dosing was deemed too toxic because of delayed hepatotoxicity.  Hepatic toxicity was also dose limiting with the daily x 5 schedule.  Other common toxicities encountered were fatigue, myalgias, and nausea.  This latter adverse effect may have been attributable, in part, to the DMSO-based formulation.  Concns. of 17-AAG above those required for activity in preclin. models could be safely achieved in plasma.  Induction of a heat shock response and down-regulation of Akt and Raf-1 were obsd. in biomarker studies.  The MTD and toxicity profile of 17-AAG were schedule dependent.  Intermittent dosing schedules were less toxic and are recommended for future phase II studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGKeAL9KtMGbVg90H21EOLACvtfcHk0liB0mPozTHFMw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2gtL4%253D&md5=7de014104bbd48f42ec8faac2e8d92ed</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-1863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-1863%26sid%3Dliteratum%253Aachs%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DIvy%26aufirst%3DS.%2BP.%26aulast%3DKopil%26aufirst%3DC.%26aulast%3DSikorski%26aufirst%3DR.%26aulast%3DMorris%26aufirst%3DM.%2BJ.%26aulast%3DSlovin%26aufirst%3DS.%2BF.%26aulast%3DKelly%26aufirst%3DW.%2BK.%26aulast%3DDeLaCruz%26aufirst%3DA.%26aulast%3DCurley%26aufirst%3DT.%26aulast%3DHeller%26aufirst%3DG.%26aulast%3DLarson%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DL.%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DScher%26aufirst%3DH.%2BI.%26atitle%3DPhase%25201%2520trial%2520of%252017-allylamino-17-demthoxygeldanamycin%2520in%2520patients%2520with%2520advance%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1775%26epage%3D1782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Sydor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pien, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grenier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dembski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penders, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grayzel, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombella, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, J. K.</span><span> </span><span class="NLM_article-title">Development of 17-allylamino-17-dimethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">17408</span><span class="NLM_x">â</span> <span class="NLM_lpage">17413</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=17408-17413&author=J.+R.+Sydorauthor=E.+Normantauthor=C.+S.+Pienauthor=J.+R.+Porterauthor=J.+Geauthor=L.+Grenierauthor=R.+H.+Pakauthor=J.+A.+Aliauthor=M.+S.+Dembskiauthor=J.+Hudakauthor=J.+Pattersonauthor=C.+Pendersauthor=M.+Pinkauthor=M.+A.+Readauthor=J.+Sangauthor=C.+Woodwardauthor=Y.+Zhangauthor=D.+S.+Grayzelauthor=J.+Wrightauthor=J.+A.+Barrettauthor=V.+J.+Palombellaauthor=J.+Adamsauthor=J.+K.+Tong&title=Development+of+17-allylamino-17-dimethoxygeldanamycin+hydroquinone+hydrochloride+%28IPI-504%29%2C+an+anti-cancer+agent+directed+against+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DPien%26aufirst%3DC.%2BS.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DPak%26aufirst%3DR.%2BH.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DDembski%26aufirst%3DM.%2BS.%26aulast%3DHudak%26aufirst%3DJ.%26aulast%3DPatterson%26aufirst%3DJ.%26aulast%3DPenders%26aufirst%3DC.%26aulast%3DPink%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DM.%2BA.%26aulast%3DSang%26aufirst%3DJ.%26aulast%3DWoodward%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGrayzel%26aufirst%3DD.%2BS.%26aulast%3DWright%26aufirst%3DJ.%26aulast%3DBarrett%26aufirst%3DJ.%2BA.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DJ.%2BK.%26atitle%3DDevelopment%2520of%252017-allylamino-17-dimethoxygeldanamycin%2520hydroquinone%2520hydrochloride%2520%2528IPI-504%2529%252C%2520an%2520anti-cancer%2520agent%2520directed%2520against%2520Hsp90%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D17408%26epage%3D17413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Janin, Y. L.</span><span> </span><span class="NLM_article-title">ATPase inhibitiors of heat shock protein 90, second season</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">â</span> <span class="NLM_lpage">353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=342-353&author=Y.+L.+Janin&title=ATPase+inhibitiors+of+heat+shock+protein+90%2C+second+season"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJanin%26aufirst%3DY.%2BL.%26atitle%3DATPase%2520inhibitiors%2520of%2520heat%2520shock%2520protein%252090%252C%2520second%2520season%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26spage%3D342%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brekken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grecko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansfield, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span> </span><span class="NLM_article-title">Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2767</span><span class="NLM_x">â</span> <span class="NLM_lpage">2778</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050752%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2767-2778&author=S.+R.+Kasibhatlaauthor=K.+Hongauthor=M.+A.+Biamonteauthor=D.+J.+Buschauthor=P.+L.+Karjianauthor=J.+L.+Sensintaffarauthor=A.+Kamalauthor=R.+E.+Loughauthor=J.+Brekkenauthor=K.+Lundgrenauthor=R.+Greckoauthor=G.+A.+Timonyauthor=Y.+Ranauthor=R.+Mansfieldauthor=L.+C.+Fritzauthor=E.+Ulmauthor=F.+J.+Burrowsauthor=M.+F.+Boehm&title=Rationally+designed+high-affinity+2-amino-6-halopurine+heat+shock+protein+90+inhibitors+that+exhibit+potent+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm050752%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050752%252B%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DBrekken%26aufirst%3DJ.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DGrecko%26aufirst%3DR.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DMansfield%26aufirst%3DR.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DUlm%26aufirst%3DE.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26atitle%3DRationally%2520designed%2520high-affinity%25202-amino-6-halopurine%2520heat%2520shock%2520protein%252090%2520inhibitors%2520that%2520exhibit%2520potent%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2767%26epage%3D2778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Huang, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fadden, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaves, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strachan, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barabasz, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barta, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partridge, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuBois, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freed, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steed, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ommen, A, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCall, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markworth, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinkley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenks, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pronk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verleysen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, S. E.</span><span> </span><span class="NLM_article-title">Discovery of novel 2- aminobenzamide inhibitors of heat shock protein 90 as potent, selective, and orally active antitumor agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4288</span><span class="NLM_x">â</span> <span class="NLM_lpage">4305</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900230j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4288-4305&author=K.+H.+Huangauthor=J.+M.+Vealauthor=R.+P.+Faddenauthor=J.+W.+Riceauthor=J.+Eavesauthor=J.-P.+Strachanauthor=A.+F.+Barabaszauthor=B.+E.+Foleyauthor=T.+E.+Bartaauthor=W.+Maauthor=M.+A.+Silinskiauthor=M.+Huauthor=J.+M.+Partridgeauthor=A.+Scottauthor=L.+G.+DuBoisauthor=T.+Freedauthor=P.+M.+Steedauthor=A%2C+J.+Ommenauthor=E.+D.+Smithauthor=P.+F.+Hughesauthor=A.+R.+Woodwardauthor=G.+J.+Hansonauthor=W.+S.+McCallauthor=C.+J.+Markworthauthor=L.+Hinkleyauthor=M.+Jenksauthor=L.+Gengauthor=M.+Lewisauthor=J.+Ottoauthor=B.+Pronkauthor=K.+Verleysenauthor=S.+E.+Hall&title=Discovery+of+novel+2-+aminobenzamide+inhibitors+of+heat+shock+protein+90+as+potent%2C+selective%2C+and+orally+active+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm900230j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900230j%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BH.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DFadden%26aufirst%3DR.%2BP.%26aulast%3DRice%26aufirst%3DJ.%2BW.%26aulast%3DEaves%26aufirst%3DJ.%26aulast%3DStrachan%26aufirst%3DJ.-P.%26aulast%3DBarabasz%26aufirst%3DA.%2BF.%26aulast%3DFoley%26aufirst%3DB.%2BE.%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DSilinski%26aufirst%3DM.%2BA.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DPartridge%26aufirst%3DJ.%2BM.%26aulast%3DScott%26aufirst%3DA.%26aulast%3DDuBois%26aufirst%3DL.%2BG.%26aulast%3DFreed%26aufirst%3DT.%26aulast%3DSteed%26aufirst%3DP.%2BM.%26aulast%3DOmmen%26aufirst%3DA%252C%2BJ.%26aulast%3DSmith%26aufirst%3DE.%2BD.%26aulast%3DHughes%26aufirst%3DP.%2BF.%26aulast%3DWoodward%26aufirst%3DA.%2BR.%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DMcCall%26aufirst%3DW.%2BS.%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26aulast%3DHinkley%26aufirst%3DL.%26aulast%3DJenks%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DOtto%26aufirst%3DJ.%26aulast%3DPronk%26aufirst%3DB.%26aulast%3DVerleysen%26aufirst%3DK.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DDiscovery%2520of%2520novel%25202-%2520aminobenzamide%2520inhibitors%2520of%2520heat%2520shock%2520protein%252090%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4288%26epage%3D4305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgognoni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N. G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fromont, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padfield, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radimerski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmonite, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walls, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span> </span><span class="NLM_article-title">Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-<i>d</i>]pyrimidine inhibitors of the Hsp90 molecular chaperone</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4794</span><span class="NLM_x">â</span> <span class="NLM_lpage">4809</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900357y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1ehsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4794-4809&author=P.+A.+Broughauthor=X.+Barrilauthor=J.+Borgognoniauthor=P.+Cheneauthor=N.+G.+M.+Daviesauthor=B.+Davisauthor=M.+J.+Drysdaleauthor=B.+Dymockauthor=S.+A.+Ecclesauthor=C.+Garcia-Echeverriaauthor=C.+Fromontauthor=A.+Hayesauthor=R.+E.+Hubbardauthor=A.+M.+Jordanauthor=M.+R.+Jensenauthor=A.+Masseyauthor=A.+Merrettauthor=A.+Padfieldauthor=R.+Parsonsauthor=T.+Radimerskiauthor=F.+I.+Raynaudauthor=A.+Robertsonauthor=S.+D.+Roughleyauthor=J.+Schoepferauthor=H.+Simmoniteauthor=S.+Y.+Sharpauthor=A.+Surgenorauthor=M.+Valentiauthor=S.+Wallsauthor=P.+Webbauthor=M.+Woodauthor=P.+Workmanauthor=L.+Wright&title=Combining+hit+identification+strategies%3A+fragment-based+and+in+silico+approaches+to+orally+active+2-aminothieno%5B2%2C3-d%5Dpyrimidine+inhibitors+of+the+Hsp90+molecular+chaperone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-d]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone</span></div><div class="casAuthors">Brough, Paul A.; Barril, Xavier; Borgognoni, Jenifer; Chene, Patrick; Davies, Nicholas G. M.; Davis, Ben; Drysdale, Martin J.; Dymock, Brian; Eccles, Suzanne A.; Garcia-Echeverria, Carlos; Fromont, Christophe; Hayes, Angela; Hubbard, Roderick E.; Jordan, Allan M.; Jensen, Michael Rugaard; Massey, Andrew; Merrett, Angela; Padfield, Antony; Parsons, Rachel; Radimerski, Thomas; Raynaud, Florence I.; Robertson, Alan; Roughley, Stephen D.; Schoepfer, Joseph; Simmonite, Heather; Sharp, Swee Y.; Surgenor, Allan; Valenti, Melanie; Walls, Steven; Webb, Paul; Wood, Mike; Workman, Paul; Wright, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4794-4809</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the Hsp90 mol. chaperone are showing considerable promise as potential mol. therapeutic agents for the treatment of cancer.  Here we describe novel 2-aminothieno[2,3-d]pyrimidine ATP competitive Hsp90 inhibitors, which were designed by combining structural elements of distinct low affinity hits generated from fragment-based and in silico screening exercises in concert with structural information from X-ray protein crystallog.  Examples from this series have high affinity (IC50 = 50-100 nM) for Hsp90 as measured in a fluorescence polarization (FP) competitive binding assay and are active in human cancer cell lines where they inhibit cell proliferation and exhibit a characteristic profile of depletion of oncogenic proteins and concomitant elevation of Hsp72.  Several compds. caused tumor growth regression at well tolerated doses when administered orally in a human BT474 human breast cancer xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqofpAier7tW7Vg90H21EOLACvtfcHk0lgUBoNxoVCwDQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1ehsbs%253D&md5=4d1988060b0f87dc776e1972ea14808e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm900357y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900357y%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DDavies%26aufirst%3DN.%2BG.%2BM.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26aulast%3DFromont%26aufirst%3DC.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMerrett%26aufirst%3DA.%26aulast%3DPadfield%26aufirst%3DA.%26aulast%3DParsons%26aufirst%3DR.%26aulast%3DRadimerski%26aufirst%3DT.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobertson%26aufirst%3DA.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DSchoepfer%26aufirst%3DJ.%26aulast%3DSimmonite%26aufirst%3DH.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWalls%26aufirst%3DS.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26atitle%3DCombining%2520hit%2520identification%2520strategies%253A%2520fragment-based%2520and%2520in%2520silico%2520approaches%2520to%2520orally%2520active%25202-aminothieno%255B2%252C3-d%255Dpyrimidine%2520inhibitors%2520of%2520the%2520Hsp90%2520molecular%2520chaperone%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4794%26epage%3D4809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Hopkins, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groome, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">â</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm200128m&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm200128m&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=L.+A.+Hopkinsauthor=C.+R.+Groomeauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2ebKvLJfO7MqBrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DL.%2BA.%26aulast%3DGroome%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lesson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">â</span> <span class="NLM_lpage">890</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Lessonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLesson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid assessment of a novel series of selective CB<sub>2</sub> agonists using parallel synthesis protocols: a lipophilic efficiency (LipE) analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4406</span><span class="NLM_x">â</span> <span class="NLM_lpage">4409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Fjm200128m&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Fjm200128m&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+assessment+of+a+novel+series+of+selective+CB2+agonists+using+parallel+synthesis+protocols%3A+a+lipophilic+efficiency+%28LipE%29+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0lgV6cFnoLNv7g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520assessment%2520of%2520a%2520novel%2520series%2520of%2520selective%2520CB2%2520agonists%2520using%2520parallel%2520synthesis%2520protocols%253A%2520a%2520lipophilic%2520efficiency%2520%2528LipE%2529%2520analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4406%26epage%3D4409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Sides, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leschinger, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walenta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNay, J. L.,  Jr.</span><span> </span><span class="NLM_article-title">The tolerability and adverse event profile of moxonidine</span> <span class="citation_source-journal">Rev. Contemp. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">â</span> <span class="NLM_lpage">499</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A528%3ADyaK1cXlvVans7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=491-499&author=G.+D.+Sidesauthor=M.+I.+Leschingerauthor=R.+Walentaauthor=J.+L.+McNay&title=The+tolerability+and+adverse+event+profile+of+moxonidine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The tolerability and adverse event profile of moxonidine</span></div><div class="casAuthors">Sides, Gregory D.; Leschinger, Monika I.; Walenta, Rainer; McNay, John L., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in Contemporary Pharmacotherapy</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">491-499</span>CODEN:
                <span class="NLM_cas:coden">RCPHFW</span>;
        ISSN:<span class="NLM_cas:issn">0954-8602</span>.
    
            (<span class="NLM_cas:orgname">Marius Press</span>)
        </div><div class="casAbstract">A review with 24 refs.  Moxonidine, an orally-administered antihypertensive drug, is a selective imidazoline I1-receptor agonist.  The human safety database for moxonidine is extensive.  Adverse events obsd. are well recognized, dose-related and benign.  The most common adverse events reported by patients taking moxonidine for blood pressure control include dry mouth, somnolence and headache.  These symptoms often subside during the first few weeks of treatment.  Less common adverse events include dizziness, peripheral edema, nausea, back pain, abdominal pain, vasodilatation and rash.  Moxonidine administration is well tolerated over a broad dose range and a documented treatment duration in long-term studies of up to 2 yr.  The greater the duration of moxonidine treatment, the less the incidence and severity of adverse events.  The likelihood of serious and potentially life-threatening adverse events is very low.  Rebound hypertension following discontinuation of moxonidine at the currently approved doses is not obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXYNf3N7MvELVg90H21EOLACvtfcHk0lh76VeEpEHOvA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvVans7w%253D&md5=0df8d2a595ac1134b2bd9d961d351bd8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSides%26aufirst%3DG.%2BD.%26aulast%3DLeschinger%26aufirst%3DM.%2BI.%26aulast%3DWalenta%26aufirst%3DR.%26aulast%3DMcNay%26aufirst%3DJ.%2BL.%26atitle%3DThe%2520tolerability%2520and%2520adverse%2520event%2520profile%2520of%2520moxonidine%26jtitle%3DRev.%2520Contemp.%2520Pharmacother.%26date%3D1998%26volume%3D9%26spage%3D491%26epage%3D499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Kung, P.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digits, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaptason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neul, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zientek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elleraas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajiwala, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehring, M. R.</span><span> </span><span class="NLM_article-title">Dihydroxyphenylisoindoline amides as orally bioavailable inhibitors of the heat shock protein 90 (Hsp90) molecular chaperone</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">â</span> <span class="NLM_lpage">503</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901209q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=499-503&author=P.-P.+Kungauthor=B.+Huangauthor=G.+Zhangauthor=J.+Z.+Zhouauthor=J.+Wangauthor=J.+A.+Digitsauthor=J.+Skaptasonauthor=S.+Yamazakiauthor=D.+Neulauthor=M.+Zientekauthor=J.+Elleraasauthor=P.+Mehtaauthor=M.-J.+Yinauthor=M.+J.+Hickeyauthor=K.+S.+Gajiwalaauthor=C.+Rodgersauthor=J.+F.+Daviesauthor=M.+R.+Gehring&title=Dihydroxyphenylisoindoline+amides+as+orally+bioavailable+inhibitors+of+the+heat+shock+protein+90+%28Hsp90%29+molecular+chaperone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm901209q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901209q%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DJ.%2BZ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDigits%26aufirst%3DJ.%2BA.%26aulast%3DSkaptason%26aufirst%3DJ.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DNeul%26aufirst%3DD.%26aulast%3DZientek%26aufirst%3DM.%26aulast%3DElleraas%26aufirst%3DJ.%26aulast%3DMehta%26aufirst%3DP.%26aulast%3DYin%26aufirst%3DM.-J.%26aulast%3DHickey%26aufirst%3DM.%2BJ.%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DRodgers%26aufirst%3DC.%26aulast%3DDavies%26aufirst%3DJ.%2BF.%26aulast%3DGehring%26aufirst%3DM.%2BR.%26atitle%3DDihydroxyphenylisoindoline%2520amides%2520as%2520orally%2520bioavailable%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%2520%2528Hsp90%2529%2520molecular%2520chaperone%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D499%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Mehta, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walls, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehring, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, M.-J.</span><span> </span><span class="NLM_article-title">A novel class of specific Hsp90 small molecule inhibitors demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">300</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">â</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm200128m&amp;key=10.1016%2Fj.canlet.2010.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm200128m&amp;key=20926183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGns7%252FK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2011&pages=30-39&author=P.+P.+Mehtaauthor=P.-P.+Kungauthor=S.+Yamazakiauthor=M.+Wallsauthor=A.+Shenauthor=L.+Nguyenauthor=M.+Gehringauthor=G.+Losauthor=T.+Smealauthor=M.-J.+Yin&title=A+novel+class+of+specific+Hsp90+small+molecule+inhibitors+demonstrate+in+vitro+and+in+vivo+anti-tumor+activity+in+human+melanoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A novel class of specific Hsp90 small molecule inhibitors demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells</span></div><div class="casAuthors">Mehta, Pramod P.; Kung, Pei-Pei; Yamazaki, Shinji; Walls, Marlena; Shen, Andrea; Nguyen, Leslie; Gehring, Michael R.; Los, Gerrit; Smeal, Tod; Yin, Min-Jean</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">300</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-39</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Hsp90 is required for conformational maturation and stability of numerous key signaling proteins (clients) involved in cell proliferation and transformation.  Here we describe 2 novel Hsp90 inhibitors, PF-4470296 and PF-3823863, demonstrate a differential sensitivity in B-Raf mutant (V600E) vs. wild-type protein degrdn.  These 2 inhibitors inhibit proliferation and anchorage-independent growth, and abolish in vivo xenograft tumor growth in melanoma cells regardless of B-Raf mutation status.  Mutant B-Raf protein and other Hsp90 clients, such as cMet, ErbB2, C-Raf, and AKT, are degraded in cells and xenograft tumors.  Our results indicate that Hsp90 inhibitors induce anti-tumor activity in melanoma cells and are likely to show therapeutic benefit in melanoma patients by collaboratively targeting multiple pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNMSNEVcm2SrVg90H21EOLACvtfcHk0lh76VeEpEHOvA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGns7%252FK&md5=ed606cba29eb6ac9acc90f0ebf715c10</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2010.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2010.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DMehta%26aufirst%3DP.%2BP.%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DWalls%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DGehring%26aufirst%3DM.%26aulast%3DLos%26aufirst%3DG.%26aulast%3DSmeal%26aufirst%3DT.%26aulast%3DYin%26aufirst%3DM.-J.%26atitle%3DA%2520novel%2520class%2520of%2520specific%2520Hsp90%2520small%2520molecule%2520inhibitors%2520demonstrate%2520in%2520vitro%2520and%2520in%2520vivo%2520anti-tumor%2520activity%2520in%2520human%2520melanoma%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2011%26volume%3D300%26spage%3D30%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Diaz, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitza, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gintant, G. A.</span><span> </span><span class="NLM_article-title">The [<sup>3</sup>H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: comparison of intact cell and membrane preparations and effects of altering [K<sup>+</sup>]<sub>o</sub></span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">â</span> <span class="NLM_lpage">199</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm200128m&amp;key=10.1016%2Fj.vascn.2004.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm200128m&amp;key=15519905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFOmtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2004&pages=187-199&author=G.+J.+Diazauthor=K.+Daniellauthor=S.+T.+Leitzaauthor=R.+L.+Martinauthor=Z.+Suauthor=J.+S.+McDermottauthor=B.+F.+Coxauthor=G.+A.+Gintant&title=The+%5B3H%5Ddofetilide+binding+assay+is+a+predictive+screening+tool+for+hERG+blockade+and+proarrhythmia%3A+comparison+of+intact+cell+and+membrane+preparations+and+effects+of+altering+%5BK%2B%5Do"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o</span></div><div class="casAuthors">Diaz, Gilbert J.; Daniell, Katina; Leitza, Sandra T.; Martin, Ruth L.; Su, Zhi; McDermott, Jeffrey S.; Cox, Bryan F.; Gintant, Gary A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-199</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: The human ether-a-go-go-related gene (hERG) encodes a potassium channel responsible for the cardiac delayed rectifier current (IKr) involved in ventricular repolarization.  Drugs that block hERG have been assocd. with QT interval prolongation and serious, sometimes fatal, cardiac arrhythmias (including torsade de pointes).  While displacement of [3H]dofetilide, a potent methanesulfonanilide hERG blocker, from cells heterologously expressing hERG has been suggested as a screening assay, questions have been raised about its predictive value.Methods: To validate the utility of this assay as a screening tool, we performed a series of satn. and competition binding studies using [3H]dofetilide as ligand and either intact cells or membrane prepns. from HEK 293 cells stably transfected with hERG K+ channels.  The object of these expts. was to (1) compare binding Ki values for 22 hERG blockers using intact cells or membrane homogenates to det. whether maintaining cell integrity enhanced assay reliability; (2) evaluate the ability of different K+ concns. (2, 5, 10, 20, and 60 mM) to modulate hERG binding; and (3) to establish the predictive value of the assay by comparing Ki values from binding studies at 5 and 60 mM [K+]o to functional IC50 values for hERG current block using 56 structurally diverse drugs.Results: We found (a) comparable Ki values in the intact cell and isolated membrane binding assays, although there were some differences in rank order; (b) increasing [K+]o lowered the Kd and increased the Bmax for [3H]dofetilide, particularly in the membrane assay; and (c) good correlation between binding Ki values and functional IC50 values for hERG current block.Discussion: In conclusion, increasing K+ concns. results in an increase in both [3H]dofetilide affinity for hERG and available binding sites, particularly when using membrane homogenates.  There are no meaningful differences between Ki values when comparing intact cell vs. membrane assay, neither are there meaningful trends with increasing [K+]o within assays.  There is good correlation between binding Ki values and functional (whole-cell patch clamp) IC50 values at both 5 and 60 mM K+ concns. (R2 values of .824 and .863, resp.).  The simplicity, predictability, and adaptability to high-throughput platforms make the [3H]dofetilide membrane binding assay a useful tool for screening and ranking compds. for their potential to block the hERG K+ channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJEs_DWLzvI7Vg90H21EOLACvtfcHk0ljsB7lry_euUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFOmtLk%253D&md5=28c925ef02404c53443dc90eae961ed1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2004.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2004.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DG.%2BJ.%26aulast%3DDaniell%26aufirst%3DK.%26aulast%3DLeitza%26aufirst%3DS.%2BT.%26aulast%3DMartin%26aufirst%3DR.%2BL.%26aulast%3DSu%26aufirst%3DZ.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DCox%26aufirst%3DB.%2BF.%26aulast%3DGintant%26aufirst%3DG.%2BA.%26atitle%3DThe%2520%255B3H%255Ddofetilide%2520binding%2520assay%2520is%2520a%2520predictive%2520screening%2520tool%2520for%2520hERG%2520blockade%2520and%2520proarrhythmia%253A%2520comparison%2520of%2520intact%2520cell%2520and%2520membrane%2520preparations%2520and%2520effects%2520of%2520altering%2520%255BK%252B%255Do%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2004%26volume%3D50%26spage%3D187%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Kreusch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesley, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, X.-J.</span><span> </span><span class="NLM_article-title">Crystal structures of human Hsp90a-complexed with dihydroxyphenylprazoles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1475</span><span class="NLM_x">â</span> <span class="NLM_lpage">1478</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1475-1478&author=A.+Kreuschauthor=S.+Hanauthor=A.+Brinkerauthor=V.+Zhouauthor=H.-S.+Choiauthor=Y.+Heauthor=S.+A.+Lesleyauthor=J.+Caldwellauthor=X.-J.+Gu&title=Crystal+structures+of+human+Hsp90a-complexed+with+dihydroxyphenylprazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKreusch%26aufirst%3DA.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DBrinker%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DV.%26aulast%3DChoi%26aufirst%3DH.-S.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLesley%26aufirst%3DS.%2BA.%26aulast%3DCaldwell%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DX.-J.%26atitle%3DCrystal%2520structures%2520of%2520human%2520Hsp90a-complexed%2520with%2520dihydroxyphenylprazoles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1475%26epage%3D1478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">van Breeman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span> </span><span class="NLM_article-title">Caco-2 cell permeability assays to measure drug absorption</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">â</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm200128m&amp;key=10.1517%2F17425255.1.2.175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm200128m&amp;key=16922635" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=175-185&author=R.+B.+van+Breemanauthor=Y.+Li&title=Caco-2+cell+permeability+assays+to+measure+drug+absorption"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1517%2F17425255.1.2.175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.1.2.175%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BBreeman%26aufirst%3DR.%2BB.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DCaco-2%2520cell%2520permeability%2520assays%2520to%2520measure%2520drug%2520absorption%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2005%26volume%3D1%26spage%3D175%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Tseng, G. N. Ikr</span><span> </span><span class="NLM_article-title">The hERG channel</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">â</span> <span class="NLM_lpage">849</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm200128m&amp;key=10.1006%2Fjmcc.2000.1317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm200128m&amp;key=11343409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtlSlur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=835-849&author=G.+N.+Ikr+Tseng&title=The+hERG+channel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">IKr: The hERG Channel</span></div><div class="casAuthors">Tseng, Gea-Ny</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">835-849</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review with 127 refs.  The rapid delayed rectifier (IKr) channel is important for cardiac action potential repolarization.  Suppressing IKr function, due to either genetic defects in its pore-forming subunit (hERG) or adverse drug effects, can lead to long-QT (LQT) syndrome that carries increased risk of life-threatening arrhythmias.  The implication of IKr in cardiac arrhythmias and in anti-arrhythmic/pro-arrhythmic actions of drugs has driven intensive research interests in its structure-function relationship, the linkage between LQT-assocd. mutations and changes in channel function, and the mechanism of drug actions.  This review will cover the following topics: (1) heterogeneous contribution of IKr to action potential repolarization in the heart, (2) structure-function relationship of IKr/hERG channels, (3) role of regulatory Î²-subunits in IKr/hERG channel function, (4) structural basis for the unique pharmacol. properties of IKr/hERG channels, and (5) IKr/hERG channel modulation by changes in cellular milieu under physiol. and pathol. conditions of the heart.  It is anticipated that further advances in our understanding of IKr/hERG, particularly in the areas of roles of different (Î± and Î²) subunits in native IKr function, alterations in IKr function in diseased hearts, and the 3-dimensional structure of the IKr/hERG pore based on homol. modeling using the KcsA model, will help us better define the role of IKr in arrhythmias and design therapeutic agents that can increase IKr and are useful for LQT syndrome.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosJF3FMau7lrVg90H21EOLACvtfcHk0ljsB7lry_euUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtlSlur0%253D&md5=8ac2a68a42a07e396ad06d68c3a5abad</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1006%2Fjmcc.2000.1317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmcc.2000.1317%26sid%3Dliteratum%253Aachs%26aulast%3DTseng%26aufirst%3DG.%2BN.%2BIkr%26atitle%3DThe%2520hERG%2520channel%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2001%26volume%3D33%26spage%3D835%26epage%3D849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Giuliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jairaj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zafiu, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span> </span><span class="NLM_article-title">Direct determination of unbound intrinsic drug clearance in the microsomal stability assay</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1319</span><span class="NLM_x">â</span> <span class="NLM_lpage">1324</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=1319-1324&author=C.+Giulianoauthor=M.+Jairajauthor=C.+M.+Zafiuauthor=R.+Laufer&title=Direct+determination+of+unbound+intrinsic+drug+clearance+in+the+microsomal+stability+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DJairaj%26aufirst%3DM.%26aulast%3DZafiu%26aufirst%3DC.%2BM.%26aulast%3DLaufer%26aufirst%3DR.%26atitle%3DDirect%2520determination%2520of%2520unbound%2520intrinsic%2520drug%2520clearance%2520in%2520the%2520microsomal%2520stability%2520assay%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D1319%26epage%3D1324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgognoni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.-M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N. G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northfield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walmsley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span> </span><span class="NLM_article-title">4,5-Diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">â</span> <span class="NLM_lpage">218</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701018h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=196-218&author=P.+A.+Broughauthor=W.+Aherneauthor=X.+Barrilauthor=J.+Borgognoniauthor=K.+Boxallauthor=J.+E.+Cansfieldauthor=K.-M.+J.+Cheungauthor=I.+Collinsauthor=N.+G.+M.+Daviesauthor=M.+Drysdaleauthor=B.+Dymockauthor=S.+A.+Ecclesauthor=H.+Finchauthor=A.+Finkauthor=A.+Hayesauthor=R.+Howesauthor=R.+E.+Hubbardauthor=K.+Jamesauthor=A.+M.+Jordanauthor=A.+Lockieauthor=V.+Martinsauthor=A.+Masseyauthor=T.+P.+Matthewsauthor=E.+McDonaldauthor=C.+J.+Northfieldauthor=L.+H.+Pearlauthor=C.+Prodromouauthor=S.+Rayauthor=F.+I.+Raynaudauthor=S.+D.+Roughleyauthor=S.+Y.+Sharpauthor=A.+Surgenorauthor=D.+L.+Walmsleyauthor=P.+Webbauthor=M.+Woodauthor=P.+Workmanauthor=L.+Wright&title=4%2C5-Diarylisoxazole+Hsp90+chaperone+inhibitors%3A+potential+therapeutic+agents+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm701018h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701018h%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DDavies%26aufirst%3DN.%2BG.%2BM.%26aulast%3DDrysdale%26aufirst%3DM.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFinch%26aufirst%3DH.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DLockie%26aufirst%3DA.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWalmsley%26aufirst%3DD.%2BL.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26atitle%3D4%252C5-Diarylisoxazole%2520Hsp90%2520chaperone%2520inhibitors%253A%2520potential%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D196%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Chessari, G.; Congreve, M. S.; Callaghan, O.; Cowan, S. R.; Murray, C. W.; Woolford, A. J.-A.; OâBrien, M. A.; Woodhead, A. J.</span> PCT Int. Appl. 2006123165,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chessari%2C+G.%3B+Congreve%2C+M.+S.%3B+Callaghan%2C+O.%3B+Cowan%2C+S.+R.%3B+Murray%2C+C.+W.%3B+Woolford%2C+A.+J.-A.%3B+O%E2%80%99Brien%2C+M.+A.%3B+Woodhead%2C+A.+J.+PCT+Int.+Appl.+2006123165%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChessari%26aufirst%3DG.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Hossain, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timberlake, J. W.</span><span> </span><span class="NLM_article-title">Synthesis of bisbicyclo[1.1.1]pentyldiazene. The smallest bridgehead diazene</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">6282</span><span class="NLM_x">â</span> <span class="NLM_lpage">6285</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo010212u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=6282-6285&author=M.+T.+Hossainauthor=J.+W.+Timberlake&title=Synthesis+of+bisbicyclo%5B1.1.1%5Dpentyldiazene.+The+smallest+bridgehead+diazene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjo010212u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo010212u%26sid%3Dliteratum%253Aachs%26aulast%3DHossain%26aufirst%3DM.%2BT.%26aulast%3DTimberlake%26aufirst%3DJ.%2BW.%26atitle%3DSynthesis%2520of%2520bisbicyclo%255B1.1.1%255Dpentyldiazene.%2520The%2520smallest%2520bridgehead%2520diazene%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D6282%26epage%3D6285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Dow, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpino, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadcock, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iredale, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaSilva-Jardine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paight, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâConnor, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nduaka, C. I.</span><span> </span><span class="NLM_article-title">Discovery of 2-(2-chlorophenyl)-3-(4-chlorophenyl)-7-(2,2-difluoropropyl)-6,7-dihydro-2<i>H</i>-pyrazolo[3,4-<i>f</i>][1,4]oxazepin-8-(5<i>H</i>)-one (PF-514273), a novel, bicyclic lactam-based cannabinoid-1 receptor antagonist for the treatment of obesity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2652</span><span class="NLM_x">â</span> <span class="NLM_lpage">2655</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900255t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2652-2655&author=R.+L.+Dowauthor=P.+A.+Carpinoauthor=J.+R.+Hadcockauthor=S.+C.+Blackauthor=P.+A.+Iredaleauthor=P.+DaSilva-Jardineauthor=S.+R.+Schneiderauthor=E.+S.+Paightauthor=D.+A.+Griffithauthor=D.+O.+Scottauthor=R.+E.+O%E2%80%99Connorauthor=C.+I.+Nduaka&title=Discovery+of+2-%282-chlorophenyl%29-3-%284-chlorophenyl%29-7-%282%2C2-difluoropropyl%29-6%2C7-dihydro-2H-pyrazolo%5B3%2C4-f%5D%5B1%2C4%5Doxazepin-8-%285H%29-one+%28PF-514273%29%2C+a+novel%2C+bicyclic+lactam-based+cannabinoid-1+receptor+antagonist+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm900255t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900255t%26sid%3Dliteratum%253Aachs%26aulast%3DDow%26aufirst%3DR.%2BL.%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26aulast%3DHadcock%26aufirst%3DJ.%2BR.%26aulast%3DBlack%26aufirst%3DS.%2BC.%26aulast%3DIredale%26aufirst%3DP.%2BA.%26aulast%3DDaSilva-Jardine%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DS.%2BR.%26aulast%3DPaight%26aufirst%3DE.%2BS.%26aulast%3DGriffith%26aufirst%3DD.%2BA.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%2BE.%26aulast%3DNduaka%26aufirst%3DC.%2BI.%26atitle%3DDiscovery%2520of%25202-%25282-chlorophenyl%2529-3-%25284-chlorophenyl%2529-7-%25282%252C2-difluoropropyl%2529-6%252C7-dihydro-2H-pyrazolo%255B3%252C4-f%255D%255B1%252C4%255Doxazepin-8-%25285H%2529-one%2520%2528PF-514273%2529%252C%2520a%2520novel%252C%2520bicyclic%2520lactam-based%2520cannabinoid-1%2520receptor%2520antagonist%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2652%26epage%3D2655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">McHugh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proctor, G. R.</span><span> </span><span class="NLM_article-title">Ring expansion of some heterocyclic Î²-keto esters with dimethyl acetylenedicarboxylate. Part 2. Synthesis of azepine, azocine, benzazocine, and benzazonine derivatives</span> <span class="citation_source-journal">J. Chem. Res., Miniprint</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_fpage">2230</span><span class="NLM_x">â</span> <span class="NLM_lpage">2253</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1984&pages=2230-2253&author=M.+McHughauthor=G.+R.+Proctor&title=Ring+expansion+of+some+heterocyclic+%CE%B2-keto+esters+with+dimethyl+acetylenedicarboxylate.+Part+2.+Synthesis+of+azepine%2C+azocine%2C+benzazocine%2C+and+benzazonine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcHugh%26aufirst%3DM.%26aulast%3DProctor%26aufirst%3DG.%2BR.%26atitle%3DRing%2520expansion%2520of%2520some%2520heterocyclic%2520%25CE%25B2-keto%2520esters%2520with%2520dimethyl%2520acetylenedicarboxylate.%2520Part%25202.%2520Synthesis%2520of%2520azepine%252C%2520azocine%252C%2520benzazocine%252C%2520and%2520benzazonine%2520derivatives%26jtitle%3DJ.%2520Chem.%2520Res.%252C%2520Miniprint%26date%3D1984%26spage%3D2230%26epage%3D2253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Lau, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppesen, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimvall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohlweg, R.</span><span> </span><span class="NLM_article-title">Ureas with histamine H3-antagonist receptor activityâa new scaffold discovered by lead-hopping from cinnamic acid amides</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5303</span><span class="NLM_x">â</span> <span class="NLM_lpage">5308</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5303-5308&author=J.+F.+Lauauthor=C.+B.+Jeppesenauthor=K.+Rimvallauthor=R.+Hohlweg&title=Ureas+with+histamine+H3-antagonist+receptor+activity%E2%80%94a+new+scaffold+discovered+by+lead-hopping+from+cinnamic+acid+amides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DJ.%2BF.%26aulast%3DJeppesen%26aufirst%3DC.%2BB.%26aulast%3DRimvall%26aufirst%3DK.%26aulast%3DHohlweg%26aufirst%3DR.%26atitle%3DUreas%2520with%2520histamine%2520H3-antagonist%2520receptor%2520activity%25E2%2580%2594a%2520new%2520scaffold%2520discovered%2520by%2520lead-hopping%2520from%2520cinnamic%2520acid%2520amides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5303%26epage%3D5308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Blaszykowski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aktoudianakis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bressy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberico, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lautens, M.</span><span> </span><span class="NLM_article-title">Preparation of annulated nitrogen-containing heterocycles via a one-pot palladium-catalyzed alkylation/direct arylation sequence</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2043</span><span class="NLM_x">â</span> <span class="NLM_lpage">2045</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol060447y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=2043-2045&author=C.+Blaszykowskiauthor=E.+Aktoudianakisauthor=C.+Bressyauthor=D.+Albericoauthor=M.+Lautens&title=Preparation+of+annulated+nitrogen-containing+heterocycles+via+a+one-pot+palladium-catalyzed+alkylation%2Fdirect+arylation+sequence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fol060447y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol060447y%26sid%3Dliteratum%253Aachs%26aulast%3DBlaszykowski%26aufirst%3DC.%26aulast%3DAktoudianakis%26aufirst%3DE.%26aulast%3DBressy%26aufirst%3DC.%26aulast%3DAlberico%26aufirst%3DD.%26aulast%3DLautens%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520annulated%2520nitrogen-containing%2520heterocycles%2520via%2520a%2520one-pot%2520palladium-catalyzed%2520alkylation%252Fdirect%2520arylation%2520sequence%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D2043%26epage%3D2045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">England, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, L.</span><span> </span><span class="NLM_article-title">An improved synthesis of a novel Î±<sub>1A</sub> partial agonist including a new two-step synthesis of 4-fluoropyrazole</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2849</span><span class="NLM_x">â</span> <span class="NLM_lpage">2851</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=2849-2851&author=K.+Englandauthor=H.+Masonauthor=R.+Osborneauthor=L.+Roberts&title=An+improved+synthesis+of+a+novel+%CE%B11A+partial+agonist+including+a+new+two-step+synthesis+of+4-fluoropyrazole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEngland%26aufirst%3DK.%26aulast%3DMason%26aufirst%3DH.%26aulast%3DOsborne%26aufirst%3DR.%26aulast%3DRoberts%26aufirst%3DL.%26atitle%3DAn%2520improved%2520synthesis%2520of%2520a%2520novel%2520%25CE%25B11A%2520partial%2520agonist%2520including%2520a%2520new%2520two-step%2520synthesis%2520of%25204-fluoropyrazole%26jtitle%3DTetrahedron%2520Lett.%26date%3D2010%26volume%3D51%26spage%3D2849%26epage%3D2851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 27 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Tobias M. Milzarek, <span class="NLM_string-name hlFld-ContribAuthor">Tobias A. M. Gulder</span>. </span><span class="cited-content_cbyCitation_article-title">Total Synthesis of the Ambigols: A Cyanobacterial Class of Polyhalogenated Natural Products. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (1)
                                     , 102-106. <a href="https://doi.org/10.1021/acs.orglett.0c03784" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03784</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03784%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DTotal%252BSynthesis%252Bof%252Bthe%252BAmbigols%25253A%252BA%252BCyanobacterial%252BClass%252Bof%252BPolyhalogenated%252BNatural%252BProducts%26aulast%3DMilzarek%26aufirst%3DTobias%2BM.%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D13112020%26date%3D11122020%26volume%3D23%26issue%3D1%26spage%3D102%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Son Tung Ngo, Khanh B. Vu, Le Minh Bui, <span class="NLM_string-name hlFld-ContribAuthor">Van V. Vu</span>. </span><span class="cited-content_cbyCitation_article-title">Effective Estimation of Ligand-Binding Affinity Using Biased Sampling Method. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (2)
                                     , 3887-3893. <a href="https://doi.org/10.1021/acsomega.8b03258" title="DOI URL">https://doi.org/10.1021/acsomega.8b03258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b03258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b03258%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DEffective%252BEstimation%252Bof%252BLigand-Binding%252BAffinity%252BUsing%252BBiased%252BSampling%252BMethod%26aulast%3DNgo%26aufirst%3DSon%2BTung%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D14122018%26date%3D08022019%26volume%3D4%26issue%3D2%26spage%3D3887%26epage%3D3893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Subrata  Das</span>, <span class="hlFld-ContribAuthor ">Subarna J.  Kalita</span>, <span class="hlFld-ContribAuthor ">Pranjal  Bharali</span>, <span class="hlFld-ContribAuthor ">Bolin K.  Konwar</span>, <span class="hlFld-ContribAuthor ">Babulal  Das</span>, and <span class="hlFld-ContribAuthor ">Ashim J.  Thakur</span>  . </span><span class="cited-content_cbyCitation_article-title">Organic Reactions in âGreen Surfactantâ: An Avenue to Bisuracil Derivative. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2013,</strong> <em>1 </em>
                                    (12)
                                     , 1530-1536. <a href="https://doi.org/10.1021/sc4002774" title="DOI URL">https://doi.org/10.1021/sc4002774</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/sc4002774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fsc4002774%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DOrganic%252BReactions%252Bin%252B%2525E2%252580%25259CGreen%252BSurfactant%2525E2%252580%25259D%25253A%252BAn%252BAvenue%252Bto%252BBisuracil%252BDerivative%26aulast%3DDas%26aufirst%3DSubrata%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D04042013%26date%3D01092013%26date%3D17092013%26date%3D02122013%26date%3D05092013%26volume%3D1%26issue%3D12%26spage%3D1530%26epage%3D1536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Se-Ho  Kim</span>, <span class="hlFld-ContribAuthor ">Ashok  Bajji</span>, <span class="hlFld-ContribAuthor ">Rajendra  Tangallapally</span>, <span class="hlFld-ContribAuthor ">Benjamin  Markovitz</span>, <span class="hlFld-ContribAuthor ">Richard  Trovato</span>, <span class="hlFld-ContribAuthor ">Mark  Shenderovich</span>, <span class="hlFld-ContribAuthor ">Vijay  Baichwal</span>, <span class="hlFld-ContribAuthor ">Paul  Bartel</span>, <span class="hlFld-ContribAuthor ">Daniel  Cimbora</span>, <span class="hlFld-ContribAuthor ">Rena  McKinnon</span>, <span class="hlFld-ContribAuthor ">Rosann  Robinson</span>, <span class="hlFld-ContribAuthor ">Damon  Papac</span>, <span class="hlFld-ContribAuthor ">Daniel  Wettstein</span>, <span class="hlFld-ContribAuthor ">Robert  Carlson</span>, and <span class="hlFld-ContribAuthor ">Kraig M.  Yager</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of (2S)-1-[4-(2-{6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9H-purin-9-yl}ethyl)piperidin-1-yl]-2-hydroxypropan-1-one (MPC-3100), a Purine-Based Hsp90 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (17)
                                     , 7480-7501. <a href="https://doi.org/10.1021/jm3004619" title="DOI URL">https://doi.org/10.1021/jm3004619</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3004619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3004619%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%2525282S%252529-1-%25255B4-%2525282-%25257B6-Amino-8-%25255B%2525286-bromo-1%25252C3-benzodioxol-5-yl%252529sulfanyl%25255D-9H-purin-9-yl%25257Dethyl%252529piperidin-1-yl%25255D-2-hydroxypropan-1-one%252B%252528MPC-3100%252529%25252C%252Ba%252BPurine-Based%252BHsp90%252BInhibitor%26aulast%3DKim%26aufirst%3DSe-Ho%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D02042012%26date%3D31082012%26date%3D13092012%26date%3D22082012%26volume%3D55%26issue%3D17%26spage%3D7480%26epage%3D7501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Duc Tuan  Cao</span>, <span class="hlFld-ContribAuthor ">Thi Mai  Huong Doan</span>, <span class="hlFld-ContribAuthor ">Van Cuong  Pham</span>, <span class="hlFld-ContribAuthor ">Thi Hong  Minh Le</span>, <span class="hlFld-ContribAuthor ">Jung-Woo  Chae</span>, <span class="hlFld-ContribAuthor ">Hwi-yeol  Yun</span>, <span class="hlFld-ContribAuthor ">Min-Kyun  Na</span>, <span class="hlFld-ContribAuthor ">Young-Ho  Kim</span>, <span class="hlFld-ContribAuthor ">Minh Quan  Pham</span>, <span class="hlFld-ContribAuthor ">Van Hung  Nguyen</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular design of anticancer drugs from marine fungi derivatives. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (33)
                                     , 20173-20179. <a href="https://doi.org/10.1039/D1RA01855H" title="DOI URL">https://doi.org/10.1039/D1RA01855H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1RA01855H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1RA01855H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DMolecular%252Bdesign%252Bof%252Banticancer%252Bdrugs%252Bfrom%252Bmarine%252Bfungi%252Bderivatives%26aulast%3DCao%26aufirst%3DDuc%2BTuan%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D33%26spage%3D20173%26epage%3D20179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin E.  Blass</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro ADME and in vivo pharmacokinetics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 305-369. <a href="https://doi.org/10.1016/B978-0-12-817214-8.00006-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-817214-8.00006-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-817214-8.00006-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-817214-8.00006-3%26sid%3Dliteratum%253Aachs%26atitle%3DIn%252Bvitro%252BADME%252Band%252Bin%252Bvivo%252Bpharmacokinetics%26aulast%3DBlass%26aufirst%3DBenjamin%2BE.%26date%3D2021%26spage%3D305%26epage%3D369%26pub%3DElsevier%26atitle%3DBasic%252BPrinciples%252Bof%252BDrug%252BDiscovery%252Band%252BDevelopment%26date%3D2021%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Igor I.  Gerus</span>, <span class="hlFld-ContribAuthor ">Yury I.  Zhuk</span>, <span class="hlFld-ContribAuthor ">Liliya M.  Kacharova</span>, <span class="hlFld-ContribAuthor ">Gerd-Volker  RÃ¶schenthaler</span>, <span class="hlFld-ContribAuthor ">Elena N.  Shaitanova</span>, <span class="hlFld-ContribAuthor ">Alexandr E.  Sorochinskii</span>, <span class="hlFld-ContribAuthor ">Sergey I.  Vdovenko</span>, <span class="hlFld-ContribAuthor ">Jacek  Wojcik</span>. </span><span class="cited-content_cbyCitation_article-title">Uncommon fluorination of enones with xenon difluoride. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2020,</strong> <em>229 </em>, 109413. <a href="https://doi.org/10.1016/j.jfluchem.2019.109413" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2019.109413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2019.109413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2019.109413%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DUncommon%252Bfluorination%252Bof%252Benones%252Bwith%252Bxenon%252Bdifluoride%26aulast%3DGerus%26aufirst%3DIgor%2BI.%26date%3D2020%26volume%3D229%26spage%3D109413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gemma M.  Locke</span>, <span class="hlFld-ContribAuthor ">Stefan S. R.  Bernhard</span>, <span class="hlFld-ContribAuthor ">Mathias O.  Senge</span>. </span><span class="cited-content_cbyCitation_article-title">Nonconjugated Hydrocarbons as RigidâLinear Motifs: Isosteres for Material Sciences and Bioorganic and Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Chemistry â A European Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (18)
                                     , 4590-4647. <a href="https://doi.org/10.1002/chem.201804225" title="DOI URL">https://doi.org/10.1002/chem.201804225</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201804225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201804225%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DNonconjugated%252BHydrocarbons%252Bas%252BRigid%2525E2%252580%252590Linear%252BMotifs%25253A%252BIsosteres%252Bfor%252BMaterial%252BSciences%252Band%252BBioorganic%252Band%252BMedicinal%252BChemistry%26aulast%3DLocke%26aufirst%3DGemma%2BM.%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D18%26spage%3D4590%26epage%3D4647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alicia M.  DilmaÃ§</span>, <span class="hlFld-ContribAuthor ">Eduard  Spuling</span>, <span class="hlFld-ContribAuthor ">Armin  deâMeijere</span>, <span class="hlFld-ContribAuthor ">Stefan  BrÃ¤se</span>. </span><span class="cited-content_cbyCitation_article-title">Propellane: von chemischen KuriositÃ¤ten zu âexplosivenâ Materialen und Naturstoffen. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2017,</strong> <em>129 </em>
                                    (21)
                                     , 5778-5813. <a href="https://doi.org/10.1002/ange.201603951" title="DOI URL">https://doi.org/10.1002/ange.201603951</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201603951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201603951%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DPropellane%25253A%252Bvon%252Bchemischen%252BKuriosit%2525C3%2525A4ten%252Bzu%252B%2525E2%252580%25259Cexplosiven%2525E2%252580%25259D%252BMaterialen%252Bund%252BNaturstoffen%26aulast%3DDilma%25C3%25A7%26aufirst%3DAlicia%2BM.%26date%3D2017%26date%3D2017%26volume%3D129%26issue%3D21%26spage%3D5778%26epage%3D5813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alicia M.  DilmaÃ§</span>, <span class="hlFld-ContribAuthor ">Eduard  Spuling</span>, <span class="hlFld-ContribAuthor ">Armin  deâMeijere</span>, <span class="hlFld-ContribAuthor ">Stefan  BrÃ¤se</span>. </span><span class="cited-content_cbyCitation_article-title">Propellanes-From a Chemical Curiosity to âExplosiveâ Materials and Natural Products. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2017,</strong> <em>56 </em>
                                    (21)
                                     , 5684-5718. <a href="https://doi.org/10.1002/anie.201603951" title="DOI URL">https://doi.org/10.1002/anie.201603951</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201603951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201603951%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DPropellanes-From%252Ba%252BChemical%252BCuriosity%252Bto%252B%2525E2%252580%25259CExplosive%2525E2%252580%25259D%252BMaterials%252Band%252BNatural%252BProducts%26aulast%3DDilma%25C3%25A7%26aufirst%3DAlicia%2BM.%26date%3D2017%26date%3D2017%26volume%3D56%26issue%3D21%26spage%3D5684%26epage%3D5718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Diercxsens</span>. </span><span class="cited-content_cbyCitation_article-title">2,2-Difluoroethylamine. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 1-4. <a href="https://doi.org/10.1002/047084289X.rn02075" title="DOI URL">https://doi.org/10.1002/047084289X.rn02075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/047084289X.rn02075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F047084289X.rn02075%26sid%3Dliteratum%253Aachs%26atitle%3D2%25252C2-Difluoroethylamine%26aulast%3DDiercxsens%26aufirst%3DNicolas%26date%3D2017%26date%3D2017%26spage%3D1%26epage%3D4%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DEncyclopedia%252Bof%252BReagents%252Bfor%252BOrganic%252BSynthesis%26date%3D2001%26date%3D2001%26volume%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A Elisa  Pasqua</span>, <span class="hlFld-ContribAuthor ">B.  Wilding</span>, <span class="hlFld-ContribAuthor ">M.D.  Cheeseman</span>, <span class="hlFld-ContribAuthor ">K.  Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Protein Synthesis, Folding, and Degradation Pathways in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 202-280. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12395-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12395-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12395-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12395-9%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BProtein%252BSynthesis%25252C%252BFolding%25252C%252Band%252BDegradation%252BPathways%252Bin%252BCancer%26aulast%3DPasqua%26aufirst%3DA%2BElisa%26date%3D2017%26spage%3D202%26epage%3D280%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veronica  Salmaso</span>, <span class="hlFld-ContribAuthor ">Mattia  Sturlese</span>, <span class="hlFld-ContribAuthor ">Alberto  Cuzzolin</span>, <span class="hlFld-ContribAuthor ">Stefano  Moro</span>. </span><span class="cited-content_cbyCitation_article-title">DockBench as docking selector tool: the lesson learned from D3R Grand Challenge 2015. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2016,</strong> <em>30 </em>
                                    (9)
                                     , 773-789. <a href="https://doi.org/10.1007/s10822-016-9966-4" title="DOI URL">https://doi.org/10.1007/s10822-016-9966-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-016-9966-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-016-9966-4%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DDockBench%252Bas%252Bdocking%252Bselector%252Btool%25253A%252Bthe%252Blesson%252Blearned%252Bfrom%252BD3R%252BGrand%252BChallenge%252B2015%26aulast%3DSalmaso%26aufirst%3DVeronica%26date%3D2016%26date%3D2016%26volume%3D30%26issue%3D9%26spage%3D773%26epage%3D789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R.  Gianatassio</span>, <span class="hlFld-ContribAuthor ">J. M.  Lopchuk</span>, <span class="hlFld-ContribAuthor ">J.  Wang</span>, <span class="hlFld-ContribAuthor ">C.-M.  Pan</span>, <span class="hlFld-ContribAuthor ">L. R.  Malins</span>, <span class="hlFld-ContribAuthor ">L.  Prieto</span>, <span class="hlFld-ContribAuthor ">T. A.  Brandt</span>, <span class="hlFld-ContribAuthor ">M. R.  Collins</span>, <span class="hlFld-ContribAuthor ">G. M.  Gallego</span>, <span class="hlFld-ContribAuthor ">N. W.  Sach</span>, <span class="hlFld-ContribAuthor ">J. E.  Spangler</span>, <span class="hlFld-ContribAuthor ">H.  Zhu</span>, <span class="hlFld-ContribAuthor ">J.  Zhu</span>, <span class="hlFld-ContribAuthor ">P. S.  Baran</span>. </span><span class="cited-content_cbyCitation_article-title">Strain-release amination. </span><span class="cited-content_cbyCitation_journal-name">Science</span><span> <strong>2016,</strong> <em>351 </em>
                                    (6270)
                                     , 241-246. <a href="https://doi.org/10.1126/science.aad6252" title="DOI URL">https://doi.org/10.1126/science.aad6252</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/science.aad6252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscience.aad6252%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%26atitle%3DStrain-release%252Bamination%26aulast%3DGianatassio%26aufirst%3DR.%26date%3D2016%26date%3D2016%26volume%3D351%26issue%3D6270%26spage%3D241%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Galina N.  Lipunova</span>, <span class="hlFld-ContribAuthor ">Emiliya V.  Nosova</span>, <span class="hlFld-ContribAuthor ">Valery N.  Charushin</span>, <span class="hlFld-ContribAuthor ">Oleg N.  Chupakhin</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorine-containing pyrazoles and their condensed derivatives: Synthesis and biological activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2015,</strong> <em>175 </em>, 84-109. <a href="https://doi.org/10.1016/j.jfluchem.2015.03.011" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2015.03.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2015.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2015.03.011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DFluorine-containing%252Bpyrazoles%252Band%252Btheir%252Bcondensed%252Bderivatives%25253A%252BSynthesis%252Band%252Bbiological%252Bactivity%26aulast%3DLipunova%26aufirst%3DGalina%2BN.%26date%3D2015%26volume%3D175%26spage%3D84%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias V.  Westphal</span>, <span class="hlFld-ContribAuthor ">Bernd T.  WolfstÃ¤dter</span>, <span class="hlFld-ContribAuthor ">Jean-Marc  Plancher</span>, <span class="hlFld-ContribAuthor ">John  Gatfield</span>, <span class="hlFld-ContribAuthor ">Erick M.  Carreira</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of
              tert
              -Butyl Isosteres: Case Studies of Physicochemical and Pharmacokinetic Properties, Efficacies, and Activities. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2015,</strong> <em>10 </em>
                                    (3)
                                     , 461-469. <a href="https://doi.org/10.1002/cmdc.201402502" title="DOI URL">https://doi.org/10.1002/cmdc.201402502</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201402502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201402502%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DEvaluation%252Bof%252Btert%252B-Butyl%252BIsosteres%25253A%252BCase%252BStudies%252Bof%252BPhysicochemical%252Band%252BPharmacokinetic%252BProperties%25252C%252BEfficacies%25252C%252Band%252BActivities%26aulast%3DWestphal%26aufirst%3DMatthias%2BV.%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D3%26spage%3D461%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Punit  Kaur</span>, <span class="hlFld-ContribAuthor ">Tarundeep  Singh</span>, <span class="hlFld-ContribAuthor ">Moses  Galukande</span>, <span class="hlFld-ContribAuthor ">Sunil  Krishnan</span>, <span class="hlFld-ContribAuthor ">Alexzander A. A.  Asea</span>. </span><span class="cited-content_cbyCitation_article-title">Heat Shock Proteins in Triple-Negative Breast Cancer (TNBC) Treatment. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 129-149. <a href="https://doi.org/10.1007/978-3-319-17211-8_8" title="DOI URL">https://doi.org/10.1007/978-3-319-17211-8_8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-17211-8_8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-17211-8_8%26sid%3Dliteratum%253Aachs%26atitle%3DHeat%252BShock%252BProteins%252Bin%252BTriple-Negative%252BBreast%252BCancer%252B%252528TNBC%252529%252BTreatment%26aulast%3DKaur%26aufirst%3DPunit%26date%3D2015%26spage%3D129%26epage%3D149%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHeat%252BShock%252BProtein-Based%252BTherapies%26aulast%3DAsea%26aufirst%3DAlexzander%2BA.A.%26date%3D2015%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin E.  Blass</span>. </span><span class="cited-content_cbyCitation_article-title">InÂ vitro ADME and InÂ vivo Pharmacokinetics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 245-306. <a href="https://doi.org/10.1016/B978-0-12-411508-8.00006-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-411508-8.00006-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-411508-8.00006-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-411508-8.00006-2%26sid%3Dliteratum%253Aachs%26atitle%3DIn%2525C2%2525A0vitro%252BADME%252Band%252BIn%2525C2%2525A0vivo%252BPharmacokinetics%26aulast%3DBlass%26aufirst%3DBenjamin%2BE.%26date%3D2015%26spage%3D245%26epage%3D306%26pub%3DElsevier%26atitle%3DBasic%252BPrinciples%252Bof%252BDrug%252BDiscovery%252Band%252BDevelopment%26date%3D2015%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ping  He</span>, <span class="hlFld-ContribAuthor ">Jing  Wu</span>, <span class="hlFld-ContribAuthor ">Yang-Gen  Hu</span>, <span class="hlFld-ContribAuthor ">Zai-Fang  Li</span>, <span class="hlFld-ContribAuthor ">Qiu-Fei  Hou</span>, <span class="hlFld-ContribAuthor ">Yan-Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Kun  Zhao</span>, <span class="hlFld-ContribAuthor ">Erli  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient and Selective Construction of Pyrrolo[3,2-d]pyrimidine Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2014,</strong> <em>35 </em>
                                    (2)
                                     , 617-621. <a href="https://doi.org/10.5012/bkcs.2014.35.2.617" title="DOI URL">https://doi.org/10.5012/bkcs.2014.35.2.617</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5012/bkcs.2014.35.2.617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5012%2Fbkcs.2014.35.2.617%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DEfficient%252Band%252BSelective%252BConstruction%252Bof%252BPyrrolo%25255B3%25252C2-d%25255Dpyrimidine%252BDerivatives%26aulast%3DHe%26aufirst%3DPing%26date%3D2014%26volume%3D35%26issue%3D2%26spage%3D617%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Swee  Sharp</span>, <span class="hlFld-ContribAuthor ">Keith  Jones</span>, <span class="hlFld-ContribAuthor ">Paul  Workman</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting Cancer Dependence on Molecular Chaperones. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 239-274. <a href="https://doi.org/10.1016/B978-0-12-396521-9.00009-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-396521-9.00009-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396521-9.00009-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396521-9.00009-7%26sid%3Dliteratum%253Aachs%26atitle%3DExploiting%252BCancer%252BDependence%252Bon%252BMolecular%252BChaperones%26aulast%3DSharp%26aufirst%3DSwee%26date%3D2014%26spage%3D239%26epage%3D274%26pub%3DElsevier%26atitle%3DCancer%252BDrug%252BDesign%252Band%252BDiscovery%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fan  Yang</span>, <span class="hlFld-ContribAuthor ">Liang  Feng</span>, <span class="hlFld-ContribAuthor ">Nengzhong  Wang</span>, <span class="hlFld-ContribAuthor ">Xuge  Liu</span>, <span class="hlFld-ContribAuthor ">Jun  Li</span>, <span class="hlFld-ContribAuthor ">Yuehai  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Practical synthesis of C1â8 fragment of autolytimycin via a chelation-controlled diastereoselective addition of diisopropenylzinc to Î±-methoxy aldehyde. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2013,</strong> <em>69 </em>
                                    (45)
                                     , 9463-9468. <a href="https://doi.org/10.1016/j.tet.2013.08.067" title="DOI URL">https://doi.org/10.1016/j.tet.2013.08.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2013.08.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2013.08.067%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DPractical%252Bsynthesis%252Bof%252BC1%2525E2%252580%2525938%252Bfragment%252Bof%252Bautolytimycin%252Bvia%252Ba%252Bchelation-controlled%252Bdiastereoselective%252Baddition%252Bof%252Bdiisopropenylzinc%252Bto%252B%2525CE%2525B1-methoxy%252Baldehyde%26aulast%3DYang%26aufirst%3DFan%26date%3D2013%26volume%3D69%26issue%3D45%26spage%3D9463%26epage%3D9468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shinji  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Zhongzhou  Shen</span>, <span class="hlFld-ContribAuthor ">Ying  Jiang</span>, <span class="hlFld-ContribAuthor ">Bill J.  Smith</span>, <span class="hlFld-ContribAuthor ">Paolo  Vicini</span>. </span><span class="cited-content_cbyCitation_article-title">Application of Target-Mediated Drug Disposition Model to Small Molecule Heat Shock Protein 90 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism and Disposition</span><span> <strong>2013,</strong> <em>41 </em>
                                    (6)
                                     , 1285-1294. <a href="https://doi.org/10.1124/dmd.113.051490" title="DOI URL">https://doi.org/10.1124/dmd.113.051490</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/dmd.113.051490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fdmd.113.051490%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520and%2520Disposition%26atitle%3DApplication%252Bof%252BTarget-Mediated%252BDrug%252BDisposition%252BModel%252Bto%252BSmall%252BMolecule%252BHeat%252BShock%252BProtein%252B90%252BInhibitors%26aulast%3DYamazaki%26aufirst%3DShinji%26date%3D2013%26date%3D2013%26volume%3D41%26issue%3D6%26spage%3D1285%26epage%3D1294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">The Drug Discovery Process. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 1-12. <a href="https://doi.org/10.1002/9783527645640.ch1" title="DOI URL">https://doi.org/10.1002/9783527645640.ch1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527645640.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527645640.ch1%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDrug%252BDiscovery%252BProcess%26date%3D2013%26date%3D2013%26spage%3D1%26epage%3D12%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DLead%252BOptimization%252Bfor%252BMedicinal%252BChemists%26aulast%3DZaragoza%2BD%25C3%25B6rwald%26aufirst%3DFlorencio%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth H.  Huang</span>, <span class="hlFld-ContribAuthor ">Thomas E.  Barta</span>, <span class="hlFld-ContribAuthor ">John W.  Rice</span>, <span class="hlFld-ContribAuthor ">Emilie D.  Smith</span>, <span class="hlFld-ContribAuthor ">Andy J.  Ommen</span>, <span class="hlFld-ContribAuthor ">Wei  Ma</span>, <span class="hlFld-ContribAuthor ">James M.  Veal</span>, <span class="hlFld-ContribAuthor ">R. Patrick  Fadden</span>, <span class="hlFld-ContribAuthor ">Amy F.  Barabasz</span>, <span class="hlFld-ContribAuthor ">Briana E.  Foley</span>, <span class="hlFld-ContribAuthor ">Philip F.  Hughes</span>, <span class="hlFld-ContribAuthor ">Gunnar J.  Hanson</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Markworth</span>, <span class="hlFld-ContribAuthor ">Melanie  Silinski</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Partridge</span>, <span class="hlFld-ContribAuthor ">Paul M.  Steed</span>, <span class="hlFld-ContribAuthor ">Steven E.  Hall</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel aminoquinazolin-7-yl 6,7-dihydro-indol-4-ones as potent, selective inhibitors of heat shock protein 90. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (7)
                                     , 2550-2554. <a href="https://doi.org/10.1016/j.bmcl.2012.01.137" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.01.137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.01.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.01.137%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252Baminoquinazolin-7-yl%252B6%25252C7-dihydro-indol-4-ones%252Bas%252Bpotent%25252C%252Bselective%252Binhibitors%252Bof%252Bheat%252Bshock%252Bprotein%252B90%26aulast%3DHuang%26aufirst%3DKenneth%2BH.%26date%3D2012%26volume%3D22%26issue%3D7%26spage%3D2550%26epage%3D2554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Larry  Yet</span>. </span><span class="cited-content_cbyCitation_article-title">Six-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 393-420. <a href="https://doi.org/10.1016/B978-0-08-096807-0.00013-0" title="DOI URL">https://doi.org/10.1016/B978-0-08-096807-0.00013-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-096807-0.00013-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-096807-0.00013-0%26sid%3Dliteratum%253Aachs%26atitle%3DSix-Membered%252BRing%252BSystems%26aulast%3DYet%26aufirst%3DLarry%26date%3D2012%26spage%3D393%26epage%3D420%26pub%3DElsevier%26date%3D2012%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shinji  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Leslie  Nguyen</span>, <span class="hlFld-ContribAuthor ">Sylvia  Vekich</span>, <span class="hlFld-ContribAuthor ">Zhongzhou  Shen</span>, <span class="hlFld-ContribAuthor ">Min-Jean  Yin</span>, <span class="hlFld-ContribAuthor ">Pramod P.  Mehta</span>, <span class="hlFld-ContribAuthor ">Pei-Pei  Kung</span>, <span class="hlFld-ContribAuthor ">Paolo  Vicini</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetic-Pharmacodynamic Modeling of Biomarker Response and Tumor Growth Inhibition to an Orally Available Heat Shock Protein 90 Inhibitor in a Human Tumor Xenograft Mouse Model. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2011,</strong> <em>338 </em>
                                    (3)
                                     , 964-973. <a href="https://doi.org/10.1124/jpet.111.181339" title="DOI URL">https://doi.org/10.1124/jpet.111.181339</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.111.181339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.111.181339%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DPharmacokinetic-Pharmacodynamic%252BModeling%252Bof%252BBiomarker%252BResponse%252Band%252BTumor%252BGrowth%252BInhibition%252Bto%252Ban%252BOrally%252BAvailable%252BHeat%252BShock%252BProtein%252B90%252BInhibitor%252Bin%252Ba%252BHuman%252BTumor%252BXenograft%252BMouse%252BModel%26aulast%3DYamazaki%26aufirst%3DShinji%26date%3D2011%26date%3D2011%26volume%3D338%26issue%3D3%26spage%3D964%26epage%3D973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pramod P.  Mehta</span>, <span class="hlFld-ContribAuthor ">Pamela  Whalen</span>, <span class="hlFld-ContribAuthor ">Sangita M.  Baxi</span>, <span class="hlFld-ContribAuthor ">Pei-Pei  Kung</span>, <span class="hlFld-ContribAuthor ">Shinji  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Min-Jean  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Effective Targeting of Triple-Negative Breast Cancer Cells by PF-4942847, a Novel Oral Inhibitor of Hsp 90. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2011,</strong> <em>17 </em>
                                    (16)
                                     , 5432-5442. <a href="https://doi.org/10.1158/1078-0432.CCR-11-0592" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-11-0592</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-11-0592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-11-0592%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DEffective%252BTargeting%252Bof%252BTriple-Negative%252BBreast%252BCancer%252BCells%252Bby%252BPF-4942847%25252C%252Ba%252BNovel%252BOral%252BInhibitor%252Bof%252BHsp%252B90%26aulast%3DMehta%26aufirst%3DPramod%2BP.%26date%3D2011%26date%3D2011%26volume%3D17%26issue%3D16%26spage%3D5432%26epage%3D5442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Geldanamycin and its semisynthetic derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0012.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of known orally bioavailable Hsp90 non-benzoquinone inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0014.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overlap of bound conformations of <b>6</b> and <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0018.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structure of <b>10</b> bound to the Hsp90 enzyme.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0017.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Design of pyrrolodinopyrimidine Hsp90 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0019.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Crystal structure of <b>16</b> bound to the Hsp90 enzyme. The urea moiety of <b>16</b> forms additional hydrogen-bond interactions with Asn106 and Gly97 of Hsp90 protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0026.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Crystal structure of <b>35</b> bound to the Hsp90 enzyme. The pyrazole moiety occupied the same space as the trifluoromethyl moiety present in compound <b>17</b> as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0029.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Relationship between in vivo biomarkers (Her and Akt) inhibition and plasma unbound concentration for <b>42</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0001.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Tumor growth inhibition experiments of <b>42</b> (A) and <b>1c</b> (B) in A2058 model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0002.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Body weight measurement during tumor growth inhibition experiment using <b>42</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0003.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Compound <b>42</b> prolongs the survival of A2058 tumor-bearing animals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0004.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) guanidine carbonate, <i>t</i>-BuOH, 85 Â°C, 12 h, 52%; (b) POCl<sub>3</sub>, CH<sub>3</sub>CN, 81 Â°C, 3 h, 23%; (c) iodotrimethylsilane, CH<sub>3</sub>CN, 81 Â°C, 4 h, 79%.</p></p></figure><figure data-id="sch2" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0005.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) isocyanates, DMSO, 23 Â°C, 3 h, or amines, CDI, THF, 23 Â°C, 3 h, 19â64%; (b) <b>61</b>, Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, 85 Â°C, 8 h; (c) 1-iodo-4,4,4-trifluorobutane, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 65 Â°C, 4 h, 36%.</p></p></figure><figure data-id="sch3" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0006.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>62</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 50 Â°C, 1 h, 53.7%; (b) <b>61</b>, Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, 85 Â°C, 8 h; (c) alkylating agents, Cs<sub>2</sub>CO<sub>3</sub>, DMSO, 65 Â°C, 1 h, 23â51%.</p></p></figure><figure data-id="sch4" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0007.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>61</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, 85 Â°C, 4.5 h, 76%; (b) 2-bromoethylpyrazole, K<sub>2</sub>CO<sub>3</sub>, DMSO, 55 Â°C, 1.5 h, 64%; (c) iodotrimethylsilane, CHCl<sub>3</sub>, 23 Â°C, 24 h, 96%; (d) CDI, amines, THF, TEA, 60 Â°C, 4 h, 40â53%.</p></p></figure><figure data-id="sch5" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/medium/jm-2011-00128m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0008.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200128m/production/images/large/jm-2011-00128m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200128m&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) di-<i>tert</i>-butyl dicarbonate, DIPEA, H<sub>2</sub>O/dioxane, 23 Â°C, 1.5 h, 22%; (b) <b>61/63</b>, Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, dioxane, microwave 120 Â°C, 40 min, 38%/60%; (c) bromoethylpyrazole/<b>65</b>, Cs<sub>2</sub>CO<sub>3</sub>/K<sub>2</sub>CO<sub>3</sub>, DMF, 70â100 Â°C, 1â2 h, 60â67%; (d) HCl (in dioxane, 4 M), 23 Â°C, 1â3 h; (e) CDI, amines, THF, TEA, 60 Â°C, 2 h, 27â59% (<b>26</b>â<b>33</b>) and 52â95.6% (<b>38</b>â<b>42</b>).</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i67">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40342" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40342" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Lai, B.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanek, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keh, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanks, K. W.</span><span> </span><span class="NLM_article-title">Quantitation and intracellular localization of the 85K heat shock protein by using monoclonal and polyclonal antibodies</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2802</span><span class="NLM_x">â</span> <span class="NLM_lpage">2810</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200128m&amp;key=10.1128%2FMCB.4.12.2802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm200128m&amp;key=6396506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A528%3ADyaL2MXit1Cjuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1984&pages=2802-2810&author=B.-T.+Laiauthor=N.+W.+Chinauthor=A.+E.+Stanekauthor=W.+Kehauthor=K.+W.+Lanks&title=Quantitation+and+intracellular+localization+of+the+85K+heat+shock+protein+by+using+monoclonal+and+polyclonal+antibodies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitation and intracellular localization of the 85K heat-shock protein by using monoclonal and polyclonal antibodies</span></div><div class="casAuthors">Lai, Baitang; Chin, Nena W.; Stanek, Albert E.; Keh, William; Lanks, Karl W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2802-10</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">Two monoclonal antibodies were produced against the human 85,000-mol.-wt. heat-shock protein (hsp85).  One of these, 16F1, cross-reacts with the murine homolog and is shown by peptide map immunoblots to be directed against an epitope different from that recognized by the other monoclonal antibody, 9D2.  Both monoclonal antibodies recognize only a single 85,000-mol.-wt. (Mr) species in 2-dimensional immunoblots.  Immunopptn. did not reveal an assocn. of this heat-shock protein with any other protein in HeLa cells.  Immunoperoxidase staining showed a purely cytosolic distribution at both light and electron microscopic levels and no assocn. with membranes, mitochondria, or other organelles.  The 9D2 monoclonal antibody and a polyclonal antimurine hsp85 antibody were used to identify the antigens and to quantitate their levels in a variety of normal tissues by immunoautoradiog.  Relative abundance in the various tissues as detd. by Coomassie blue staining correlates reasonably well with the immunoreactivity.  Testis and brain, for example, have high hsp85 levels, whereas heart and skeletal muscle have little or none.  The Mr-85,000 SDS-polyacrylamide gel band in testis and brain lysates was further confirmed to be hsp85 by one-dimensional partial proteolytic peptide mapping.  Based on these data and previous observations showing that synthesis and levels of the protein are altered by depriving cultured cells of glucose, it is speculated that intracellular hsp85 levels depend on differences in the intermediary metab. of glucose in the various tissues.  Furthermore, it appears that high basal levels of this heat-shock protein may not necessarily protect cells against heat shock, since testis is one of the most heat-sensitive tissues and has the highest hsp85 level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojgyxTUSdHg7Vg90H21EOLACvtfcHk0lg74x8n6uoEaA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXit1Cjuw%253D%253D&md5=8677e1d87c1fcfd121207799ec735a6a</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1128%2FMCB.4.12.2802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.4.12.2802%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DB.-T.%26aulast%3DChin%26aufirst%3DN.%2BW.%26aulast%3DStanek%26aufirst%3DA.%2BE.%26aulast%3DKeh%26aufirst%3DW.%26aulast%3DLanks%26aufirst%3DK.%2BW.%26atitle%3DQuantitation%2520and%2520intracellular%2520localization%2520of%2520the%252085K%2520heat%2520shock%2520protein%2520by%2520using%2520monoclonal%2520and%2520polyclonal%2520antibodies%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1984%26volume%3D4%26spage%3D2802%26epage%3D2810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, A.</span><span> </span><span class="NLM_article-title">Hsp90 as a new therapeutic target for cancer therapy: the story unfolds</span> <span class="citation_source-journal">Expert Opin. Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">â</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm200128m&amp;key=10.1517%2F14712598.2.1.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm200128m&amp;key=11772336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVaksw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=3-24&author=P.+Workmanauthor=A.+Maloney&title=Hsp90+as+a+new+therapeutic+target+for+cancer+therapy%3A+the+story+unfolds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 as a new therapeutic target for cancer therapy: the story unfolds</span></div><div class="casAuthors">Maloney, Alison; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-24</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review. Current anticancer drug-development strategies involve identifying novel mol. targets which are crucial for tumorigenesis.  The mol. chaperone heat-shock protein (HSP) 90 is of interest as an anticancer drug target because of its importance in maintaining the conformation, stability and function of key oncogenic client proteins involved in signal transduction pathways leading to proliferation, cell cycle progression, and apoptosis, as well as other features of the malignant phenotype such as invasion, angiogenesis and metastasis.  The natural-product HSP90 inhibitors geldanamycin and radicicol exert their antitumor effect by inhibiting the intrinsic ATPase activity of HSP90, resulting in degrdn. of HSP90 client proteins via the ubiquitin proteosome pathway.  Anticancer selectivity may derive from the simultaneous combinatorial effects of HSP90 inhibitors on multiple cancer targets and pathways. 17-Allylamino-17-demethoxygeldanamycin (17AAG) showed good activity and cancer selectivity in preclin. models and has now progressed to Phase I clin. trials in cancer patients with encouraging initial results.  Phase II trials including combination studies with cytotoxic agents are now being planned and these should allow the therapeutic activity of 17AAG to be detd.  Second-generation HSP90 inhibitors may be designed to overcome some of the drawbacks of 17AAG, including limited oral bioavailability and soly.  They could also be engineered to target specific functions of HSP90, which may not only provide greater mol. selectivity and clin. benefit but may also increase understanding of the complex functions of this mol. chaperone.  HSP90 inhibitors provide proof of concept for drugs directed at HSP90 and protein folding and this principle may be applicable to other medical conditions involving protein aggregation and stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxpya4HhGPu7Vg90H21EOLACvtfcHk0lg74x8n6uoEaA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVaksw%253D%253D&md5=b0542acde22286a95578e3ef4dac0d8e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F14712598.2.1.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14712598.2.1.3%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DMaloney%26aufirst%3DA.%26atitle%3DHsp90%2520as%2520a%2520new%2520therapeutic%2520target%2520for%2520cancer%2520therapy%253A%2520the%2520story%2520unfolds%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2002%26volume%3D2%26spage%3D3%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimnaugh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosser, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarden, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Sensitivity of mature ErbB2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein 90</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">3702</span><span class="NLM_x">â</span> <span class="NLM_lpage">3708</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=3702-3708&author=W.+Xuauthor=E.+Mimnaughauthor=M.+F.+Rosserauthor=C.+Nicchittaauthor=M.+Marcuauthor=Y.+Yardenauthor=L.+Neckers&title=Sensitivity+of+mature+ErbB2+to+geldanamycin+is+conferred+by+its+kinase+domain+and+is+mediated+by+the+chaperone+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DW.%26aulast%3DMimnaugh%26aufirst%3DE.%26aulast%3DRosser%26aufirst%3DM.%2BF.%26aulast%3DNicchitta%26aufirst%3DC.%26aulast%3DMarcu%26aufirst%3DM.%26aulast%3DYarden%26aufirst%3DY.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DSensitivity%2520of%2520mature%2520ErbB2%2520to%2520geldanamycin%2520is%2520conferred%2520by%2520its%2520kinase%2520domain%2520and%2520is%2520mediated%2520by%2520the%2520chaperone%2520protein%252090%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D3702%26epage%3D3708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruo, T.</span><span> </span><span class="NLM_article-title">Modulation of AKT kinase activity by binding to Hsp90</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">10832</span><span class="NLM_x">â</span> <span class="NLM_lpage">10837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=10832-10837&author=S.+Satoauthor=N.+Fujitaauthor=T.+Tsuruo&title=Modulation+of+AKT+kinase+activity+by+binding+to+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DS.%26aulast%3DFujita%26aufirst%3DN.%26aulast%3DTsuruo%26aufirst%3DT.%26atitle%3DModulation%2520of%2520AKT%2520kinase%2520activity%2520by%2520binding%2520to%2520Hsp90%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D10832%26epage%3D10837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siligardi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâBrien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolfson, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panaretou, B.</span><span> </span><span class="NLM_article-title">Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">754</span><span class="NLM_x">â</span> <span class="NLM_lpage">762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=754-762&author=C.+Prodromouauthor=G.+Siligardiauthor=R.+O%E2%80%99Brienauthor=D.+N.+Woolfsonauthor=L.+Reganauthor=B.+Panaretou&title=Regulation+of+Hsp90+ATPase+activity+by+tetratricopeptide+repeat+%28TPR%29-domain+co-chaperones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DSiligardi%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DR.%26aulast%3DWoolfson%26aufirst%3DD.%2BN.%26aulast%3DRegan%26aufirst%3DL.%26aulast%3DPanaretou%26aufirst%3DB.%26atitle%3DRegulation%2520of%2520Hsp90%2520ATPase%2520activity%2520by%2520tetratricopeptide%2520repeat%2520%2528TPR%2529-domain%2520co-chaperones%26jtitle%3DEMBO%2520J.%26date%3D1999%26volume%3D18%26spage%3D754%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Dutta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inouye, M.</span><span> </span><span class="NLM_article-title">GHKL, an emergent ATPase/kinase superfamily</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">â</span> <span class="NLM_lpage">28</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2000&pages=24-28&author=R.+Duttaauthor=M.+Inouye&title=GHKL%2C+an+emergent+ATPase%2Fkinase+superfamily"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDutta%26aufirst%3DR.%26aulast%3DInouye%26aufirst%3DM.%26atitle%3DGHKL%252C%2520an%2520emergent%2520ATPase%252Fkinase%2520superfamily%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2000%26volume%3D25%26spage%3D24%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Obermann, W. M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sondermann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartl, F. U.</span><span> </span><span class="NLM_article-title">In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">901</span><span class="NLM_x">â</span> <span class="NLM_lpage">910</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=1998&pages=901-910&author=W.+M.+J.+Obermannauthor=H.+Sondermannauthor=A.+A.+Russoauthor=N.+P.+Pavletichauthor=F.+U.+Hartl&title=In+vivo+function+of+Hsp90+is+dependent+on+ATP+binding+and+ATP+hydrolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObermann%26aufirst%3DW.%2BM.%2BJ.%26aulast%3DSondermann%26aufirst%3DH.%26aulast%3DRusso%26aufirst%3DA.%2BA.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26atitle%3DIn%2520vivo%2520function%2520of%2520Hsp90%2520is%2520dependent%2520on%2520ATP%2520binding%2520and%2520ATP%2520hydrolysis%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D1998%26volume%3D143%26spage%3D901%26epage%3D910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mimnaugh, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Costa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L. M.</span><span> </span><span class="NLM_article-title">Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">8324</span><span class="NLM_x">â</span> <span class="NLM_lpage">8328</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200128m&amp;key=10.1073%2Fpnas.91.18.8324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200128m&amp;key=8078881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A528%3ADyaK2cXlslKnsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=8324-8328&author=L.+Whitesellauthor=E.+G.+Mimnaughauthor=B.+De+Costaauthor=C.+E.+Myersauthor=L.+M.+Neckers&title=Inhibition+of+heat+shock+protein+HSP90-pp60v-src+heteroprotein+complex+formation+by+benzoquinone+ansamycins%3A+essential+role+for+stress+proteins+in+oncogenic+transformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation</span></div><div class="casAuthors">Whitesell, Luke; Mimnaugh, Edward G.; De Costa, Brian; Myers, Charles E.; Neckers, Leonard M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8324-8</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The mol. mechanisms by which oncogenic tyrosine kinases induce cellular transformation are unclear.  Herbimycin A, geldanamycin, and certain other benzoquinone ansamycins display an unusual capacity to revert tyrosine kinase-induced oncogenic transformation.  As an approach to the study of v-src-mediated transformation, the authors examd. ansamycin action in transformed cells and found that drug-induced reversion could be achieved without direct inhibition of src phosphorylating activity.  To identify mechanisms other than kinase inhibition for drug-mediated reversion, the authors prepd. a solid phase-immobilized geldanamycin deriv. and affinity pptd. the mol. targets with which the drug interacted.  In a range of cell lines, immobilized geldanamycin bound elements of a major class of heat shock protein (HSP90) in a stable and pharmacol. specific manner.  Consistent with these binding data, the authors found that sol. geldanamycin and herbimycin A inhibited specifically the formation of a previously described src-HSP90 heteroprotein complex.  A related benzoquinone ansamycin that failed to revert transformed cells did not inhibit the formation of this complex.  These results demonstrate that HSP participation in multimol. complex formation is required for src-mediated transformation and can provide a target for drug modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfTW8DJOglQLVg90H21EOLACvtfcHk0lgcVIQe20tyzQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlslKnsLw%253D&md5=18f1cad01698df44adaa05ef3da9f850</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.18.8324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.18.8324%26sid%3Dliteratum%253Aachs%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DMimnaugh%26aufirst%3DE.%2BG.%26aulast%3DDe%2BCosta%26aufirst%3DB.%26aulast%3DMyers%26aufirst%3DC.%2BE.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DInhibition%2520of%2520heat%2520shock%2520protein%2520HSP90-pp60v-src%2520heteroprotein%2520complex%2520formation%2520by%2520benzoquinone%2520ansamycins%253A%2520essential%2520role%2520for%2520stress%2520proteins%2520in%2520oncogenic%2520transformation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1994%26volume%3D91%26spage%3D8324%26epage%3D8328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reigan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, D.</span><span> </span><span class="NLM_article-title">Enzymatic reduction and glutathione conjugation of benzoquinone ansamycin heat shock protein 90 inhibitors: relevance for toxicity and mechanism of action</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2050</span><span class="NLM_x">â</span> <span class="NLM_lpage">2057</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=2050-2057&author=W.+Guoauthor=P.+Reiganauthor=D.+Siegelauthor=D.+Ross&title=Enzymatic+reduction+and+glutathione+conjugation+of+benzoquinone+ansamycin+heat+shock+protein+90+inhibitors%3A+relevance+for+toxicity+and+mechanism+of+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DReigan%26aufirst%3DP.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DEnzymatic%2520reduction%2520and%2520glutathione%2520conjugation%2520of%2520benzoquinone%2520ansamycin%2520heat%2520shock%2520protein%252090%2520inhibitors%253A%2520relevance%2520for%2520toxicity%2520and%2520mechanism%2520of%2520action%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D2050%26epage%3D2057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Solit, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikorski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slovin, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLaCruz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egorin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scher, H. I.</span><span> </span><span class="NLM_article-title">Phase 1 trial of 17-allylamino-17-demthoxygeldanamycin in patients with advance cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1775</span><span class="NLM_x">â</span> <span class="NLM_lpage">1782</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm200128m&amp;key=10.1158%2F1078-0432.CCR-06-1863" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200128m&amp;key=17363532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2gtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1775-1782&author=D.+B.+Solitauthor=S.+P.+Ivyauthor=C.+Kopilauthor=R.+Sikorskiauthor=M.+J.+Morrisauthor=S.+F.+Slovinauthor=W.+K.+Kellyauthor=A.+DeLaCruzauthor=T.+Curleyauthor=G.+Hellerauthor=S.+Larsonauthor=L.+Schwartzauthor=M.+J.+Egorinauthor=N.+Rosenauthor=H.+I.+Scher&title=Phase+1+trial+of+17-allylamino-17-demthoxygeldanamycin+in+patients+with+advance+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer</span></div><div class="casAuthors">Solit, David B.; Ivy, S. Percy; Kopil, Catherine; Sikorski, Rachel; Morris, Michael J.; Slovin, Susan F.; Kelly, W. Kevin; DeLaCruz, Anthony; Curley, Tracy; Heller, Glenn; Larson, Steven; Schwartz, Lawrence; Egorin, Merrill J.; Rosen, Neal; Scher, Howard I.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1775-1782</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To define the max. tolerated dose (MTD), toxicities, and pharmacokinetics of 17-allylamino-17-demethoxygeldanamycin (17-AAG) when administered using continuous and intermittent dosing schedules.  Patients with progressive solid tumor malignancies were treated with 17-AAG using an accelerated titrn. dose escalation schema.  The starting dose and schedule were 5 mg/m2 daily for 5 days with cycles repeated every 21 days.  Dosing modifications based on safety, pharmacodynamic modeling, and clin. outcomes led to the evaluation of the following schedules: daily x 3 repeated every 14 days; twice weekly (days 1, 4, 8, and 11) for 2 wk every 3 wk; and twice weekly (days 1 and 4) without interruption.  During cycle 1, blood was collected for pharmacokinetic and pharmacodynamic studies.  Fifty-four eligible patients were treated.  The MTD was schedule dependent: 56 mg/m2 on the daily x 5 schedule; 112 mg/m2 on the daily x 3 schedule; and 220 mg/m2 on the days 1, 4, 8, and 11 every-21-day schedule.  Continuous twice-weekly dosing was deemed too toxic because of delayed hepatotoxicity.  Hepatic toxicity was also dose limiting with the daily x 5 schedule.  Other common toxicities encountered were fatigue, myalgias, and nausea.  This latter adverse effect may have been attributable, in part, to the DMSO-based formulation.  Concns. of 17-AAG above those required for activity in preclin. models could be safely achieved in plasma.  Induction of a heat shock response and down-regulation of Akt and Raf-1 were obsd. in biomarker studies.  The MTD and toxicity profile of 17-AAG were schedule dependent.  Intermittent dosing schedules were less toxic and are recommended for future phase II studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGKeAL9KtMGbVg90H21EOLACvtfcHk0lgD2KqlWZ8vYA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2gtL4%253D&md5=7de014104bbd48f42ec8faac2e8d92ed</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-1863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-1863%26sid%3Dliteratum%253Aachs%26aulast%3DSolit%26aufirst%3DD.%2BB.%26aulast%3DIvy%26aufirst%3DS.%2BP.%26aulast%3DKopil%26aufirst%3DC.%26aulast%3DSikorski%26aufirst%3DR.%26aulast%3DMorris%26aufirst%3DM.%2BJ.%26aulast%3DSlovin%26aufirst%3DS.%2BF.%26aulast%3DKelly%26aufirst%3DW.%2BK.%26aulast%3DDeLaCruz%26aufirst%3DA.%26aulast%3DCurley%26aufirst%3DT.%26aulast%3DHeller%26aufirst%3DG.%26aulast%3DLarson%26aufirst%3DS.%26aulast%3DSchwartz%26aufirst%3DL.%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DScher%26aufirst%3DH.%2BI.%26atitle%3DPhase%25201%2520trial%2520of%252017-allylamino-17-demthoxygeldanamycin%2520in%2520patients%2520with%2520advance%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1775%26epage%3D1782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Sydor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pien, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grenier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dembski, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penders, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grayzel, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palombella, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, J. K.</span><span> </span><span class="NLM_article-title">Development of 17-allylamino-17-dimethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">17408</span><span class="NLM_x">â</span> <span class="NLM_lpage">17413</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=17408-17413&author=J.+R.+Sydorauthor=E.+Normantauthor=C.+S.+Pienauthor=J.+R.+Porterauthor=J.+Geauthor=L.+Grenierauthor=R.+H.+Pakauthor=J.+A.+Aliauthor=M.+S.+Dembskiauthor=J.+Hudakauthor=J.+Pattersonauthor=C.+Pendersauthor=M.+Pinkauthor=M.+A.+Readauthor=J.+Sangauthor=C.+Woodwardauthor=Y.+Zhangauthor=D.+S.+Grayzelauthor=J.+Wrightauthor=J.+A.+Barrettauthor=V.+J.+Palombellaauthor=J.+Adamsauthor=J.+K.+Tong&title=Development+of+17-allylamino-17-dimethoxygeldanamycin+hydroquinone+hydrochloride+%28IPI-504%29%2C+an+anti-cancer+agent+directed+against+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSydor%26aufirst%3DJ.%2BR.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DPien%26aufirst%3DC.%2BS.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DGrenier%26aufirst%3DL.%26aulast%3DPak%26aufirst%3DR.%2BH.%26aulast%3DAli%26aufirst%3DJ.%2BA.%26aulast%3DDembski%26aufirst%3DM.%2BS.%26aulast%3DHudak%26aufirst%3DJ.%26aulast%3DPatterson%26aufirst%3DJ.%26aulast%3DPenders%26aufirst%3DC.%26aulast%3DPink%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DM.%2BA.%26aulast%3DSang%26aufirst%3DJ.%26aulast%3DWoodward%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGrayzel%26aufirst%3DD.%2BS.%26aulast%3DWright%26aufirst%3DJ.%26aulast%3DBarrett%26aufirst%3DJ.%2BA.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DJ.%2BK.%26atitle%3DDevelopment%2520of%252017-allylamino-17-dimethoxygeldanamycin%2520hydroquinone%2520hydrochloride%2520%2528IPI-504%2529%252C%2520an%2520anti-cancer%2520agent%2520directed%2520against%2520Hsp90%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D17408%26epage%3D17413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Janin, Y. L.</span><span> </span><span class="NLM_article-title">ATPase inhibitiors of heat shock protein 90, second season</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">â</span> <span class="NLM_lpage">353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=342-353&author=Y.+L.+Janin&title=ATPase+inhibitiors+of+heat+shock+protein+90%2C+second+season"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJanin%26aufirst%3DY.%2BL.%26atitle%3DATPase%2520inhibitiors%2520of%2520heat%2520shock%2520protein%252090%252C%2520second%2520season%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26spage%3D342%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Kasibhatla, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busch, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karjian, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brekken, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grecko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timony, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ran, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansfield, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span> </span><span class="NLM_article-title">Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2767</span><span class="NLM_x">â</span> <span class="NLM_lpage">2778</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050752%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2767-2778&author=S.+R.+Kasibhatlaauthor=K.+Hongauthor=M.+A.+Biamonteauthor=D.+J.+Buschauthor=P.+L.+Karjianauthor=J.+L.+Sensintaffarauthor=A.+Kamalauthor=R.+E.+Loughauthor=J.+Brekkenauthor=K.+Lundgrenauthor=R.+Greckoauthor=G.+A.+Timonyauthor=Y.+Ranauthor=R.+Mansfieldauthor=L.+C.+Fritzauthor=E.+Ulmauthor=F.+J.+Burrowsauthor=M.+F.+Boehm&title=Rationally+designed+high-affinity+2-amino-6-halopurine+heat+shock+protein+90+inhibitors+that+exhibit+potent+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm050752%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050752%252B%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DBusch%26aufirst%3DD.%2BJ.%26aulast%3DKarjian%26aufirst%3DP.%2BL.%26aulast%3DSensintaffar%26aufirst%3DJ.%2BL.%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DLough%26aufirst%3DR.%2BE.%26aulast%3DBrekken%26aufirst%3DJ.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DGrecko%26aufirst%3DR.%26aulast%3DTimony%26aufirst%3DG.%2BA.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DMansfield%26aufirst%3DR.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DUlm%26aufirst%3DE.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26atitle%3DRationally%2520designed%2520high-affinity%25202-amino-6-halopurine%2520heat%2520shock%2520protein%252090%2520inhibitors%2520that%2520exhibit%2520potent%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2767%26epage%3D2778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Huang, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fadden, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eaves, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strachan, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barabasz, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barta, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partridge, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuBois, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freed, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steed, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ommen, A, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCall, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markworth, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinkley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenks, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pronk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verleysen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, S. E.</span><span> </span><span class="NLM_article-title">Discovery of novel 2- aminobenzamide inhibitors of heat shock protein 90 as potent, selective, and orally active antitumor agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4288</span><span class="NLM_x">â</span> <span class="NLM_lpage">4305</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900230j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4288-4305&author=K.+H.+Huangauthor=J.+M.+Vealauthor=R.+P.+Faddenauthor=J.+W.+Riceauthor=J.+Eavesauthor=J.-P.+Strachanauthor=A.+F.+Barabaszauthor=B.+E.+Foleyauthor=T.+E.+Bartaauthor=W.+Maauthor=M.+A.+Silinskiauthor=M.+Huauthor=J.+M.+Partridgeauthor=A.+Scottauthor=L.+G.+DuBoisauthor=T.+Freedauthor=P.+M.+Steedauthor=A%2C+J.+Ommenauthor=E.+D.+Smithauthor=P.+F.+Hughesauthor=A.+R.+Woodwardauthor=G.+J.+Hansonauthor=W.+S.+McCallauthor=C.+J.+Markworthauthor=L.+Hinkleyauthor=M.+Jenksauthor=L.+Gengauthor=M.+Lewisauthor=J.+Ottoauthor=B.+Pronkauthor=K.+Verleysenauthor=S.+E.+Hall&title=Discovery+of+novel+2-+aminobenzamide+inhibitors+of+heat+shock+protein+90+as+potent%2C+selective%2C+and+orally+active+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm900230j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900230j%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DK.%2BH.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DFadden%26aufirst%3DR.%2BP.%26aulast%3DRice%26aufirst%3DJ.%2BW.%26aulast%3DEaves%26aufirst%3DJ.%26aulast%3DStrachan%26aufirst%3DJ.-P.%26aulast%3DBarabasz%26aufirst%3DA.%2BF.%26aulast%3DFoley%26aufirst%3DB.%2BE.%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DSilinski%26aufirst%3DM.%2BA.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DPartridge%26aufirst%3DJ.%2BM.%26aulast%3DScott%26aufirst%3DA.%26aulast%3DDuBois%26aufirst%3DL.%2BG.%26aulast%3DFreed%26aufirst%3DT.%26aulast%3DSteed%26aufirst%3DP.%2BM.%26aulast%3DOmmen%26aufirst%3DA%252C%2BJ.%26aulast%3DSmith%26aufirst%3DE.%2BD.%26aulast%3DHughes%26aufirst%3DP.%2BF.%26aulast%3DWoodward%26aufirst%3DA.%2BR.%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DMcCall%26aufirst%3DW.%2BS.%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26aulast%3DHinkley%26aufirst%3DL.%26aulast%3DJenks%26aufirst%3DM.%26aulast%3DGeng%26aufirst%3DL.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DOtto%26aufirst%3DJ.%26aulast%3DPronk%26aufirst%3DB.%26aulast%3DVerleysen%26aufirst%3DK.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DDiscovery%2520of%2520novel%25202-%2520aminobenzamide%2520inhibitors%2520of%2520heat%2520shock%2520protein%252090%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4288%26epage%3D4305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgognoni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N. G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fromont, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padfield, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radimerski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepfer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmonite, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walls, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span> </span><span class="NLM_article-title">Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-<i>d</i>]pyrimidine inhibitors of the Hsp90 molecular chaperone</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4794</span><span class="NLM_x">â</span> <span class="NLM_lpage">4809</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900357y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1ehsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4794-4809&author=P.+A.+Broughauthor=X.+Barrilauthor=J.+Borgognoniauthor=P.+Cheneauthor=N.+G.+M.+Daviesauthor=B.+Davisauthor=M.+J.+Drysdaleauthor=B.+Dymockauthor=S.+A.+Ecclesauthor=C.+Garcia-Echeverriaauthor=C.+Fromontauthor=A.+Hayesauthor=R.+E.+Hubbardauthor=A.+M.+Jordanauthor=M.+R.+Jensenauthor=A.+Masseyauthor=A.+Merrettauthor=A.+Padfieldauthor=R.+Parsonsauthor=T.+Radimerskiauthor=F.+I.+Raynaudauthor=A.+Robertsonauthor=S.+D.+Roughleyauthor=J.+Schoepferauthor=H.+Simmoniteauthor=S.+Y.+Sharpauthor=A.+Surgenorauthor=M.+Valentiauthor=S.+Wallsauthor=P.+Webbauthor=M.+Woodauthor=P.+Workmanauthor=L.+Wright&title=Combining+hit+identification+strategies%3A+fragment-based+and+in+silico+approaches+to+orally+active+2-aminothieno%5B2%2C3-d%5Dpyrimidine+inhibitors+of+the+Hsp90+molecular+chaperone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-d]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone</span></div><div class="casAuthors">Brough, Paul A.; Barril, Xavier; Borgognoni, Jenifer; Chene, Patrick; Davies, Nicholas G. M.; Davis, Ben; Drysdale, Martin J.; Dymock, Brian; Eccles, Suzanne A.; Garcia-Echeverria, Carlos; Fromont, Christophe; Hayes, Angela; Hubbard, Roderick E.; Jordan, Allan M.; Jensen, Michael Rugaard; Massey, Andrew; Merrett, Angela; Padfield, Antony; Parsons, Rachel; Radimerski, Thomas; Raynaud, Florence I.; Robertson, Alan; Roughley, Stephen D.; Schoepfer, Joseph; Simmonite, Heather; Sharp, Swee Y.; Surgenor, Allan; Valenti, Melanie; Walls, Steven; Webb, Paul; Wood, Mike; Workman, Paul; Wright, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4794-4809</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the Hsp90 mol. chaperone are showing considerable promise as potential mol. therapeutic agents for the treatment of cancer.  Here we describe novel 2-aminothieno[2,3-d]pyrimidine ATP competitive Hsp90 inhibitors, which were designed by combining structural elements of distinct low affinity hits generated from fragment-based and in silico screening exercises in concert with structural information from X-ray protein crystallog.  Examples from this series have high affinity (IC50 = 50-100 nM) for Hsp90 as measured in a fluorescence polarization (FP) competitive binding assay and are active in human cancer cell lines where they inhibit cell proliferation and exhibit a characteristic profile of depletion of oncogenic proteins and concomitant elevation of Hsp72.  Several compds. caused tumor growth regression at well tolerated doses when administered orally in a human BT474 human breast cancer xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqofpAier7tW7Vg90H21EOLACvtfcHk0lhQ5XBIbLCpmg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1ehsbs%253D&md5=4d1988060b0f87dc776e1972ea14808e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm900357y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900357y%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DDavies%26aufirst%3DN.%2BG.%2BM.%26aulast%3DDavis%26aufirst%3DB.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26aulast%3DFromont%26aufirst%3DC.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMerrett%26aufirst%3DA.%26aulast%3DPadfield%26aufirst%3DA.%26aulast%3DParsons%26aufirst%3DR.%26aulast%3DRadimerski%26aufirst%3DT.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobertson%26aufirst%3DA.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DSchoepfer%26aufirst%3DJ.%26aulast%3DSimmonite%26aufirst%3DH.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWalls%26aufirst%3DS.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26atitle%3DCombining%2520hit%2520identification%2520strategies%253A%2520fragment-based%2520and%2520in%2520silico%2520approaches%2520to%2520orally%2520active%25202-aminothieno%255B2%252C3-d%255Dpyrimidine%2520inhibitors%2520of%2520the%2520Hsp90%2520molecular%2520chaperone%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4794%26epage%3D4809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Hopkins, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groome, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">â</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm200128m&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm200128m&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=L.+A.+Hopkinsauthor=C.+R.+Groomeauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eZeQF98raOaybntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DL.%2BA.%26aulast%3DGroome%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lesson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">â</span> <span class="NLM_lpage">890</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Lessonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLesson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid assessment of a novel series of selective CB<sub>2</sub> agonists using parallel synthesis protocols: a lipophilic efficiency (LipE) analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4406</span><span class="NLM_x">â</span> <span class="NLM_lpage">4409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=16&amp;doi=10.1021%2Fjm200128m&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=8&amp;doi=10.1021%2Fjm200128m&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+assessment+of+a+novel+series+of+selective+CB2+agonists+using+parallel+synthesis+protocols%3A+a+lipophilic+efficiency+%28LipE%29+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0liQ6IHU1CIG2A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520assessment%2520of%2520a%2520novel%2520series%2520of%2520selective%2520CB2%2520agonists%2520using%2520parallel%2520synthesis%2520protocols%253A%2520a%2520lipophilic%2520efficiency%2520%2528LipE%2529%2520analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4406%26epage%3D4409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Sides, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leschinger, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walenta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNay, J. L.,  Jr.</span><span> </span><span class="NLM_article-title">The tolerability and adverse event profile of moxonidine</span> <span class="citation_source-journal">Rev. Contemp. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">â</span> <span class="NLM_lpage">499</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A528%3ADyaK1cXlvVans7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1998&pages=491-499&author=G.+D.+Sidesauthor=M.+I.+Leschingerauthor=R.+Walentaauthor=J.+L.+McNay&title=The+tolerability+and+adverse+event+profile+of+moxonidine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The tolerability and adverse event profile of moxonidine</span></div><div class="casAuthors">Sides, Gregory D.; Leschinger, Monika I.; Walenta, Rainer; McNay, John L., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in Contemporary Pharmacotherapy</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">491-499</span>CODEN:
                <span class="NLM_cas:coden">RCPHFW</span>;
        ISSN:<span class="NLM_cas:issn">0954-8602</span>.
    
            (<span class="NLM_cas:orgname">Marius Press</span>)
        </div><div class="casAbstract">A review with 24 refs.  Moxonidine, an orally-administered antihypertensive drug, is a selective imidazoline I1-receptor agonist.  The human safety database for moxonidine is extensive.  Adverse events obsd. are well recognized, dose-related and benign.  The most common adverse events reported by patients taking moxonidine for blood pressure control include dry mouth, somnolence and headache.  These symptoms often subside during the first few weeks of treatment.  Less common adverse events include dizziness, peripheral edema, nausea, back pain, abdominal pain, vasodilatation and rash.  Moxonidine administration is well tolerated over a broad dose range and a documented treatment duration in long-term studies of up to 2 yr.  The greater the duration of moxonidine treatment, the less the incidence and severity of adverse events.  The likelihood of serious and potentially life-threatening adverse events is very low.  Rebound hypertension following discontinuation of moxonidine at the currently approved doses is not obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXYNf3N7MvELVg90H21EOLACvtfcHk0liQ6IHU1CIG2A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlvVans7w%253D&md5=0df8d2a595ac1134b2bd9d961d351bd8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSides%26aufirst%3DG.%2BD.%26aulast%3DLeschinger%26aufirst%3DM.%2BI.%26aulast%3DWalenta%26aufirst%3DR.%26aulast%3DMcNay%26aufirst%3DJ.%2BL.%26atitle%3DThe%2520tolerability%2520and%2520adverse%2520event%2520profile%2520of%2520moxonidine%26jtitle%3DRev.%2520Contemp.%2520Pharmacother.%26date%3D1998%26volume%3D9%26spage%3D491%26epage%3D499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Kung, P.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digits, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaptason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neul, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zientek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elleraas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, M.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajiwala, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehring, M. R.</span><span> </span><span class="NLM_article-title">Dihydroxyphenylisoindoline amides as orally bioavailable inhibitors of the heat shock protein 90 (Hsp90) molecular chaperone</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">â</span> <span class="NLM_lpage">503</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901209q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=499-503&author=P.-P.+Kungauthor=B.+Huangauthor=G.+Zhangauthor=J.+Z.+Zhouauthor=J.+Wangauthor=J.+A.+Digitsauthor=J.+Skaptasonauthor=S.+Yamazakiauthor=D.+Neulauthor=M.+Zientekauthor=J.+Elleraasauthor=P.+Mehtaauthor=M.-J.+Yinauthor=M.+J.+Hickeyauthor=K.+S.+Gajiwalaauthor=C.+Rodgersauthor=J.+F.+Daviesauthor=M.+R.+Gehring&title=Dihydroxyphenylisoindoline+amides+as+orally+bioavailable+inhibitors+of+the+heat+shock+protein+90+%28Hsp90%29+molecular+chaperone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm901209q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901209q%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DZhou%26aufirst%3DJ.%2BZ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDigits%26aufirst%3DJ.%2BA.%26aulast%3DSkaptason%26aufirst%3DJ.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DNeul%26aufirst%3DD.%26aulast%3DZientek%26aufirst%3DM.%26aulast%3DElleraas%26aufirst%3DJ.%26aulast%3DMehta%26aufirst%3DP.%26aulast%3DYin%26aufirst%3DM.-J.%26aulast%3DHickey%26aufirst%3DM.%2BJ.%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DRodgers%26aufirst%3DC.%26aulast%3DDavies%26aufirst%3DJ.%2BF.%26aulast%3DGehring%26aufirst%3DM.%2BR.%26atitle%3DDihydroxyphenylisoindoline%2520amides%2520as%2520orally%2520bioavailable%2520inhibitors%2520of%2520the%2520heat%2520shock%2520protein%252090%2520%2528Hsp90%2529%2520molecular%2520chaperone%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D499%26epage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Mehta, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walls, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehring, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, M.-J.</span><span> </span><span class="NLM_article-title">A novel class of specific Hsp90 small molecule inhibitors demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">300</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">â</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm200128m&amp;key=10.1016%2Fj.canlet.2010.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm200128m&amp;key=20926183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGns7%252FK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=2011&pages=30-39&author=P.+P.+Mehtaauthor=P.-P.+Kungauthor=S.+Yamazakiauthor=M.+Wallsauthor=A.+Shenauthor=L.+Nguyenauthor=M.+Gehringauthor=G.+Losauthor=T.+Smealauthor=M.-J.+Yin&title=A+novel+class+of+specific+Hsp90+small+molecule+inhibitors+demonstrate+in+vitro+and+in+vivo+anti-tumor+activity+in+human+melanoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A novel class of specific Hsp90 small molecule inhibitors demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells</span></div><div class="casAuthors">Mehta, Pramod P.; Kung, Pei-Pei; Yamazaki, Shinji; Walls, Marlena; Shen, Andrea; Nguyen, Leslie; Gehring, Michael R.; Los, Gerrit; Smeal, Tod; Yin, Min-Jean</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">300</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-39</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Hsp90 is required for conformational maturation and stability of numerous key signaling proteins (clients) involved in cell proliferation and transformation.  Here we describe 2 novel Hsp90 inhibitors, PF-4470296 and PF-3823863, demonstrate a differential sensitivity in B-Raf mutant (V600E) vs. wild-type protein degrdn.  These 2 inhibitors inhibit proliferation and anchorage-independent growth, and abolish in vivo xenograft tumor growth in melanoma cells regardless of B-Raf mutation status.  Mutant B-Raf protein and other Hsp90 clients, such as cMet, ErbB2, C-Raf, and AKT, are degraded in cells and xenograft tumors.  Our results indicate that Hsp90 inhibitors induce anti-tumor activity in melanoma cells and are likely to show therapeutic benefit in melanoma patients by collaboratively targeting multiple pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNMSNEVcm2SrVg90H21EOLACvtfcHk0lita1iKeHNbcQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGns7%252FK&md5=ed606cba29eb6ac9acc90f0ebf715c10</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2010.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2010.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DMehta%26aufirst%3DP.%2BP.%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DWalls%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DGehring%26aufirst%3DM.%26aulast%3DLos%26aufirst%3DG.%26aulast%3DSmeal%26aufirst%3DT.%26aulast%3DYin%26aufirst%3DM.-J.%26atitle%3DA%2520novel%2520class%2520of%2520specific%2520Hsp90%2520small%2520molecule%2520inhibitors%2520demonstrate%2520in%2520vitro%2520and%2520in%2520vivo%2520anti-tumor%2520activity%2520in%2520human%2520melanoma%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2011%26volume%3D300%26spage%3D30%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Diaz, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitza, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gintant, G. A.</span><span> </span><span class="NLM_article-title">The [<sup>3</sup>H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: comparison of intact cell and membrane preparations and effects of altering [K<sup>+</sup>]<sub>o</sub></span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">â</span> <span class="NLM_lpage">199</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm200128m&amp;key=10.1016%2Fj.vascn.2004.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm200128m&amp;key=15519905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFOmtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2004&pages=187-199&author=G.+J.+Diazauthor=K.+Daniellauthor=S.+T.+Leitzaauthor=R.+L.+Martinauthor=Z.+Suauthor=J.+S.+McDermottauthor=B.+F.+Coxauthor=G.+A.+Gintant&title=The+%5B3H%5Ddofetilide+binding+assay+is+a+predictive+screening+tool+for+hERG+blockade+and+proarrhythmia%3A+comparison+of+intact+cell+and+membrane+preparations+and+effects+of+altering+%5BK%2B%5Do"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o</span></div><div class="casAuthors">Diaz, Gilbert J.; Daniell, Katina; Leitza, Sandra T.; Martin, Ruth L.; Su, Zhi; McDermott, Jeffrey S.; Cox, Bryan F.; Gintant, Gary A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-199</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: The human ether-a-go-go-related gene (hERG) encodes a potassium channel responsible for the cardiac delayed rectifier current (IKr) involved in ventricular repolarization.  Drugs that block hERG have been assocd. with QT interval prolongation and serious, sometimes fatal, cardiac arrhythmias (including torsade de pointes).  While displacement of [3H]dofetilide, a potent methanesulfonanilide hERG blocker, from cells heterologously expressing hERG has been suggested as a screening assay, questions have been raised about its predictive value.Methods: To validate the utility of this assay as a screening tool, we performed a series of satn. and competition binding studies using [3H]dofetilide as ligand and either intact cells or membrane prepns. from HEK 293 cells stably transfected with hERG K+ channels.  The object of these expts. was to (1) compare binding Ki values for 22 hERG blockers using intact cells or membrane homogenates to det. whether maintaining cell integrity enhanced assay reliability; (2) evaluate the ability of different K+ concns. (2, 5, 10, 20, and 60 mM) to modulate hERG binding; and (3) to establish the predictive value of the assay by comparing Ki values from binding studies at 5 and 60 mM [K+]o to functional IC50 values for hERG current block using 56 structurally diverse drugs.Results: We found (a) comparable Ki values in the intact cell and isolated membrane binding assays, although there were some differences in rank order; (b) increasing [K+]o lowered the Kd and increased the Bmax for [3H]dofetilide, particularly in the membrane assay; and (c) good correlation between binding Ki values and functional IC50 values for hERG current block.Discussion: In conclusion, increasing K+ concns. results in an increase in both [3H]dofetilide affinity for hERG and available binding sites, particularly when using membrane homogenates.  There are no meaningful differences between Ki values when comparing intact cell vs. membrane assay, neither are there meaningful trends with increasing [K+]o within assays.  There is good correlation between binding Ki values and functional (whole-cell patch clamp) IC50 values at both 5 and 60 mM K+ concns. (R2 values of .824 and .863, resp.).  The simplicity, predictability, and adaptability to high-throughput platforms make the [3H]dofetilide membrane binding assay a useful tool for screening and ranking compds. for their potential to block the hERG K+ channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJEs_DWLzvI7Vg90H21EOLACvtfcHk0lhnLGAsgtmSHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFOmtLk%253D&md5=28c925ef02404c53443dc90eae961ed1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2004.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2004.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DDiaz%26aufirst%3DG.%2BJ.%26aulast%3DDaniell%26aufirst%3DK.%26aulast%3DLeitza%26aufirst%3DS.%2BT.%26aulast%3DMartin%26aufirst%3DR.%2BL.%26aulast%3DSu%26aufirst%3DZ.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DCox%26aufirst%3DB.%2BF.%26aulast%3DGintant%26aufirst%3DG.%2BA.%26atitle%3DThe%2520%255B3H%255Ddofetilide%2520binding%2520assay%2520is%2520a%2520predictive%2520screening%2520tool%2520for%2520hERG%2520blockade%2520and%2520proarrhythmia%253A%2520comparison%2520of%2520intact%2520cell%2520and%2520membrane%2520preparations%2520and%2520effects%2520of%2520altering%2520%255BK%252B%255Do%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2004%26volume%3D50%26spage%3D187%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Kreusch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesley, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, X.-J.</span><span> </span><span class="NLM_article-title">Crystal structures of human Hsp90a-complexed with dihydroxyphenylprazoles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1475</span><span class="NLM_x">â</span> <span class="NLM_lpage">1478</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1475-1478&author=A.+Kreuschauthor=S.+Hanauthor=A.+Brinkerauthor=V.+Zhouauthor=H.-S.+Choiauthor=Y.+Heauthor=S.+A.+Lesleyauthor=J.+Caldwellauthor=X.-J.+Gu&title=Crystal+structures+of+human+Hsp90a-complexed+with+dihydroxyphenylprazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKreusch%26aufirst%3DA.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DBrinker%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DV.%26aulast%3DChoi%26aufirst%3DH.-S.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLesley%26aufirst%3DS.%2BA.%26aulast%3DCaldwell%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DX.-J.%26atitle%3DCrystal%2520structures%2520of%2520human%2520Hsp90a-complexed%2520with%2520dihydroxyphenylprazoles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1475%26epage%3D1478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">van Breeman, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span> </span><span class="NLM_article-title">Caco-2 cell permeability assays to measure drug absorption</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">â</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm200128m&amp;key=10.1517%2F17425255.1.2.175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm200128m&amp;key=16922635" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2005&pages=175-185&author=R.+B.+van+Breemanauthor=Y.+Li&title=Caco-2+cell+permeability+assays+to+measure+drug+absorption"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1517%2F17425255.1.2.175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.1.2.175%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BBreeman%26aufirst%3DR.%2BB.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DCaco-2%2520cell%2520permeability%2520assays%2520to%2520measure%2520drug%2520absorption%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2005%26volume%3D1%26spage%3D175%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Tseng, G. N. Ikr</span><span> </span><span class="NLM_article-title">The hERG channel</span> <span class="citation_source-journal">J. Mol. Cell. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">â</span> <span class="NLM_lpage">849</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm200128m&amp;key=10.1006%2Fjmcc.2000.1317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm200128m&amp;key=11343409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm200128m&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtlSlur0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2001&pages=835-849&author=G.+N.+Ikr+Tseng&title=The+hERG+channel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">IKr: The hERG Channel</span></div><div class="casAuthors">Tseng, Gea-Ny</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">835-849</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review with 127 refs.  The rapid delayed rectifier (IKr) channel is important for cardiac action potential repolarization.  Suppressing IKr function, due to either genetic defects in its pore-forming subunit (hERG) or adverse drug effects, can lead to long-QT (LQT) syndrome that carries increased risk of life-threatening arrhythmias.  The implication of IKr in cardiac arrhythmias and in anti-arrhythmic/pro-arrhythmic actions of drugs has driven intensive research interests in its structure-function relationship, the linkage between LQT-assocd. mutations and changes in channel function, and the mechanism of drug actions.  This review will cover the following topics: (1) heterogeneous contribution of IKr to action potential repolarization in the heart, (2) structure-function relationship of IKr/hERG channels, (3) role of regulatory Î²-subunits in IKr/hERG channel function, (4) structural basis for the unique pharmacol. properties of IKr/hERG channels, and (5) IKr/hERG channel modulation by changes in cellular milieu under physiol. and pathol. conditions of the heart.  It is anticipated that further advances in our understanding of IKr/hERG, particularly in the areas of roles of different (Î± and Î²) subunits in native IKr function, alterations in IKr function in diseased hearts, and the 3-dimensional structure of the IKr/hERG pore based on homol. modeling using the KcsA model, will help us better define the role of IKr in arrhythmias and design therapeutic agents that can increase IKr and are useful for LQT syndrome.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosJF3FMau7lrVg90H21EOLACvtfcHk0linvRhqAAP-ZA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtlSlur0%253D&md5=8ac2a68a42a07e396ad06d68c3a5abad</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1006%2Fjmcc.2000.1317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmcc.2000.1317%26sid%3Dliteratum%253Aachs%26aulast%3DTseng%26aufirst%3DG.%2BN.%2BIkr%26atitle%3DThe%2520hERG%2520channel%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2001%26volume%3D33%26spage%3D835%26epage%3D849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Giuliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jairaj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zafiu, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span> </span><span class="NLM_article-title">Direct determination of unbound intrinsic drug clearance in the microsomal stability assay</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1319</span><span class="NLM_x">â</span> <span class="NLM_lpage">1324</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=1319-1324&author=C.+Giulianoauthor=M.+Jairajauthor=C.+M.+Zafiuauthor=R.+Laufer&title=Direct+determination+of+unbound+intrinsic+drug+clearance+in+the+microsomal+stability+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DJairaj%26aufirst%3DM.%26aulast%3DZafiu%26aufirst%3DC.%2BM.%26aulast%3DLaufer%26aufirst%3DR.%26atitle%3DDirect%2520determination%2520of%2520unbound%2520intrinsic%2520drug%2520clearance%2520in%2520the%2520microsomal%2520stability%2520assay%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D1319%26epage%3D1324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgognoni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.-M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N. G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northfield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walmsley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span> </span><span class="NLM_article-title">4,5-Diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">â</span> <span class="NLM_lpage">218</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701018h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=196-218&author=P.+A.+Broughauthor=W.+Aherneauthor=X.+Barrilauthor=J.+Borgognoniauthor=K.+Boxallauthor=J.+E.+Cansfieldauthor=K.-M.+J.+Cheungauthor=I.+Collinsauthor=N.+G.+M.+Daviesauthor=M.+Drysdaleauthor=B.+Dymockauthor=S.+A.+Ecclesauthor=H.+Finchauthor=A.+Finkauthor=A.+Hayesauthor=R.+Howesauthor=R.+E.+Hubbardauthor=K.+Jamesauthor=A.+M.+Jordanauthor=A.+Lockieauthor=V.+Martinsauthor=A.+Masseyauthor=T.+P.+Matthewsauthor=E.+McDonaldauthor=C.+J.+Northfieldauthor=L.+H.+Pearlauthor=C.+Prodromouauthor=S.+Rayauthor=F.+I.+Raynaudauthor=S.+D.+Roughleyauthor=S.+Y.+Sharpauthor=A.+Surgenorauthor=D.+L.+Walmsleyauthor=P.+Webbauthor=M.+Woodauthor=P.+Workmanauthor=L.+Wright&title=4%2C5-Diarylisoxazole+Hsp90+chaperone+inhibitors%3A+potential+therapeutic+agents+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm701018h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701018h%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DDavies%26aufirst%3DN.%2BG.%2BM.%26aulast%3DDrysdale%26aufirst%3DM.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFinch%26aufirst%3DH.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DLockie%26aufirst%3DA.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWalmsley%26aufirst%3DD.%2BL.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26atitle%3D4%252C5-Diarylisoxazole%2520Hsp90%2520chaperone%2520inhibitors%253A%2520potential%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D196%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Chessari, G.; Congreve, M. S.; Callaghan, O.; Cowan, S. R.; Murray, C. W.; Woolford, A. J.-A.; OâBrien, M. A.; Woodhead, A. J.</span> PCT Int. Appl. 2006123165,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chessari%2C+G.%3B+Congreve%2C+M.+S.%3B+Callaghan%2C+O.%3B+Cowan%2C+S.+R.%3B+Murray%2C+C.+W.%3B+Woolford%2C+A.+J.-A.%3B+O%E2%80%99Brien%2C+M.+A.%3B+Woodhead%2C+A.+J.+PCT+Int.+Appl.+2006123165%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChessari%26aufirst%3DG.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Hossain, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timberlake, J. W.</span><span> </span><span class="NLM_article-title">Synthesis of bisbicyclo[1.1.1]pentyldiazene. The smallest bridgehead diazene</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">6282</span><span class="NLM_x">â</span> <span class="NLM_lpage">6285</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo010212u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=6282-6285&author=M.+T.+Hossainauthor=J.+W.+Timberlake&title=Synthesis+of+bisbicyclo%5B1.1.1%5Dpentyldiazene.+The+smallest+bridgehead+diazene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjo010212u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo010212u%26sid%3Dliteratum%253Aachs%26aulast%3DHossain%26aufirst%3DM.%2BT.%26aulast%3DTimberlake%26aufirst%3DJ.%2BW.%26atitle%3DSynthesis%2520of%2520bisbicyclo%255B1.1.1%255Dpentyldiazene.%2520The%2520smallest%2520bridgehead%2520diazene%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D6282%26epage%3D6285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Dow, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpino, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadcock, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iredale, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaSilva-Jardine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paight, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâConnor, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nduaka, C. I.</span><span> </span><span class="NLM_article-title">Discovery of 2-(2-chlorophenyl)-3-(4-chlorophenyl)-7-(2,2-difluoropropyl)-6,7-dihydro-2<i>H</i>-pyrazolo[3,4-<i>f</i>][1,4]oxazepin-8-(5<i>H</i>)-one (PF-514273), a novel, bicyclic lactam-based cannabinoid-1 receptor antagonist for the treatment of obesity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2652</span><span class="NLM_x">â</span> <span class="NLM_lpage">2655</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900255t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2652-2655&author=R.+L.+Dowauthor=P.+A.+Carpinoauthor=J.+R.+Hadcockauthor=S.+C.+Blackauthor=P.+A.+Iredaleauthor=P.+DaSilva-Jardineauthor=S.+R.+Schneiderauthor=E.+S.+Paightauthor=D.+A.+Griffithauthor=D.+O.+Scottauthor=R.+E.+O%E2%80%99Connorauthor=C.+I.+Nduaka&title=Discovery+of+2-%282-chlorophenyl%29-3-%284-chlorophenyl%29-7-%282%2C2-difluoropropyl%29-6%2C7-dihydro-2H-pyrazolo%5B3%2C4-f%5D%5B1%2C4%5Doxazepin-8-%285H%29-one+%28PF-514273%29%2C+a+novel%2C+bicyclic+lactam-based+cannabinoid-1+receptor+antagonist+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm900255t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900255t%26sid%3Dliteratum%253Aachs%26aulast%3DDow%26aufirst%3DR.%2BL.%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26aulast%3DHadcock%26aufirst%3DJ.%2BR.%26aulast%3DBlack%26aufirst%3DS.%2BC.%26aulast%3DIredale%26aufirst%3DP.%2BA.%26aulast%3DDaSilva-Jardine%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DS.%2BR.%26aulast%3DPaight%26aufirst%3DE.%2BS.%26aulast%3DGriffith%26aufirst%3DD.%2BA.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%2BE.%26aulast%3DNduaka%26aufirst%3DC.%2BI.%26atitle%3DDiscovery%2520of%25202-%25282-chlorophenyl%2529-3-%25284-chlorophenyl%2529-7-%25282%252C2-difluoropropyl%2529-6%252C7-dihydro-2H-pyrazolo%255B3%252C4-f%255D%255B1%252C4%255Doxazepin-8-%25285H%2529-one%2520%2528PF-514273%2529%252C%2520a%2520novel%252C%2520bicyclic%2520lactam-based%2520cannabinoid-1%2520receptor%2520antagonist%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2652%26epage%3D2655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">McHugh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proctor, G. R.</span><span> </span><span class="NLM_article-title">Ring expansion of some heterocyclic Î²-keto esters with dimethyl acetylenedicarboxylate. Part 2. Synthesis of azepine, azocine, benzazocine, and benzazonine derivatives</span> <span class="citation_source-journal">J. Chem. Res., Miniprint</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_fpage">2230</span><span class="NLM_x">â</span> <span class="NLM_lpage">2253</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1984&pages=2230-2253&author=M.+McHughauthor=G.+R.+Proctor&title=Ring+expansion+of+some+heterocyclic+%CE%B2-keto+esters+with+dimethyl+acetylenedicarboxylate.+Part+2.+Synthesis+of+azepine%2C+azocine%2C+benzazocine%2C+and+benzazonine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcHugh%26aufirst%3DM.%26aulast%3DProctor%26aufirst%3DG.%2BR.%26atitle%3DRing%2520expansion%2520of%2520some%2520heterocyclic%2520%25CE%25B2-keto%2520esters%2520with%2520dimethyl%2520acetylenedicarboxylate.%2520Part%25202.%2520Synthesis%2520of%2520azepine%252C%2520azocine%252C%2520benzazocine%252C%2520and%2520benzazonine%2520derivatives%26jtitle%3DJ.%2520Chem.%2520Res.%252C%2520Miniprint%26date%3D1984%26spage%3D2230%26epage%3D2253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Lau, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppesen, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimvall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohlweg, R.</span><span> </span><span class="NLM_article-title">Ureas with histamine H3-antagonist receptor activityâa new scaffold discovered by lead-hopping from cinnamic acid amides</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5303</span><span class="NLM_x">â</span> <span class="NLM_lpage">5308</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5303-5308&author=J.+F.+Lauauthor=C.+B.+Jeppesenauthor=K.+Rimvallauthor=R.+Hohlweg&title=Ureas+with+histamine+H3-antagonist+receptor+activity%E2%80%94a+new+scaffold+discovered+by+lead-hopping+from+cinnamic+acid+amides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DJ.%2BF.%26aulast%3DJeppesen%26aufirst%3DC.%2BB.%26aulast%3DRimvall%26aufirst%3DK.%26aulast%3DHohlweg%26aufirst%3DR.%26atitle%3DUreas%2520with%2520histamine%2520H3-antagonist%2520receptor%2520activity%25E2%2580%2594a%2520new%2520scaffold%2520discovered%2520by%2520lead-hopping%2520from%2520cinnamic%2520acid%2520amides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5303%26epage%3D5308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Blaszykowski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aktoudianakis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bressy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberico, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lautens, M.</span><span> </span><span class="NLM_article-title">Preparation of annulated nitrogen-containing heterocycles via a one-pot palladium-catalyzed alkylation/direct arylation sequence</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2043</span><span class="NLM_x">â</span> <span class="NLM_lpage">2045</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol060447y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=2043-2045&author=C.+Blaszykowskiauthor=E.+Aktoudianakisauthor=C.+Bressyauthor=D.+Albericoauthor=M.+Lautens&title=Preparation+of+annulated+nitrogen-containing+heterocycles+via+a+one-pot+palladium-catalyzed+alkylation%2Fdirect+arylation+sequence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fol060447y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol060447y%26sid%3Dliteratum%253Aachs%26aulast%3DBlaszykowski%26aufirst%3DC.%26aulast%3DAktoudianakis%26aufirst%3DE.%26aulast%3DBressy%26aufirst%3DC.%26aulast%3DAlberico%26aufirst%3DD.%26aulast%3DLautens%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520annulated%2520nitrogen-containing%2520heterocycles%2520via%2520a%2520one-pot%2520palladium-catalyzed%2520alkylation%252Fdirect%2520arylation%2520sequence%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D2043%26epage%3D2045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">England, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, L.</span><span> </span><span class="NLM_article-title">An improved synthesis of a novel Î±<sub>1A</sub> partial agonist including a new two-step synthesis of 4-fluoropyrazole</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2849</span><span class="NLM_x">â</span> <span class="NLM_lpage">2851</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=2849-2851&author=K.+Englandauthor=H.+Masonauthor=R.+Osborneauthor=L.+Roberts&title=An+improved+synthesis+of+a+novel+%CE%B11A+partial+agonist+including+a+new+two-step+synthesis+of+4-fluoropyrazole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEngland%26aufirst%3DK.%26aulast%3DMason%26aufirst%3DH.%26aulast%3DOsborne%26aufirst%3DR.%26aulast%3DRoberts%26aufirst%3DL.%26atitle%3DAn%2520improved%2520synthesis%2520of%2520a%2520novel%2520%25CE%25B11A%2520partial%2520agonist%2520including%2520a%2520new%2520two-step%2520synthesis%2520of%25204-fluoropyrazole%26jtitle%3DTetrahedron%2520Lett.%26date%3D2010%26volume%3D51%26spage%3D2849%26epage%3D2851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3R4M" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3R4M','PDB','3R4M'); return false;">PDB: 3R4M</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3R4N" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3R4N','PDB','3R4N'); return false;">PDB: 3R4N</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3R4O" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3R4O','PDB','3R4O'); return false;">PDB: 3R4O</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3R4P" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3R4P','PDB','3R4P'); return false;">PDB: 3R4P</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i64"><a href="/doi/suppl/10.1021/jm200128m">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_03028"></div></div></div></div></div><hr /></hr><p class="last">Experimental details and analytical data for <b>9</b>, <b>10</b>, <b>11</b>, <b>24</b>, <b>25</b>, <b>36</b>, <b>37</b>, <b>61</b>, and <b>63</b>, in vitro enzymatic competitive binding assay, cell assay, in vivo biologicals, and pharmacokinetic experiments. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200128m/suppl_file/jm200128m_si_001.pdf">jm200128m_si_001.pdf (185.75 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm200128m&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm200128m%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-9%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm200128m" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992aaa6ffb3d9a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
